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SUMMARY
The T-helper (Th) cell immune response in mice 
to various alphaviruses and the structural envelope 
(E) glycoproteins El and E2 of Venezuelan equine 
encephalitis (VEE) TC-83 virus was investigated. 
Antigens analysed included the structural 
glycoproteins expressed in a recombinant vaccinia- 
VEE virus (TC-5A), sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis separated El and 
E2, and synthetic peptides prepared from the 
extramembranal domain of the E2 and selected regions 
of the El. Subunit peptides, prepared from the 
biologically important amino terminus (amino acids 
[AA] 1-25) of the E2 of VEE Trinidad donkey virus, 
were also analysed. Th cells from spleens of C3H, 
C57BL/6 or BALB/c mice immunized with virus, 
glycoprotein or free peptide and enriched by nylon 
wool chromatography were analysed for recognition of 
antigen in an in vitro lymphoblastogenesis test 
(LBT). The associated antibody response was also 
measured using an indirect enzyme-linked 
immunosorbent assay with the appropriate antigens.
The predominant proliferating cell type in LBTs 
secreted IL-2 and was of the Th-cell phenotype Thy- 
1+, Lyt-1+, 2-, L3T4+. The LBT and antibody 
responses in C3H mice to VEE, western and eastern 
equine encephalitis viruses were primarily virus 
specific. The Th-cell response to the recombinant 
TC-5A virus was similar to that seen with VEE virus. 
VEE virus Th cells recognized both the E2 and El 
glycoproteins in LBT and the glycoproteins were able 
to prime mice for an anamnestic antibody response to 
conformationally dependent B-cell epitopes present 
on the challenge VEE virus. E2 and El synthetic 
peptides defined various immunodominant virus- 
reactive Th-cell epitopes, and genetic restriction 
of the immune response was seen. The subunit 
peptides defined multiple Th- and B-cell elements 
and a dominant Th-cell epitope was found in peptide
• • • 
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S3 (AA 9-19)• The results from this study indicate 
that both the El and E2 glycoproteins contain Th- 
cell epitopes of biological importance and that a 
single residue interchange can alter the expression 
of both Th- and B-cell epitopes.
TABLE OF CONTENTS
Title............................................. i
Summary...................................   ii
Table of Contents..........     iv
Acknowledgments................................. xii
Declaration.............................   xiii
List of Tables.........  xiv
List of Figures............................... .xvii
List of Abbreviations.........  xix
CHAPTER 1:
LITERATURE REVIEW................................. 1
VENEZUELAN EQUINE ENCEPHALOMYELITIS VIRUS.....1
Taxonomy............................      1
Structure and Replication............... 4
Epidemiology............................ 9
Pathogenesis and Virulence............. 10
Vaccines............................... 13
IMMUNOLOGY OF VEE AND RELATED VIRUSES....... 17
Antigenic Structure of the El and E2
Glycoproteins....................... 17
Molecular Correlates of Antigenic
Structure........................... 20
Monoclonal Antibody Analysis of the El
and E2 Glycoproteins.................21
In Vivo Analysis of the Immune
Response.....  .............. 25
Humoral Immune Response................ 28
Cellular Immune Response............... 34
Cross-Protection Among Various
Alphaviruses........................ 41
Summary of the Alphavirus Immune
Response............................ 44
IMMUNOLOGY OF THE MURINE TH-CELL IMMUNE
RESPONSE.................................... 46
-v-
Antigen Presenting Cells and Ligand
Binding............................. 46
Internalization, Processing and
Presentation of Ligands............. 49
Th-Cell Recognition of Class II MHC- 
Peptide Complexes on Antigen 
Presenting Cells: CD4+ Activation
Requirements........................ 54
Th-Cell Subsets........................ 58
In Vitro Analysis of Th-Cell
Activation.......................... 62
Th-Cell Epitopes: Predictive
Algorithms.......................... 63
Th-Cell Epitopes: Structural and
Functional Characteristics.......... 69
Th-Cell Memory......................... 72
Th-Cell Epitopes: Immunodominance........74
Th-Cell Epitopes: Associated Antibody
Response............................ 78
CURRENT APPROACHES FOR VACCINE
DEVELOPMENT.....  81
Immunogen Expression Systems............81
Recombinant Vaccinia Virus
as a Vector......................... 82
Synthetic Peptides as Viral
Vaccines............................ 85
AIMS OF THESIS................................... 89
CHAPTER 2:
MATERIALS AND METHODS. . .......................... 92
CELL CULTURES............................... 92
VIRUSES  ............................... 93
-vi-
PREPARATION OF VEE TC-83 VIRUS El
AND E2 GLYCOPROTEINS..................... 96
COMPUTER ANALYSES........................... 98
SYNTHETIC PEPTIDES......................... 100
MICE AND IMMUNIZATIONS...................   101
ENZYME LINKED IMMUNOSORBENT ASSAY.......... 104
SEROLOGICAL ASSAYS......................... 105
IN VITRO LYMPHOBLASTOGENESIS............... 106
Responder Th cells.................... 106
Antigen Presenting Cells...............108
Lymphoblastogenesis Test.............. 109
ANALYSES OF LBT RESULTS.................... 110
INTERLEUKIN-2 ANALYSIS.................   Ill
PHENOTYPIC ANALYSES.  .................... 112
T-Cell Depletion...................... 112
Flow Cytometry........................ 114
CHAPTER 3:
SPECIFICITY OF THE MURINE TH-CELL IMMUNE
RESPONSE TO VEE AND OTHER ENCEPHALITIC
ALPHAVIRUSES.......................   116
SUMMARY............   116
INTRODUCTION............................... 117
RESULTS......   119
ELISA Analysis of Viruses..............119
Antigen Processing Requirements....... 119
Phenotypes of T Cells..................122
Th-Cell Responses......................125
B-Cell Responses...................... 128
IL-2 Analysis......................... 131
Recognition of VEE Subtype Viruses
by TC-83 Virus Th Cells............ 131
B-Cell Response Following Secondary
Inoculation...............   131
DISCUSSION................................. 134
Specificity of the Th- and B-Cell
Responses.......................... 134
Molecular Correlates of Alphavirus 
Th- and B-Cell Epitope
Specificity........................ 137
Immunological Correlates of Alphavirus 
Th- and B-Cell Epitope
Specificity........................ 138
Significance of Cross-Priming and 
Cross-Protection in Alphavirus 
Immunity...........   139
CHAPTER 4s
MURINE TH-CELL IMMUNE RESPONSE TO RECOMBINANT
VACCINIA VEE TC-83 VIRUS........................ 142
SUMMARY.................................... 142
INTRODUCTION............................... 143
RESULTS.................................... 144
Th-cell Immune Response to VAC,
Recombinant VAC (TC-5A) and TC-83
Viruses............................ 144
IL-2 and Phenotypic Analyses of VAC
and TC-5A Virus-Induced Th Cells....147
Antibody Response to TC-83 Virus.......154
Recognition of VEE Subtype Viruses by
TC-5A virus Th cells and antisera...159
-viii-
DISCUSSION................................. 162
Evaluation of the Th-Cell Immune
Response to TC-5A Virus............ 162
Fidelity of the TC-5A Virus-Induced
Th-Cell Immune Response to the TC-83
Virus Structural Proteins.......... 163
Th-Cell Epitope Relationships Among
the VEE Subtype Viruses............ 164
Potential Efficacy of the TC-5A
Virus as a Vaccine Candidate....... 165
CHAPTER 5:
LYMPHOBLASTOGENIC AND IMMUNOGENIC ANALYSES 
OF THE TH-CELL EPITOPES ON THE El AND E2 
GLYCOPROTEINS OF TC-83 VIRUS.................... 167
SUMMARY.................................... 167
INTRODUCTION............................... 168
RESULTS.......    169
Lymphoblastogenic analysis of the
El and E2 glycoproteins.............169
El and E2 Th-Cell Epitopes Prime Mice 
for an Enhanced Antibody Response 
Following Challenge with TC-83
Virus. ............................ 170
Immunological Evaluation of the El
and E2 Glycoproteins Immobilized on 
Microparticles of Nitrocellulose....178
DISCUSSION...............................   .185
Biological and Functional Relevance 
of the El and E2 Glycoprotein Th-
Cell Epitopes...................... 185
Immunological Appraisal of the El and 
E2 Glycoproteins Immobilized on 
Nitrocellulose......................186
Priming and B-Cell Response
Characteristics of Individual and 
Virion Associated El and E2
Glycoproteins...................... 187
Vaccine Potential of the El and E2
Glycoproteins...................... 189
CHAPTER 6:
TH-CELL ANALYSIS OF SYNTHETIC PEPTIDES OF THE 
E2 AND El GLYCOPROTEINS OF VENEZUELAN EQUINE 
ENCEPHALITIS VIRUS. .  ........................... 190
SUMMARY.................................... 190
INTRODUCTION.  ........................... 192
RESULTS.................................... 194
Prediction of T-Cell Epitopes within 
the E2 and El Sequences of TRD and
TC-83 Viruses...................... 194
Synthetic Peptides.................... 200
Synthetic Peptide Th-Cell Epitope
Analysis in Mice................... 203
Synthetic Peptide B-Cell Response
in Mice............................ 211
Comparative Analyses of Predicted 
Versus Actual Th- and B-Cell 
Epitopes on the Synthetic 
Peptides........................... 214
DISCUSSION................................. 217
Appraisal of T-Cell Epitope
Predictive Algorithms.............. 217
Immunodominant E2 and El Th-Cell
Epitopes........................... 218
B-Cell Response as a Correlate of
Th-Cell Activation................. 221
Effect of a Single Residue Change on
Th- and B-Cell Fine Specificity 222
-X-
CHAPTER 7;
ANALYSIS OF THE TH- AND B-CELL DETERMINANTS
ON A SYNTHETIC PEPTIDE FROM THE AMINO
TERMINUS OF VEE TRD VIRUS THAT INDUCES
PROTECTIVE ANTIBODY IN MICE..................... 225
SUMMARY.................................... 225
INTRODUCTION............................... 227
RESULTS.................................... 229
Synthetic Peptides.................... 229
Th-Cell Epitope Analysis.............. 229
B-Cell Epitope Analysis............... 235
DISCUSSION................................. 237
TRD VE2pep0l and Subunit Peptides
Define Multiple Th-cell Epitopes....237 
B-Cell Response as Related to Th-
Cell Induction..........  241
A Single Amino Acid Defines a B-Cell 
Epitope that may be Important in 
Protection...............   242
CHAPTER 8:
GLOBAL DISCUSSION........    244
Specificity of the VEE Virus Th- and 
B-Cell Responses Following Virus
Inoculation........................ 244
Cross-Help Among El and E2
Glycoprotein-Induced Th Cells...... 245
Priming Characteristics of the El
E2 Glycoproteins................... 246
Development of a VEE Virus Synthetic
Peptide Vaccine.........  248
A Single Amino Acid Interchange Can 
Affect the Specificity of both Th- 
and B-Cell Responses............... 249
-xi-
Th-Cell Response to a Recombinant VAC
VEE TC-83 Virus.................... 250
Bioethical Considerations.............. 251
CONCLUSIONS..................................... 253
REFERENCES...................................... 254
ACKNOWLEDGMENTS
This thesis is dedicated to all the technical 
people that I have worked with in laboratory for 
nearly thirty years who have strived to do the best 
science possible hoping that it would make a 
difference. I thank the late Dr. Robert A.
Zimmerman for laying my immunological foundation. I 
also thank Drs. Dennis W. Trent and August V.
Vorndam for supporting me at a critical time in my 
career. I am especially indebted to my thesis 
advisors, friends and colleagues Drs. John T.
Roehrig and Alan D.T. Barrett for their guidance and 
support during this endeavour. Dr. Richard M. 
Kinney, who truly understood the duality of the 
collaborative program, was there for me at all times 
as was Dick Bolin who had to put up with me every 
day for the past four years. Lastly, I would like 
to thank my family past and present and my three
ladies --- CM, ALM and EEM for their love and
support through this whole process which ultimately 
made the difference.
-xiii-
DECLARATION
This thesis is a product of my own composition 
and the data presented have not been previously used 
for another degree. All of the laboratory work and 
word processing were performed by myself except for 
the collaborations as noted below. Richard Kinney 
constructed the recombinant Vaccinia Venezuelan 
equine encephalitis virus and provided partially 
purified Vaccinia and recombinant Vaccinia viruses 
for research described in this thesis. He also 
assisted in some initial experiments. The synthetic 
peptides were prepared by Ann Hunt. She also 
performed the quantitative ninhydrin tests on the 
synthetic peptides. John Brubaker assisted with 
some experiments. Mike Fox and Leslie Armstrong 
from the Department of Radiological Health Sciences, 
Colorado State University, Fort Collins, Colorado, 
performed the flow cytometry. Wells Harvey and Brad 
Lucas from the same department did the cell 
irradiations. All of the work presented in this 
thesis was done under the supervision of John 
Roehrig and Alan Barrett.
-xiv- 
LIST OF TABLES
1. Antigenic classification of alphaviruses.......3
2. B-cell epitopes on TC-83 virus defined
by MABS...................................22
3. Th-cell phenotypes based on cytokine
secretion profiles.................... 60
4. Passage histories of alphaviruses used........ 94
5. Synthetic peptides from the TC-83 (E2 and
El) and TRD (E2) glycoproteins........... 102
6. Analysis of purified viruses in ELISA
with virus-specific MABs................. 120
7. Stimulation of TC-83 virus-primed, NW
passaged T cells with irradiated 
splenocytes infected with TC-83 purified 
virus.................................... 121
8. Phenotypic analysis pre- and post-
lymphoblastogenesis of NW-passaged 
lymphocytes by flow cytometry.............123
9. Effect of depletion with antisera on
proliferation of NW-passaged T cells
from alphavirus primed C3H mice...........124
10. Comparison of the lymphoblastogenic response
and IL-2 production after homologous and 
heterologous stimulation of T cells from 
mice primed with purified
alphaviruses............................. 132
11. Stimulation of TC-83 virus-primed T cells 
with various VEE subtype viruses..... 133
-XV-
List of Tables (continued)
12. Biological and binding activity of pooled
sera from TC-83 virus-primed mice
given a secondary challenge with
various alphaviruses..  .................. 135
13. Analyses of Th cells from TC-83, VAC
and TC-5A virus immunized mice for IL-2 
production and lymphoblastogenesis....... 152
14. Stimulation of TC-83 and TC-5A virus-
immune Th cells with a battery of VEE 
subtype viruses.......................... 160
15. ELISA reactivity of antisera from TC-83
and TC-5A virus-immunized mice with 
various VEE subtype viruses.............. 161
16. Immunological analysis using ELISA of
TC-83 virus El and E2 glycoproteins
soaked out of SDS-PAGE gels.............. 171
17. Analysis of the lymphoblastogenic response
to the El and E2 glycoproteins........... 172
18. Enhanced TC-83 virus B-cell response
following virus challenge in mice
primed with El or E2 glycoprotein....... 176
19. Detection by ELISA of El and E2
glycoproteins immobilized on 
microparticles of nitrocellulose......... 181
20. ELISA analysis of sera pre- and post-
TC-83 virus challenge from mice 
immunized with El and E2 glycoproteins 
immobilized on microparticles of 
nitrocellulose..........   183
List of Tables (continued)
21. VEE E2 and El glycoprotein synthetic
peptides and predicted T-cell
epitopes................................. 201
22. VEE synthetic peptide and virus related
lymphoblastogenic response of Th cells 
from three strains of mice representing 
three different haplotypes............... 2 09
23. Antibody response to VEE virus E2 and El
synthetic peptides in three strains of 
mice representing three different 
haplotypes............................... 212
24. Summary of predicted versus actual Th
and B cell epitopes on the VEE virus
E2 and El synthetic peptides............. 215
25. Three patterns of immunodominant Th-cell
reactivities among the VEE virus
synthetic peptides....................... 220
26. Sequences of TRD peptide VE2pep01 and
subunit peptides as well as TC-83
VE2pep01................................. 230
27. Lymphoblastogenic analysis of the Th-
cell epitopes on the VEE virus E2
amino terminal peptides following
primary immunization of C3H, C57BL/6
and BALB/c mice.......................... 234
28. ELISA reactivity of VEE virus, VE2pep01
(TC-83/TRD) and subunit peptides with 
antisera from TC-83 virus and peptide 
immunized mice......................... 236
-xvii-
LIST OF FIGURES
Organization of the alphavirus genome......... 7
Lymphoproliterative response over time 
of TC-83, EEE and WEE virus-primed 
Th cells. ............................... 127
ELISA analysis of serum specimens
collected at various time intervals 
from mice immunized with TC-83, EEE 
and WEE viruses.......................... 130
Lymphoproliferative response of TC-83 
and VAC virus-primed Th cells from 
individual mice.......................... 146
Lymphoproliferative response of low 
and high dose TC-5A virus-primed Th 
cells from individual mice................149
Comparative lymphoproliferative analysis 
of Th cells from TC-83, VAC and TC-5A 
virus immunization groups  151
Post-lymphoproliferative C'-depletion 
analysis of T-cell phenotypes present 
in TC-83 and TC-5A virus-immune, NW 
chromatographed splenocytes.............. 156
ELISA analysis of individual serum
specimens from high and low dose TC-5A 
immunization groups compared to pooled 
TC-83 virus antisera......................158
igG and igM antibody response in control,
El and E2 primed mice at various times 
following IP inoculation with 50 fig of 
TC-83 virus................   175
-xviii
List of Figures (continued)
10. Comparison of T-cell lymphoblastogenesis
induced by soluble PHA and PHA bound 
to microparticles of nitrocellulose......180
11. Predicted T-cell epitopes on the E2
glycoproteins of TRD and TC-83
viruses..............  197
12. Predicted T-cell epitopes on the El
glycoproteins of TRD and TC-83
viruses. ............................... 199
13. Surfaceplot computer program composite
analysis of the TRD and TC-83 virus E2
glycoproteins for putative B-cell
regions................................   .205
14. Surfaceplot computer program composite
analysis of the TRD and TC-83 virus El
glycoproteins for putative B-cell
regions.................................. 207
15. Strip of helix hydrophobicity plot for
the TRD VE2pep01 synthetic peptide
(AA 1-25)................................ 232
16. MHC restriction analysis of functional
Th-cell epitopes on TRD VE2pep01 and 
subunit peptides in three strains of 
mice representing three haplotypes....... 239
-xix
LIST OF ABBREVIATIONS
a alpha
/3 beta
y gamma
£ epsilon
f zeta
/zg microgram
AA amino acids
ADCC antibody dependent cellular cytotoxicity
ADCMC antibody-dependent complement-mediated
cellular cytotoxicity 
AMPHI amphipathic (algorithm)
APC antigen presenting cell
Arg arginine
Asn asparagine
BA boric acid
BPL /5-propio lactone
BS borate saline
C' complement
CB coating buffer
CD cluster of differentiation
cDNA complementary deoxyribonucleic acid
CF complement fixation
Ci Curie
CPE cytopathic effect
CPM counts per minute
CTL cytotoxic T lymphocyte(s)
CTLL cytotoxic T lymphocyte clone
CYC cyclophosphamide
-XX-
List of Abbreviations (continued)
DMEM Dulbecco's modified Eagle's medium
DMSO dimethyl sulfoxide
DTH delayed type hypersensitivity
EEE eastern equine encephalitis
ELISA enzyme-linked immunosorbent assay
ER endoplasmic reticulum
E envelope
FBS foetal bovine serum
FcR Fc receptors
FIA Freund's incomplete adjuvant
Fig Figure
FITC fluorescein isothiocyanate
GM-CSF granulocyte macrophage-colony stimulating
GMT geometric mean titre
H-2 murine histocompatibility gene 2
HA haemagglutination or haemagglutinin
HAC acetic acid
HAI haemagglutination inhibition
HR hour(s)
la gene products of IAIE
IC intracerebral
ICAM intercellular adhesion molecule
ID intraderma1
IEF isoelectric focusing
IFN interferon
IL interleukin
lie isoleucine
IP intraperitoneal
List of Abbreviations (continued)
ipld50 median intraperitoneal lethal dose
ir immune response genes
K killer
kDa kilodaltons
LBT lymphoblastogenesis test(s)
LCM lymphocytic choriomeningitis
LFA leukocyte function-associated
LT lymphotoxin
Lys lysine
Lyt murine T lymphocyte
M molar
MAB monoclonal antibody (ies)
ME mercaptoethanol
MEM minimal essential medium
mg milligram
MHC major histocompatibility complex
mlg membrane bound Ig
MIN minute
ml milliliters
mm millimeter
mM millimolar
MOI multiplicity of infection
mRNA messenger ribonucleic acid
NaN3 sodium azide
NK natural killer
NT neutralization
NTC nitrocellulose
NW nylon wool
-xxii-
List of Abbreviations (continued)
OD optical density
PAGE polyacrylamide gel electrophoresis
PBMC peripheral blood mononuclear cells
PBS phosphate buffered saline
PE phycoerythrin
PFU plaque forming units
PHA phytohaemagglut inin
RBC red blood cell(s)
RNA ribonucleic acid
RT room temperature
SC subcutaneous ly
SDS sodium dodecyl sulphate
SF Semliki Forest
SI stimulation index
SIR stimulation index ratio
SMB suckling mouse brain
SOHHA strip-of-helix hydrophobicity algorithm
SOHHI strip-of-helix-hydrophobicity index
TC tissue culture
tcidso median tissue culture infectious dose
TCR T-cell receptor(s)
TdR thymidine
Th T help(er)
Thy thymocyte
TNF tumour necrosis factor
TRD Trinidad
ts temperature sensitive
Tyr tyrosine
-xxiii-
List of Abbreviations (continued)
v volume
VCAM vascular cell adhesion molecule
VEE Venezuelan equine encephalitis
w weight
WEE western equine encephalitis
-1-
CHAPTER 1 
LITERATURE REVIEW 
VENEZUELAN EQUINE ENCEPHALITIS VIRUS
Taxonomy
Venezuelan equine encephalitis (VEE) virus is 
one of more than 500 known arboviruses (i.e. 
arthropod-borne viruses) the majority of which can 
be transmitted to vertebrates by the bite of an 
infected haematophagous arthropod (Karabatsos,
1985). Most of the invertebrate vectors are 
mosquitoes, but ticks, sand flies (Phelbotomidae), 
and biting midges (Culicoides, Ceratopogonidae) can 
be reservoirs for virus multiplication with 
subsequent transmission to vertebrates (Bres, 1988). 
Many of these viruses cause significant disease in 
humans. As of 1992, 115 of the 535 registered 
arboviruses have been associated with naturally or 
laboratory-acquired infections in humans (Dr. N. 
Karabatsos, Centers for Disease Control, Division of 
Vector-Bourne Infectious Diseases, personal 
communication).
VEE virus is a member of the family 
Togaviridae. The Togaviridae is comprised of three 
genera: Alphavirus (26 species including VEE virus); 
Rubivirus (rubella virus); and, Arterivirus (equine 
arteritis virus) (Francki et al., 1991).
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Initial attempts to classify antigenically the 
alphaviruses (formerly group A arboviruses) were 
based on haemagglutination inhibition (HAI), 
complement fixation (CF) and cross-protection tests 
in mice (Casals, 1957, 1963). Subsequently, using 
the more specific plaque reduction neutralization 
(NT) assay in cell culture with polyclonal antisera, 
the alphaviruses were divided into six serocomplexes 
(Porterfield, 1961; Karabatsos, 1975; Calisher et 
al., 1980). Nucleic acid sequencing of various 
alphaviruses has confirmed the antigenic 
classification scheme (reviewed by Roehrig, 1990). 
The important viruses in these complexes are listed 
in Table 1.
Antigenic differences between various VEE 
viruses were first observed by Shope (1964). Young 
and Johnson (1969) devised a classification scheme 
after analyzing a large number of VEE isolates using 
single-inoculation spiny rat (Proechimys spinosus) 
antisera in short-incubation HAI assays. From their 
results they suggested that there were four separate 
VEE virus subtypes with subtype I containing five 
antigenic variants. Subsequent studies (France et 
al., 1979; Kinney et al., 1983; Calisher et al., 
1982, 1985) have identified additional antigenic 
variants. Therefore, the VEE serocomplex now 
contains six antigenic subtypes with subtypes I and 
III defining five and three antigenic variants 
respectively (Table 1). Sequencing studies have 
suggested that the epizootic I-AB and I-C viruses
Table l. Antigenic classification of alphaviruses.*
Complex Species Subtype Variant
Venezuelan equine Venezuelan equine
encephalitis encephalitis I A (Trinidad)b
B (71-180/4)
C (P—676)
D (3880)
E (Mena II)
F (78V-3531)
II Everglades
III Mucambo (Mucambo)
(Tonate)
(71D-1252)
IV Pixuna
V Cabassou
VI AG 80-663
Western equine Western equine
encephalitis encephalitis
Sindbis
Eastern equine Eastern equine
encephalitis encephalitis
Semliki Forest Semliki Forest
Chikungunya
Mayaro
Middleburg Middleburg
Ndumu Ndumu
Barmah Forest Barmah Forest
•Adapted from Calisher and Karabatsos, 1988; Walton and Grayson, 1990. 
bParentheses enclose representative virus strains.
are more closely related to the I-D viruses than to 
the I-E or II viruses (Kinney et al., 1992a, 1992b; 
Sneider et al., 1993; Weaver et al., 1992).
Structure and Replication
VEE virus is structurally not complex. The 
mature, spherically shaped 60-70 nm diameter 
particle consists of three structural proteins and a 
single-strand ribonucleic acid (RNA) genome of 
positive polarity that is capped and polyadenylated 
(Murphy, 1980; Schlesinger and Schlesinger, 1986; 
Strauss and Strauss, 1986; Francki et al., 1991).
The VEE virus genome is approximately 11.45 
kilobases in length with a sedimentation coefficient 
of 42S. It is enclosed within a nucleocapsid which 
is 30-35 nanometers (nm) in diameter (Murphy, 1980; 
Francki, et al., 1991). The nucleocapsid is 
composed of multiple copies of a single capsid 
protein. The nucleocapsid is surrounded by a 
protective envelope (E) made up of a host-derived 
lipid bilayer which contains spikes that are 
observable by electron microscopy (Mussgay and 
Wiebel, 1963). The spikes are composed of two 
glycoproteins, El (50 kilodaltons [kDa]) and E2 (56 
kDa), which are anchored to the nucleocapsid by 
their hydrophobic C-terminal regions. The major 
external domains exist as El and E2 heterodimers 
that cluster in trimers which appear grooved in 
electron micrographs (Schlesinger and Schlesinger,
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1986; Strauss and Strauss, 1986; Harrison, 1986).
The external domains of the El and E2 
glycoproteins are biologically relevant, since they 
must interact with both the immune system and the 
cellular receptors. Blocking of attachment of VEE 
virus to cells with anti-E2 but not anti-El 
monoclonal antibodies (MABs) suggests that the E2 
may interact with the cellular receptor (Roehrig et 
al., 1988). The identification of at least three 
different cellular receptors for Sindbis virus, 
including a high affinity laminin receptor, may 
account for the wide host range of alphaviruses 
(Ubol and Griffin, 1991; Wang, K. et al., 1991,
1992). Following attachment to a cell, VEE virus is 
endocytosed and transported via endocytic vesicles 
to acidic endosomes where El mediated-fusion occurs 
exposing the nucleocapsid and releasing the viral 
RNA into the cytosol and initiating the virus 
replication cycle (Kielian and Helenius, 1986). 
Alternatively, it has been proposed that the binding 
of Sindbis virus to the cellular receptor brings 
about a rearrangement of the virion spikes 
independent of other factors (Johnston et al.,
1990). These investigators suggested that the 
altered virions are intermediates in the normal 
infectious pathway.
The alphavirus 42S RNA genome is organized into 
two distinct domains (Fig. 1). The 5'-two-thirds of 
the genome encodes the nonstructural proteins which 
are important components of the replication
Ficrure l. Organization of the alphavirus genome.
The translation product of the intracellular 26S 
mRNA is a 130 kDa polyprotein which is subsequently 
proteolytic processed to yield the virion structural 
proteins - capsid, El and E2 (hatched rectangles). 
Adapted from Kinney, 1988.
42S mRNA
NONSTRUCTURAL STRUCTURAL
26S mRNA
c E3 E2 6K E1
TRANSLATION
130 kDa
CAPSID I 100 kDa
E1
pE2 | 6K
. _________________IIJ
E3
□
machinery (Strauss and Strauss, 1986). The second 
3'-one third domain encodes a subgenomic 
polycistronic 26S mRNA which produces the structural 
proteins. The 26S mRNA is initially translated as a 
polyprotein and is then cleaved post-translationally 
(Strauss and Strauss, 1986). The capsid protein is 
the first translation product which functions as an 
autoprotease to cleave itself from the polyprotein. 
It then self assembles with nascent genomic RNA to 
form the nucleocapsid (Aliperti and Schlesinger, 
1978; Strauss and Strauss, 1986). The pE2-El 
cleavage occurs after insertion of the El into the 
endoplasmic reticulum apparently facilitated by the 
non-structural 6K polypeptide which acts as a signal 
sequence (Strauss and Strauss, 1986; Trent et al.,
1989). The pE2 is the precursor of the E2; cleavage 
of the 65 amino acids (AA) at the amino terminus 
(E3) occurs prior to the formation of mature 
virions. During migration through the rough 
endoplasmic reticulum (ER) and golgi apparatus, the 
proteins are glycosylated. (Schlesinger and 
Schlesinger, 1986; Mecham and Trent, 1982). Earlier 
studies indicated that the pE2 to E2 cleavage was 
essential for the formation of mature virions (Smith 
and Brown, 1977; Schlesinger and Schlesinger, 1986). 
However, recent investigations on alphavirus virion 
morphogenesis and glycoprotein conformation suggest 
that more than one pathway for virion maturation may 
be present (Miller and Brown, 1992; Meyer et al., 
1992). The E3 protein is not incorporated into the
virion envelope of most alphaviruses.
Epidemiology
VEE virus was first isolated from horse brain 
following an epizootic in Columbia and western 
Venezuela in the mid 1930's (Beck and Wyckoff, 1938; 
Kubes and Rios, 1939). Subsequently, various VEE 
virus strains have been isolated in South and 
Central America as well as in the United States 
(Young and Johnson, 1969). The prototype, virulent 
I-AB VEE Trinidad (TRD) virus was isolated in 1943 
in guinea pigs from the brain of a donkey that died 
during a VEE epizootic on the island of Trinidad 
(Randall and Mills, 1944; Tigertt and Downs, 1962).
Epizootic and enzootic VEE viruses have been 
isolated from a wide variety of mosquito species 
(Johnson and Martin, 1974; Sudia and Newhouse,
1975). The enzootic VEE viruses are maintained in a 
sylvatic or jungle cycle primarily within the Culex, 
subgenus Melanoconion mosquito species using small 
mammals as reservoirs (Bres, 1988; Grayson and 
Galindo, 1968, Calisher and Karabatsos, 1988). The 
I-AB and I-C viruses have periodically caused 
epizootic and epidemic outbreaks of disease. The 
last major epidemic/epizootic of VEE started in 1969 
in South America, and over the next two years spread 
through Mexico and into Texas killing more than 
100,000 horses and donkeys with a 1% mortality in 
affected humans (Groot, 1972; Lord, 1974).
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Inexplicably, natural cycles of transmission for the 
epizootic viruses have not been found. Several 
lines of biological and genetic evidence suggest 
that mutations of related enzootic viruses may 
naturally occur resulting in reversion to the 
epizootic phenotype of VEE virus (Rico-Hesse et al., 
1988a, 1988b; Kinney et al., 1992a, 1992b).
Pathogenesis and Virulence
As of 1979, there had been 115 laboratory- 
acquired VEE virus infections with 1 death as 
reported by the Subcommittee on Arbovirus Laboratory 
Safety of the American Committee on Arthropod-Borne 
Viruses (Scherer et al., 1980). This group assigned 
the VEE viruses a containment level rating of 3* 
indicating that there was considerable risk for 
severe laboratory infections by aerosol or other 
routes. VEE viruses, particularly the I-AB and I-C 
varieties are very pathogenic in a number of animal 
species including man (Shope, 1985). For example, 
100 median intraperitoneal lethal doses (IPLDs50) of 
VEE TRD virus for three-week old mice is equivalent 
to 20 plaque forming units (PFU) as measured in Vero 
cell culture (Mathews and Roehrig, 1982). The risk 
for infection is much greater when working with 
milligram (mg) quantities of concentrated, purified 
virus where 1 microgram (fig) is approximately equal 
to 10,000,000 PFU (Mathews and Roehrig, 1989).
In man, VEE virus first replicates in the skin
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and regional lymph nodes and then, through a high 
titred viraemia, disseminates to other haemopoietic 
regions, particularly the bone marrow (Shope, 1985). 
It has been shown that VEE virus will replicate in 
human monocytes (Levitt et al., 1979).
Encephalitis occurs in 0.4% of adults and 4% of 
children through disruption of the blood brain 
barrier, through an infected muscle cell at its 
neuromuscular junction, or through the olfactory 
bulb region (Shope, 1985; Ehrenkranz and Ventura, 
1974; Danes et al., 1973). Following a short 
incubation period of 1-4 days, virus can be isolated 
from the pharynx and blood during the early stages 
of the disease (Lennette and Koprowski, 1943;
Scherer et al., 1972; Shope, 1985). Clinically, 
infected patients may present with a respiratory 
illness, headache, fever and muscle pain that lasts 
3-5 days (Shope, 1985). Long-lived immunity is 
induced in humans with the detection of neutralizing 
antibody in >95% of vaccinees after 9 years (Burke 
et al., 1977).
VEE virus introduced by parenteral inoculation 
of monkeys results in marked leukopenia and 
viraemia, although central nervous system 
involvement is generally minimal and reversible 
unless monkeys are challenged intracranially 
(Gleiser et al., 1962; Monath et al., 1992). The 
clinical manifestations in monkeys are similar to 
what is seen in man; however, circulating 
neutralizing antibody following monkey vaccination
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with TC-83 is at higher levels than that seen in man 
(Monath et al., 1992).
Horses are very susceptible to VEE virus 
infection with a mortality rate of 40-80%; however, 
the disease manifestations are generally systemic 
without severe neurological involvement (Griffin, 
1986). Gross lesions were not observed in brains of 
horses infected with a I-AB virus, but severe 
meningoencephalitis was found (Bowen et al., 1992). 
There is a high-titred and prolonged viraemia which 
probably amplifies mosquito infection rates during 
epidemics (Kissling et al., 1956; Henderson et al., 
1971; Sudia and Newhouse, 1975). Neutralizing 
antibody in horses is long-lived following 
immunization with TC-83 virus. Neutralizing 
antibody was detected for up to 30 months in cohorts 
of horses studied in Central America (Walton and 
Johnson, 1972)
The susceptibility of a variety of domestic 
animals to VEE virus has been studied either 
experimentally or during VEE epizootics (reviewed by 
Johnson and Martin, 1974). VEE virus has been 
isolated from sheep and goats during epizootics, and 
domestic rabbits have a high rate of mortality. 
Experimentally infected bovines, sheep, goats and 
pigs could be infected with VEE virus but without 
clinical disease; canines became infected and died 
when high doses of virus were used. Wild rodents 
are generally resistant to VEE virus disease.
In laboratory animals, VEE virus is either
“ 1 3 “
lymphotropic or neurotropic, and a high rate of 
mortality is seen with virulent strains. Widespread 
involvement of lymphoid tissue occurs in VEE virus 
infected guinea pigs, rabbits and hamsters (Griffin, 
1986; Bradish et al., 1971). In rats and mice, VEE 
virus initially replicates in the lymph nodes and 
spleen with a significant associated viraemia that 
results in neuroinvasion by the virus (Victor et 
al., 1956; Tasker et al., 1962; Glesier et al.,
1962; Kundin, 1966; Mathews and Roehrig, 1982; Hunt 
et al., 1991). Infection of mice ranging in age 
from 5 to 80 days with more than twenty different 
strains of VEE virus defined important parameters 
for age and susceptibility to VEE virus challenge 
(Walder and Bradish, 1975, 1979). This was also 
determined in 7 to 56 day old mice with Sindbis 
virus (Griffin, 1976). Virus susceptibility or 
resistance was not associated with the humoral 
response as all age groups elicited similar levels 
of neutralizing antibody within the same time frame.
Vaccines
Three different approaches to VEE virus vaccine 
development have been used. Initially, the 
treatment of wild-type VEE TRD virus grown in chick 
embryo cultures with various concentrations of 
formaldehyde resulted in vaccine preparations that 
were either immunogenic but incompletely inactivated 
or completely inactivated and poorly immunogenic
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(Randall et al., 1949; Smith et al., 1954; Smith et 
al., 1956; Berge et al., 1961). Cole et al. (1973)
used low concentrations of formalin (0.05% - 0.1%) 
to inactivate VEE TRD virus grown in cell cultures 
of chick embryos and harvested early before 
significant cytopathic effect (CPE). Using this 
vaccine with selected adjuvants elicited antibody 
responses in mice and monkeys (Harrington et al., 
1979, 1981). Reitman et al. (1970) inactivated VEE 
virus from cell cultures with gamma-irradiation; 
these preparations were immunogenic in guinea pigs 
and hamsters.
A second approach to VEE virus vaccine 
development was to attempt to develop an attenuated 
virus by serial passage in cell culture. This 
approach had been used successfully with yellow 
fever virus (Lloyd et al., 1936; Theiler and Smith, 
1937). Passage of VEE virus in HeLa cell culture or 
chick embryo tissue devoid of neural cells for more 
than 60 passages resulted in virus that would not 
kill mice by peripheral inoculation, but did kill 
mice by intracerebral (IC) challenge (Koprowski and 
Lennette, 1946; Murphy, 1955).
Berge et al. (1961) developed an attenuated 
strain of VEE TRD virus that was avirulent for mice 
by both peripheral and IC routes. Virus grown in 
embryonated chicken eggs was serially passaged in 
guinea-pig heart cells using second to sixth passage 
of cultured cells. At tissue culture passage 45 (TC- 
45) there was a sharp decrease in deaths following
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IC inoculation of mice (8-14  grams) but this was 
not associated with a decreased median tissue 
culture infectious dose (TCID50) in guinea-pig heart 
cells. There was no reversion to virulence at 
higher passage levels (TC-80, TC-90) , although TCID50 
titres had dropped. Mice immunized with these 
passaged viruses survived IC challenge with VEE TRD 
virus. Due to a high incidence of reactogenicity in 
humans with TC-50 and TC-80, the TC-78 strain was 
plague purified in chicken fibroblast cell culture 
(McKinney et al., 1963). This purified virus was 
passaged in guinea-pig heart cells and the new TC-80 
virus was avirulent and protected various animals 
from virulent virus challenge (McKinney, 1972; 
Johnson and Martin, 1974). TC-81 was used to
prepare a stock seed virus (TC-82) from which the 
TC-83 live virus vaccine lot was prepared.
The TC-83 vaccine virus has been used 
successfully to protect both humans and horses.
More than three million horses in Texas and adjacent 
states were immunized with the TC-83 virus during 
the 1971-1972 epizootic (Reeves, 1972). Although 
the TC-83 virus has been an extremely effective 
vaccine, reactogenicity still remains a problem.
Some individuals fail to respond to TC-83 
vaccination. There are also concerns about TC-83 
reversion to a virulent phenotype. TC-50 virus, 
after three passages in mouse brain, was able to 
kill mice by the IC route (Berge et al., 1961).
Also, TC-83 virus has been isolated from mosquito
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vectors following vaccination of horses (Pedersen et 
al., 1972).
A third approach to VEE virus vaccine 
development was to formaldehyde inactivate TC-83 
virus, since there were concerns about using 
formalin inactivated wild-type VEE TRD virus derived 
vaccines (Cole et al., 1974). Although TC-83 virus 
was more efficient at preventing neuroinvasion, the 
inactivated (C-84) vaccine protected hamsters from 
subcutaneous but not aerosol challenge (Jahrling and 
Stephenson, 1984); protected horses from virus 
challenge (Foster et al., 1983); and, protected 
monkeys from intranasal challenge (Monath et al., 
1992) .
The genomes of both the virulent TRD virus and 
its attenuated vaccine derivative (TC-83) have been 
sequenced (Johnson et al., 1986; Kinney et al.,
1986, 1989). The genomes were found to differ at 12 
nucleotide positions. There were 5 AA substitutions 
in the E2 but only a single substitution in the El. 
Mutational analysis of an infectious cDNA clone of 
TC-83 virus has found that AA positions E2-120 and 
nsP2-16 in the 5'-noncoding region are important 
virulence markers (Kinney et al., 1993).
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IMMUNOLOGY OF VEE AND RELATED VIRUSES
Antigenic Structure of the El and E2
Glycoproteins
Molecular and immunological investigations with 
alphaviruses have often used Sindbis and Semliki 
Forest (SF) viruses, since containment facilities 
are not required. Electron microscopic studies 
suggested that Sindbis virus is composed of a core 
and an outer lipoprotein envelope (Morgan et al., 
1961; Acheson and Tamm, 1967). Calcium phosphate 
chromatography, showed that there was a 
haemagglutinin (HA) separate from the alphavirus 
particle (Smith and Holt, 1961). This was confirmed 
by treating Sindbis virus with Tween 80 and ether 
(Mussgay and Rott, 1964). Noninfectious HA was 
inhibited by Sindbis hyperimmune sera. Studies with 
Sindbis (Pfefferkorn and Clifford, 1964), VEE (Lust, 
1966), and SF (Friedman, 1968; Hay et al., 1968) 
viruses showed that the virion proteins were 
synthesized following infection. The estimated 
molecular weight of the HA was approximately 53 kDa 
(Strauss et al., 1968, 1969). The HA was identified 
as a glycoprotein which was later supported by 
Goldblum et al. (1970). The HA isolated from 
another alphavirus, Chikungunya, could induce in 
rabbits antibody that would inhibit HA and 
neutralize virus infectivity (Igarashi et al.,
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1970a, 1970b). Removal of the alphavirus 
glycoprotein with a proteolytic enzyme without 
damaging the lipid component, suggested that the 
glycoprotein was at the surface of the virus 
(Compans, 1971).
Using the discontinuous sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis (SDS- 
PAGE) gel system developed by Laemmli (1970) instead 
of SDS-phosphate buffered gels (Summers et al.,
1965), the HA of Sindbis virus was separated into 
two distinct proteins - El and the E2. (Schlesinger 
et al., 1972). The molar ratio of the three 
structural proteins (El, E2 and capsid) in the virus 
was estimated to be 1:1:1. Radioimmune 
precipitation of detergent separated proteins from 
various alphaviruses with antisera to both virus and 
structural proteins indicated that the capsid was 
group reactive whereas the envelope proteins 
contained both type-specific and subgroup reactive 
determinants (Dalrymple et al., 1972, 1973).
In the first detailed immunological studies of 
the VEE virus El and E2 glycoproteins, rabbit 
antisera to the E2 were positive in HAI, CF, and NT 
assays, and would passively protect mice from VEE 
TRD virus challenge (Pedersen et al., 1973; Pedersen 
and Eddy, 1974). The El antisera were only positive 
in the CF test. Mice immunized with envelope 
components from VEE virus and the other two new 
world alphaviruses - eastern equine encephalitis 
(EEE) and western equine encephalitis (WEE) viruses
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elicited virus-specific neutralizing antibody, and 
were mostly protected from homologous virus 
challenge (Pedersen, 1976).
Separation of the El and E2 glycoproteins of 
Sindbis virus by column isoelectric focusing (IEF) 
with subsequent immunological analysis, showed that 
antiserum to the El was crossreactive whereas the E2 
antibody was virus-specific and neutralized 
homologous virus (Dalrymple, 1976). Rabbit antisera 
prepared to IEF separated El and E2 glycoproteins 
from a battery of VEE serocomplex viruses supported 
previous observations that the E2 is involved in the 
biological functions of NT and HA (France et al., 
1979; Kinney et al., 1983). In addition, these 
results confirmed the original serological 
classification of the epizootic and enzootic viruses 
(Young and Johnson, 1969).
Following SDS-PAGE analyses, heterogeneity in 
molecular weights of the glycoproteins was observed 
with various alphaviruses (Pedersen et al., 1974) 
and among VEE serocomplex viruses (Kinney et al., 
1983; Wiebe and Scherer, 1979; 1980). Differences 
in elution profiles for some epizootic and enzootic 
VEE complex viruses have been seen using 
hydroxylapatite column chromatography (Jahrling and 
Eddy, 1977; Stanick et al., 1985). Plaque size has 
also been used as a phenotypic marker to distinguish 
between various members of the complex (Martin et 
al., 1982).
Molecular Correlates of Antigenic Structure
Early molecular correlates of antigenic 
structure were observed in RNA oligonucleotide 
fingerprint, tryptic peptide mapping and V8 protease 
analyses of the VEE serocomplex viruses (Trent et 
al., 1979; Kinney and Trent, 1982; Kinney et al.,
1983). Oligonucleotide fingerprint analysis of 
various WEE serocomplex viruses was able to 
distinguish between strains geographically separated 
(Trent and Grant, 1980) .' Genetic relatedness among 
stains of VEE ID and IC viruses was also noted with 
differences due to geographic distribution (Rico- 
Hesse et al., 1988a, 1988b). In all these studies, 
the corresponding serological results performed with 
polyclonal antisera against virus or E2 
glycoproteins, or MABs to the E2 glycoprotein, 
correlated with the genetic or protein analyses. 
Amino terminal AA sequencing of the El and E2 
glycoproteins of various alphaviruses showed the El 
to be more conserved than the E2 (Bell et al.,
1984). The deduced AA sequences of the El and E2 
glycoproteins derived from the sequencing of the 26S 
messenger ribonucleic acid (mRNA) of various 
alphaviruses (Roehrig, 1990) and several VEE viruses 
suggest that the El is more conserved than the E2 
(Johnson et al., 1986; Kinney et al., 1986, 1989, 
1992a, 1992b; Sneider et al., 1993). This 
correlates with the many observations that the El
-21-
elicits cross-reactive antibodies while antibodies 
to the E2 are more specific (Roehrig, 1990)
Monoclonal Antibody Analysis of the El and E2 
Glycoproteins
MAB mapping of the antigenic determinants on 
the El and E2 glycoproteins of VEE and related 
alphaviruses has elucidated the antigenic structure 
of these proteins as well as their biological 
activity and role in protection (reviewed by 
Roehrig, 1986, 1990). MABs to VEE viruses defined 
eight and four distinct B-cell determinants on the 
E2 and El glycoproteins respectively (Roehrig et 
al., 1982; Roehrig and Mathews, 1985) (Table 2). 
These epitopes were determined by ELISA cross­
reactivity and biological activity analyses. 
Competitive binding assays were used to ascertain 
spatial relationships among the epitopes. A 
critical NT site (E2C) was defined on the E2 
glycoprotein. MABs that mapped into this domain had 
either NT or NT and HA inhibiting activities. 
Furthermore, when the virus was treated with V8 
protease, these MABs recognized the same fragments. 
E2 MABs that mapped to epitopes outside of the 
"critical domain" described above did not have 
biological activity. Epitopes lying in the E2C 
domain are probably conformational in nature, since 
reduction and alkylation significantly altered their 
recognition by the appropriate MABs (Roehrig, 1990).
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Table 2. B-cell epitopes on TC-83 virus defined by MABs.*
Glycoprotein Epitope NT HAI Protection
E2 a - - -
b - - -
c +++ +++ +++
d - - N.D.b
e - - N.D.
f + - -
g + - +
h + - +
El a - - -
b + + +
c - - +
d - - +
“Adapted from Roehrig et al. (1982) ; Mathews and Roehrig
(1982); Roehrig and Mathews 
(1985).
’N.D. = Not Done
(1985); Mathews et al.
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Some E2 MABs could bind equally well to two 
different VEE complex viruses in ELISA, but 
exhibited marked differences in neutralizing virus 
or inhibiting HA suggesting that conformational 
differences existed between these viruses (Roehrig 
and Mathews, 1985).
MABs defined four epitopes on the El 
glycoprotein (Roehrig et al., 1982). Only the MAB 
to the E-lb epitope was biologically active with low 
titred HAI and NT activity. This antibody strongly 
competed with the E-2C MAB suggesting an association 
between the two epitopes. Although both the E2° and 
Elb antibodies exhibited differences in their ability 
to block virus infectivity in vitro, they were both 
very effective at protecting mice from virulent 
virus challenge (Mathews and Roehrig, 1982). Non­
neutralizing El MABs to other alphaviruses have also 
been shown to be protective (Schmaljohn et al.,
1982; Boere et al., 1983; Stanley et al., 1986; 
Mendoza et al., 1988; Wust et al., 1989).
MABs to the alphavirus glycoproteins have also 
been used to select NT escape virus variants 
(reviewed by Roehrig, 1990). Selection of stable 
TC-83 virus mutants with four anti-E2 antibodies 
that mapped into the critical NT domain was 
associated with a series of single mutations between 
AA 182 and 207 of the E2 protein (Johnson et al.,
1990) . The E2h selected variant with an AA change at 
position E2-207 was neutralized poorly by TC-83 
polyclonal antiserum. It was one of two variants
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with decreased virulence for mice suggesting that 
virus receptor interaction may have been altered.
The E2h variant also had restricted replication in 
Aedes albopictus C6/36 cell culture, and was 
restricted in dissemination from the midgut of Aedes 
albopictus mosquitoes (Woodward et al., 1991).
MABs have also detected antigenic changes in 
the conformation of alphavirus glycoproteins due to 
physical or chemical factors or due to the binding 
of another MAB (Clegg et al., 1983; Schmaljohn et 
al., 1983; Hunt and Roehrig, 1985; Meyer et al., 
1992). These antigenic changes have often been 
associated with the El glycoprotein and result in 
the appearance of cryptic epitopes that are not 
present on the intact virion. These processes are 
probably associated indirectly or directly with the 
putative fusion function of the El (reviewed by 
Roehrig, 1990). Binding of Sindbis virus to cells 
causes a programmed rearrangement of the El and E2 
glycoproteins resulting in the appearance of 
previously inaccessible or transitional epitopes 
(Johnston et al., 1990). Although MABs to the El 
and E2 glycoproteins of VEE virus have elucidated 
much about the antigenic structure of these 
proteins, the construction of infectious 
complementary deoxyribonucleic (cDNA) clones will 
result in more specific analyses of the immunologic 
response (Davis et al., 1989; Kinney et al., 1993).
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In Vivo Analysis of the Immune Response
Congenitally athymic nude (nu/nu) mice infected 
with Sindbis virus have a transient T-cell 
independent IgM response (Burns et al., 1975). A 
memory B-cell response could not be recalled upon 
secondary inoculation with virus. Normal 
littermates (nu/+) elicited IgG during the primary 
response and had a strong, secondary IgG response to 
virus. The IgG response to SF virus was 1,000-fold 
lower in nude mice when compared to heterozygous 
littermates (Suckling et al., 1982). SF virus 
infected nude mice had persisting virus in the brain 
with little pathology while their littermates had an 
enhanced inflammatory response (Jagelman et al.,
1978). When the transient IgM antibody titres 
declined at approximately three weeks in the nude 
mice, the virus titres increased rapidly. Similar 
observations were made in a study with Sindbis virus 
(Hirsch and Griffin, 1979). Nude mice were killed 
faster than normal mice by virulent VEE virus, while 
virus titres of avirulent VEE viruses in nude and 
normal mice were similar (LeBlanc et al., 1978). In 
this study, implantations of thymic tissues into 
nude mice correlated with the appearance of 
neutralizing antibody in some mice. Nude mice that 
had received normal spleen cells one day before 
infection were protected from SF virus challenge, 
and developed protective antibody (Bradish et al.,
1979). Treatment of mice with anti-thymocyte serum
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delayed replication of VEE virus and mortality in 
mice (Woodman et al,, 1975). Thymectomized mice 
reconstituted with sensitized T cells from Sindbis 
virus infected mice were able to clear Sindbis virus 
after challenge, developed antibody, and showed 
evidence of an inflammatory response (Park et al.,
1980).
When spleen cells, collected 5-6 days following 
IC inoculation with SF virus and the related Bebaru 
virus, were transferred to virus-infected mice, 
enhanced inflammation but reduced virus titres were 
seen (Hapel, 1975). The opposite occurred when 
cells were treated with anti-thymocyte serum. 
Adoptive transfer of spleen cells from Sindbis virus 
infected mice conferred protection from challenge 
with SF virus (Peck et al., 1975). This was 
considered to be T-cell mediated, since anti­
thymocyte treated splenocytes were not protective.
No antibody was detected in mice receiving these 
cells; however, recipient mice were not monitored 
for a secondary-type of antibody response following 
virus challenge to ascertain possible Th-cell 
priming. This protection was enhanced if an 
allogenic recipient was used (Peck et al., 1979).
A series of adoptive transfer experiments 
clearly demonstrated that T and B cells act 
cooperatively and that antibody is important for 
protection against VEE virus challenge (Rabinowitz 
and Adler, 1973; Rabinowitz, 1976a, 1976b;
Rabinowitz et al., 1979). Protection could be
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inhibited by treating cells with anti-thymocyte 
serum but not anti-gamma globulin prior to transfer. 
Cells from mice immunized with inactivated virus 
were not as effective as cells from mice immunized 
with live virus unless immunization included 
adjuvant. These investigators also made the 
observation that T cells help to produce antibody. 
Bradish et al. (1980) used active and adoptive 
immunization in nude and normal littermates to study 
VEE virus immunity. Nude and normal heterozygous 
littermates were immunized with TC-83 virus and then 
challenged with virulent VEE virus at day 22; all of 
the normal mice survived whereas only 50% of 
immunized nude mice survived. Normal mice, after 
transfer of cells from immunized nude mice, did not 
survive VEE virus challenge, whereas nude mice 
reconstituted with normal spleen cells survived 
virus challenge.
Reconstitution of the inflammatory response to 
Sindbis virus in mice treated with cyclophosphamide 
(CYC) required virus sensitized lymph node cells 
(McFarland et al., 1972). Antibody alone or in 
conjunction with nonspecifically sensitized cells 
was ineffective. SF virus immune cells could 
reconstitute inflammation in immunosuppressed mice 
(Doherty, 1973). While mice treated with CYC were 
more susceptible to Bebaru virus (Hapel, 1975), CYC 
had an effect on viraemia and antibody synthesis in 
SF virus infected mice only if it was administered 
before day three following virus infection (Bradish
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et al., 1975a). Protection of mice from homologous 
virus challenge by anti-Sindbis serum was prevented 
by CYC treatment (Hirsch et al., 1979). However, 
quantitative levels of protection afforded by 
various VEE MABs were not altered when tested in CYC 
treated mice (Mathews and Roehrig, 1982; Hunt et 
al., 1991).
Passive protection with polyclonal immune serum 
from the encephalitic alphaviruses requires that 
antibody be administered before neuroinvasion of the 
brain by virus has occurred (Howitt, 1932; Wyckoff 
and Tesar, 1939; Zichis and Shaughnessy, 1940; 
Olitsky et al., 1943; Rabinowitz and Adler, 1973; 
Mathews and Roehrig, 1982). Treatment of mice with 
various immunomodulating drugs (Myocrisin, sodium 
auro-thio-malate) other than CYC either potentiated 
the infection or induced immunoenhancement (Allner 
et al., 1974; Bradish et al., 1975b).
Humoral Immune Response
In vivo immunological studies indicated that 
the long-lived IgG antibody response to VEE virus 
was T-cell dependent. Biological activity in VEE 
virus antisera has routinely been evaluated with CF, 
HAI and NT assays (Casals, 1957; 1963). Although 
the HAI assay is valuable for identifying viruses 
that are distantly related, it is cross-reactive 
with more closely related groups of viruses. This 
cross-reaction can be obviated somewhat by using
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kinetic assays and single inoculation antisera to 
separate antigenically the VEE complex viruses 
(Young and Johnson, 1969). Because of the unique 
specificity of the NT assay, alphaviruses have 
routinely been identified and classified by NT 
(Karabatsos, 1975; Calisher and Karabatsos, 1988). 
VEE virus can enhance the humoral immune response to 
other proteins (human gamma globulin, sheep 
erythrocytes) in various animals (Howard et al., 
1969; Craig et al., 1969; Hruskova et al., 1972).
An enhanced response as measured by increased 
phagocytic activity following VEE virus infection 
was observed by Staab et al. (1970). Conversely, 
the presence of antibody to WEE and EEE viruses in 
horses has been shown to interfere with the humoral 
immune response to VEE virus (Calisher et al., 1973; 
Jochim et al., 1974). Presumably, the immune 
complexes formed with VEE virions and/or 
glycoproteins with pre-existing cross-reactive 
antibodies are readily cleared by phagocytic 
mechanisms not involving antigen presenting cells 
(APC) .
The mechanisms involved in the in vitro NT of 
animal viruses are varied and complex depending on 
the virus system (Dimmock, 1984). It has been 
suggested that the binding of antibody to the virion 
may alter the conformation of the virion 
glycoproteins interacting with antibody. The 
kinetics of VEE virus NT have been investigated 
(Hahon and Cooke, 1967; Hahon, 1969, 1970). First
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order NT kinetics were observed, i.e. NT began 
immediately and the reaction over time with varying 
antiserum dilutions was linear in nature. When 
constant serum versus varying virus concentrations 
were monitored kinetically, a constant amount of 
virus was neutralized irrespective of the total 
quantity of virus present. In addition, there was a 
persisting virus fraction that resisted NT even in 
the presence of excess antibody. NT could be 
reversed, but only under alkaline or acid 
conditions.
WEE virus was efficiently neutralized by F(ab')2 
fragments prepared from polyclonal hyperimmune serum 
(Cremer et al., 1975). A neutralizing MAB to SF 
virus had a 100-fold reduction in titre (104 versus 
106) when converted to F(ab')2 fragments (Boere et 
al., 1985). F(ab')2 fragments, prepared from a MAB
defining the critical NT domain on VEE virus, were, 
however, very effective at neutralizing VEE virus in 
vitro (Mathews et al., 1985). Fab and Fab' 
fragments prepared from the same MAB were not 
efficient in NT unless assayed in the presence of a 
secondary enhancing antibody (rabbit anti-mouse 
IgG). These cumulative results suggest that the Fc 
fragment is not required for in vitro NT. However, 
the bivalent form of the antibody or a bivalent 
simulation using secondary antibody is required to 
cross-link virions and prevent optimal virus- 
receptor interaction. Virus can also be neutralized 
in vitro, independent of interaction with cell
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receptors, by complement (C')-mediated virolysis 
(Sissons and Oldstone, 1985).
An extension of this study more clearly defined 
the primary mechanisms involved in the in vitro NT 
of VEE virus (Roehrig et al., 1988). Anti-E2 MABs 
binding to VEE virus in the aqueous phase were able 
to mediate NT by blocking attachment to susceptible 
cells, neutralize virus following attachment or 
neutralize virus after facilitating enhanced 
attachment. These results suggested that depending 
on the antigenic domain targeted by the MABs, 
alteration in spike topography may affect subsequent 
events in virus-cell interaction.
Interpretation of the in vivo NT of 
alphaviruses in general and VEE virus in particular 
becomes complex. The C' system is thought to be an 
important mediator of the host's protective response 
to virus infection (Hirsch et al., 1980; Hirsch, 
1982; Sissons and Oldstone, 1985). In vitro, C' has 
routinely been used in the form of fresh normal 
serum to enhance NT titres to a variety of 
alphaviruses (Chappell et al., 1971). The effect of 
C' depletion on the course of Sindbis virus 
infection in mice was inconclusive (Hirsch et al., 
1978). Another study suggested that the activation 
of C' is inversely related to the sialic acid 
content of the virus and that levels of viraemia are 
similar in untreated and C' depleted mice following 
IC inoculation with Sindbis virus (Hirsch et al.,
1981). Results contradictory to these were seen in
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a study with Ross River virus which did not activate 
either the classical or alternative C' pathways in 
the absence of antibody, and actually inhibited C' 
cleavage (Aaskov et al., 1985). A subsequent study 
tried to reconcile these differences by suggesting 
that viruses purified over potassium tartrate 
gradients inhibited cleavage of C'3 (Aaskov, 1988). 
None of these studies resolved the role of C' in in 
vivo NT of viruses.
Cremer et al. (1975) showed that F(ab')2 
fragments of polyclonal anti-WEE virus antibody were 
not protective while the intact IgG molecule was 
protective. This indicated that either C' or 
interaction with Fc receptors was important in in 
vivo NT of WEE virus. Similar results were seen in 
a study with Sindbis virus and with C' depleted 
animals indicating that C' was not required for 
protection (Hirsch et al., 1978, 1979). F(ab')2
fragments from protective SF virus anti-E2 Mabs were 
only partially protective and C' depletion or CYC 
treatment ablated protection when prophylactically 
administered at marginally protective concentrations 
(Boere et al., 1985; 1986). However, an important 
factor not considered in the interpretation of the 
results was the possible enhanced virulence of the 
virus in the immunocompromised hosts. F(ab')2 
fragments prepared from a protective anti-E2 VEE MAB 
did not protect mice from VEE TRD virus challenge 
(Mathews et al., 1985). This MAB was very efficient 
at fixing C'. Limited proteolytic digestion with
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pepsin of the Fc region of the molecule indicated 
that the Fc, independent of C', was necessary for 
protection. This was confirmed when C' depleted 
mice and mice deficient in C'5 were protected by 
this modified antibody.
Certain alphavirus MABs that will not 
neutralize virus in vitro will confer protection. 
This was first shown with anti-El MABs derived from 
VEE and Sindbis viruses (Mathews and Roehrig, 1982; 
Schmaljohn et al., 1982). Subsequently, numerous 
studies with alphaviruses have made similar 
observations with both non-neutralizing but 
protective anti-El and anti-E2 MABs (Schmaljohn et 
al., 1983; Clegg et al., 1983; Boere et al., 1983; 
Stanley et al., 1986; Hunt and Roehrig, 1985;
Mendoza et al., 1988; Wust et al., 1989). This 
apparent paradox between in vitro NT and in vivo 
protection is apparently due to cryptic B-cell 
epitopes that are not expressed on the mature virion 
but are expressed on VEE virus infected cells or 
under physical or chemical conditions that alter the 
conformation of the glycoproteins (Schmaljohn et 
al., 1983; Hunt and Roehrig, 1985). In general, 
protection by these MABs requires much more antibody 
when compared to neutralizing MABs. It has been 
proposed that the mechanism for protection occurs at 
the cell membrane where the binding of antibody 
affects a crucial step in virion morphogenesis 
(Mathews et al., 1985). A similar mechanism for 
protection was proposed for a synthetic peptide
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derived from the E2 amino terminus of VEE TRD virus 
that induced protective but non-neutralizing 
antibody (Hunt et al., 1991). Neither this antibody 
nor a protective MAB prepared to this peptide were 
able to fix C'. Other non-neutralizing anti-E2 
peptide antibodies to VEE virus (Johnson et al.,
1991) and SF virus (Grosfeld, 1992; Snijders et al., 
1992a) have also been shown to be protective. In 
the latter study, the results in C'5 deficient mice 
suggested that C' did not play a role in protection.
Antibody-dependent complement-mediated cellular 
cytotoxicity (ADCMC) is considered to be an 
important mechanism for destruction of virus- 
infected cells in vivo (Oldstone and Lampert, 1979) . 
This may be an operative mechanism for non­
neutralizing alphavirus antibodies that can fix C'. 
Studies with SF and Sindbis viruses have suggested 
that this is an important mechanism in alphavirus 
immunity (King et al., 1977; Wolcott et al., 1982b; 
Gates et al., 1982; Boere et al., 1985; 1986).
Cellular Immune Response
It is thought that certain large granular 
lymphocytes with or without antibody can mediate 
killing of virus infected cells in vivo (Klein,
1990). The effector cells are natural killer (NK) 
cells. These cells, when target cells are lysed in 
the presence of small amounts of anti-virus 
antibody, have traditionally been called killer (K)
-35-
cells (Sissons and Oldstone, 1985). This antibody- 
aided lysis has been termed antibody dependent 
cellular cytotoxicity (ADCC). It has been suggested 
that the effector mechanism of NK cells is regulated 
by recognition of major histocompatibility complex 
(MHC) class I molecules as self (Versteeg, 1992). 
When the MHC molecules have been displaced by 
replicating virus, this triggers NK cells to lyse 
the infected targets.
Resistance against challenge with a virulent 
VEE virus was noted as early as 24 hours after 
immunization of mice with an avirulent strain of VEE 
virus (Hearn and Rainey, 1960). NK cell activity 
was observed very early after infection with SF 
virus (Rodda and White, 1976). The cytotoxicity was 
non-specific and the cell was characterized as 
lacking phenotypic markers found on T cells, B-cell 
and macrophages, and the cells were non-adherent to 
nylon wool (NW) (MacFarlan et al., 1977).
Incubation of normal mouse leukocytes with L-929 
cells infected with Sindbis virus generated NK-cell 
activity (Welsh and Hallenback, 1980). NK cells 
were found in both Sindbis virus infected 
susceptible and resistant mice which did not 
correlate with protection (Hirsch, 1981). NK cells 
transferred from Sindbis virus-infected older mice 
did not confer protection to younger mice. In 
another study a non-T, CYC sensitive cell was 
required for an ADCC type of protection against 
Sindbis virus encephalitis (Hirsch et al., 1979).
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Passive cross-protection between Sindbis and SF 
viruses with hyperimmune antisera that did not 
cross-neutralize suggested that ADCC could be 
operative, since cross-ADCC could be demonstrated in 
vitro (Wust et al., 1987).
Splenic lymphocytes, collected from Balb/c mice 
at day 7 following inoculation with Sindbis virus, 
were able to lyse infected target cells (McFarland, 
1974). The effector population was shown to be T 
cells and lysis was inhibited with specific 
antiserum. A more detailed murine
histocompatibility gene 2 (H-2) restriction analysis 
showed that the cytotoxic T cell (CTL) response was 
H-2k restricted and mapped to the D region of the H-2 
complex (Mullbacher and Blanden, 1978). A 
subsequent study found that the alphavirus CTL 
response is at least cross-reactive between 
serologically defined subgroups (Mullbacher et al., 
1979). The parameters involved in CTL cross­
reactivity and genetic restriction were further 
investigated (Mullbacher and Blanden, 1979a, 1979b). 
This cross-reactive relationship among the 
alphaviruses was used to antigenically classify 
Barmah Forest virus as an alphavirus (Mullbacher et 
al., 1986).
More evidence for CTL cross-reactivity among 
the alphaviruses was shown with Sindbis and SF 
viruses (Wolcott et al., 1982b). The El 
glycoprotein was implicated as the target antigen by 
using a temperature sensitive (ts) mutant of Sindbis
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virus expressing only the El glycoprotein at the 
restrictive temperature (Wolcott et al., 1985).
Other reports gave additional support for El 
glycoprotein involvement in the CTL response 
(Wolcott et al,, 1982a, 1984).
Griffin and Johnson (1973) and Adler and 
Rabinowitz (1973) were the first investigators to 
observe virus-specific in vitro murine lymphocyte 
transformation with alphaviruses. The latter 
investigators used VEE virus and determined that:
(1) lymphoblastogenesis was dependent upon T-cells;
(2 ) that macrophages were required as accessory 
cells; and, (3) that anti-viral antibody blocks T- 
cell recognition and transformation. VEE virus- 
immune spleen cells co-cultivated with VEE virus 
infected L cells were able to inhibit VEE virus 
growth (Rabinowitz and Proctor, 1974). Macrophages 
and T cells were proposed as inhibiting virus 
multiplication. Human T cells from TC-83 virus 
vaccinees that recognized virus in lymphocyte 
transformation assays were found as early as 7 days 
following vaccination (Marker and Ascher, 1976) . 
Virus specific lymphoblastogenesis was seen with T 
cells from mice immunized with the antigenically 
unrelated alphaviruses - Ross River, Getah and 
Sindbis (Aaskov et al., 1983). None of these 
studies ascertained the possible significance of the 
in vitro T-cell proliferative response.
As early as 1979, Ashman and Mullbacher (1979) 
determined that the presence a Lyt-1+ T helper (Th) -
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cell population was an absolute requirement for the 
generation of secondary CTLs from thymocyte 
precursors in virus-immunized mice. A T-cell study 
with VEE, WEE, and EEE viruses, later demonstrated 
that the proliferative response was virus-specific 
and was associated with a virus-specific antibody 
response (Mathews and Roehrig 1989). The 
predominant proliferating lymphocyte was of the Th- 
cell cluster of differentiation (CD4+) phenotype and 
blastogenesis was associated with the secretion of 
interleukin (IL)-2. In vitro Th-cell activity was 
also associated with antibody production following 
immunization of mice with synthetic peptides 
prepared from the deduced AA sequence of the E2 
glycoprotein of SF virus (Snijders et al., 1992a).
Studies of delayed type hypersensitivity (DTH) 
with alphaviruses have been limited. Intracutaneous 
immunization with inactivated SF virus primed mice 
for a protective DTH response; no antibodies were 
detectable unless immunization was by the 
intraperitonea1 (IP) route (Kraaijeveld et al., 
1979a, 1979b). Pretreatment of mice with CYC 
enhanced the DTH response and DTH could be 
transferred to other animals with lymph node but not 
spleen cells. The adjuvant dimethyl dioctadecyl 
ammonium bromide strongly enhanced SF virus-specific 
DTH (Kraaijeveld et al., 1980). A subsequent study 
from the same laboratory using peptides of SF virus 
identified DTH-inducing T-cell epitope on the E2 
glycoprotein (Snijders et al., 1989). This epitope
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was also able to mediate Th-cell activity for 
antibody production (Snijders et al., 1992b).
The induction of interferon (IFN) by viruses 
from fibroblasts, macrophages, NK and non-NK cells 
is an important early non-specific antiviral 
response. Depending on the types of IFN induced, 
cells can be made refractory to virus infection, NK 
activity can be augmented, or events may occur that 
are important in upregulating the immune response 
(Welsh, 1986; Karupiah et al., 1990; Ramshaw et al., 
1992). Influenza virus induced IFN from allantoic 
cells of chick embryos was able to block a 
productive infection of EEE virus in chick embryo 
fibroblasts (Wagner, 1961). In another study with 
chick cells, TC-83 virus was more sensitive to IFN 
than the virulent VEE TRD virus (Jordan, 1973). In 
a study with hamsters and hamster kidney cells, 
little difference between the induction of IFN in 
vivo and in vitro by avirulent and virulent viruses 
was found (Jahrling et al., 1976). Induction of IFN 
in vivo with poly I:poly C did not inhibit the 
replication of virulent VEE virus. Hamsters 
inoculated with TC-83 virus were protected from VEE 
virulent viruses when challenged just 30 hour later 
(Jahrling, 1975). IFN appeared to be the mediator.
A multiplicity of infection of 1 with Sindbis virus 
in primary chick embryo cell culture was sufficient 
to induce maximum levels of IFN (Marcus and Fuller,
1979).
A recent study found that cell-free
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supernatants, prepared from the spleens of VEE virus 
immunized mice, were able to adoptively protect mice 
from VEE virus infection as well as transferred 
whole cells (Huprikar et al., 1990). This 
protection was not due to neutralizing antibody or 
IFN, but IL-1 and IL-2 were present. The immune 
supernatant was able to activate NK cells. These 
results show some similarities to a classical 
investigation on a putative transfer factor 
(Lawrence, 1969). Peck et al.(1975) showed that 
recipients were still protected from challenge with 
SF virus, after three seguential passages of Sindbis 
virus immune splenocytes in uninfected mice. It was 
suggested that this might be due to transfer factor. 
However, this was probably cellular and not 
lymphokine related.
The phagocytic properties of macrophages have 
been reported to be important in the early stages of 
the immune response to viruses (Welsh, 1986). VEE 
virus infected animals had increased numbers of 
reticuloendothelial cells associated with detectable 
VEE antigen (Airhart et al., 1969). In animals 
primed with VEE virus, heterologous proteins were 
rapidly eliminated following inoculation (Craig et 
al., 1969; Howard et al., 1969). In a study with 
guinea pigs infected with attenuated VEE virus, 
there was enhanced removal of circulating carbon 
particles (Staab et al., 1970). An avirulent clone 
of VEE virus was selectively removed from the blood 
of hamsters by hepatic reticuloendothelial cells
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(Jahrling and Gorelkin, 1975). Rapid clearance of 
VEE and WEE viruses from the serum of hamsters 
required the presence of specific antibody (Jahrling 
et al., 1983). The antigen-antibody complexes 
cleared were found primarily in the liver and 
spleen. It was shown that adsorption of virus to 
macrophages in vitro required antibody and C'.
These results suggested that the Fc of the IgG 
molecule was critical for clearance functions.
Cross-Protection Among Various Alphaviruses
The immunologic relationships between related 
and unrelated alphaviruses have been extensively 
investigated in cross-protection and cross-priming 
experiments in a variety of animal species. Rabbits 
immunized with EEE or WEE viruses and with 
detectable neutralizing antibody to homologous virus 
in cerebral spinal fluid, survived IC challenge with 
homologous but not heterologous virus (Morgan et 
al., 1942). Cross-protection was observed between 
Sindbis and WEE viruses but not EEE virus in 
chickens (Parks and Price, 1958). Sindbis and WEE 
viruses induced low levels of cross-neutralizing 
antibody.
Hamsters infected with the VEE complex viruses 
TC-83 (IA) or Pixuna (IV) were protected from 
challenge with VEE (IAB) and Mucambo (III) viruses 
(Scherer and Pancake, 1970). This demonstrated that 
these viruses were immunologically related.
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Hamsters immunized with VEE virus showed protection 
rates when challenged with VEE, EEE and WEE viruses 
of 98%, 59% and 37% respectively (Cole and McKinney, 
1971). EEE or WEE virus immunized hamsters against 
the same viruses had survival rates of 7%, 90%, 6% 
and 1%, 35%, 95% respectively. Neutralizing 
antibody prior to challenge was virus-specific.
EEE virus-immune guinea pigs survived 
challenge with VEE virus (Hearn, 1961). VEE virus 
immunization protected guinea pigs against a lethal 
challenge of EEE or SF virus and marginal protection 
of SF virus-immune animals was observed when 
challenged with small doses of VEE or EEE virus 
(Hearn and Rainey, 1963).
Mice immunized with chikungunya virus were 
protected from challenge with SF virus (Casals,
1957). Both viruses are in the SF virus 
serocomplex. Attenuated VEE virus protected mice 
from peripheral challenge by both VEE and EEE 
viruses (Hearn, 1961). Allen (1962) indicated that 
Sindbis virus protected mice from challenge with a 
group of antigenically related and unrelated 
alphaviruses. In the same study, Mayaro virus 
protected mice against the antigenically related 
Chikungunya and SF viruses, and Chikungunya 
immunized mice were resistant to challenge with SF 
but not VEE, EEE or WEE viruses. Mice immunized 
with an attenuated strain of VEE virus were 
protected against SF virus challenge (Hearn and 
Rainey, 1963).
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Cross-challenge tests with a variety of 
alphaviruses revealed antigenic relationships that 
were closer than those determined by serology 
(Casals, 1963). In some cases where protection was 
observed, there was no detectable HAI or NT reactive 
antibody to the challenge virus in the host. This 
study showed cross-protection relationships between 
Chikungunya and VEE viruses, Mayaro and WEE viruses, 
Mayaro and EEE viruses, EEE and SF viruses, all of 
which are serologically unrelated. Mice immunized 
IC with Sindbis virus were better protected from VEE 
virus challenge than mice immunized by extraneural 
routes (Fine et al., 1974). Several studies have 
observed cross-protection between SF and Sindbis 
viruses which are antigenically classified into 
separate complexes (Peck et al., 1975; Latif et al., 
1979; Peck et al., 1979; Smith-Owirodu et al.,
1980). Cross-protection in spiny rats with a 
battery of VEE complex viruses supported previous 
serological observations (Young and Johnson, 1969).
Cross-protection studies in equines show 
results similar to the murine studies. Six out of 
eight WEE virus immune horses survived challenge 
with EEE virus (Records and Vawter, 1935). Three 
horses, previously infected with WEE virus, survived 
EEE virus challenge (Stamm and Kissling, 1957). 
Horses immunized with WEE and EEE viruses had 
survival rates of 40% and 100% respectively 
following challenge with a virulent VEE virus, while 
90% of the control horses died following VEE virus
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challenge (Walton et al., 1989).
SUMMARY OF THE ALPHAVIRUS IMMUNE RESPONSE
Alphaviruses induce a strong Th-cell dependent 
humoral immune response to primarily conformational 
E2 determinants on the surface of the virion. These 
antibodies limit or prevent virus replication by 
interfering with virus-receptor interaction. 
Antibodies to those determinants that are the most 
protective define a "critical” domain on the E2 
involved in NT.
Antibodies to determinants on the El are mostly 
cryptic on the intact virion but are expressed on 
infected cells. These non-neutralizing antibodies 
can also be protective, but higher concentrations of 
antibodies are required. Protection with antibodies 
is Fc but not C' dependent suggesting that 
alphavirus/antibody immune complexes are captured by 
FcRs on macrophages or other phagocytic cells and 
subsequently degraded.
Cross-reactive CTLs are generated, primarily to 
the El glycoprotein, following alphavirus infection. 
Although CTLs, NK and K cells, IFN and other 
inflammatory factors may be important in the immune 
response to alphaviruses, only the presence of pre­
existing neutralizing or protective antibody will 
abrogate a lethal virus infection following virulent 
alphavirus challenge in a susceptible animal model. 
The complex immunologic interrelationships among the
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alphaviruses observed in cross-protection studies 
suggest that subcomplex and group determinant 
expression may vary from virus to virus resulting in 
differences in Th- and B-cell priming and 
activation.
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IMMUNOLOGY OP THE MURINE VIRAL TH-CELL IMMUNE 
RESPONSE
Antigen Presenting Cells and Ligand Binding
The expression of class II MHC determinants is 
obligatory for a cell to function as an APC. 
Constitutive expression of class II MHC proteins is 
consistently seen in mononuclear phagocytes, 
dendritic cells, langerhans cells and B cells (Giles 
and Capra, 1985).
The macrophage is the prototype APC (Unanue, 
1984). Macrophages are considered to be 
"professional" APC and are very efficient at 
capturing ligands. The percentage of resident 
macrophages expressing la (IA, IE) is high (25-75%) 
in the spleen, thymus and liver, but much lower 
(<10%) in the lung, blood and peritoneum (Unanue, 
1984). The percentage of macrophages expressing la 
as well as the density of class II molecules 
expressed can be upregulated during the immune 
response. Macrophages are very efficient at 
capturing ligands by both fluid phase pinocytosis 
and nonspecific adsorption (Unanue, 1984). In 
addition, Fc receptors (FcRs) on macrophages are 
also important. These can be used to bind immune 
cytophilic antibody which in turn can capture 
specific ligands (Lanzavecchia, 1990). The 
importance of cytophilic antibody was observed when 
macrophages from immune guinea pigs was able to
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present antigen to T cells at low concentrations, 
whereas macrophages from nonimmune animals required 
high concentrations of antigen (Cohen et al., 1973). 
C' receptors can also enhance ligand binding to 
macrophages (Daha and van Es, 1984).
A second cell important in antigen presentation 
is the B cell (Chestnut and Grey, 1981). Although B 
cells can specifically capture ligand by membrane 
bound (mlg), they are less efficient nonspecific 
binders of ligand than macrophages. B cells, when 
compared to macrophages, have a 1 0 0-1 0 0 0-fold lower 
capacity to pinocytose and a 10-50-fold lower 
capacity to adsorb antigen (Chestnut et al., 1982). 
It has been shown that all B cells, once ligand has 
been captured, can process and present ligands in a 
similar manner (Pierce et al., 1988), and that mlgG 
and mlgM are both efficient at capturing ligand 
(Brink et al., 1992). The differences in capturing 
ability between B cells insures that there will be 
cognate interaction with specific Th cells.
Soluble antibody (soluble receptor for antigen) 
can facilitate ligand uptake by traditional APC 
where higher antigen concentrations are required, 
whereas soluble antibody can block or compete with 
mlg for epitope binding (Lanzavecchia, 1990;
Quintana et al., 1987). FcRs, when cross-linked, 
give a negative signal to B cells (Phillips and 
Parker, 1984), whereas this is a stimulatory signal 
in macrophages to internalize the captured ligand 
(Lanzavecchia, 1990). This negative signaling in B
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cells may be a mechanism by which B cells avoid 
taking up immune complexes and functioning as 
nonspecific APC (Lanzavecchia, 1990). Immune 
complexes provide for efficient capturing of 
antigens by FcRs; however, interference with antigen 
processing can occur when formed in antibody excess 
(Manca et al., 1991).
Follicular dendritic cells (FDC) are 
stationary, nonphagocytic cells found in lymphoid 
follicles that play an important role in antigen 
presentation (Tew, 1979; Tew et al., 1980). Immune 
complexes on the dendritic cell processes become 
beaded to form immune complex-coated antibodies 
(iccosomes) which can be taken up and processed 
preferentially by B cells or by macrophages (Tew et 
al., 1990; Szakal et al., 1988). These cells appear 
not to function individually but as a part of a 
larger network or reticulum of cells (Tew et al., 
1990).
Other cells that play a role in antigen 
presentation are: Langerhans cells, interdigitating 
cells, and T cells. Langerhans cells, found in the 
skin, require collaboration from keratinocytes for 
functional antigen presentation (Geppert and Lipsky, 
1989). Interdigitating cells, found in the 
periarteriolar lymphocyte sheath and T-cell areas of 
the spleen and lymph nodes, may be important in the 
primary immune response (reviewed by Van den 
Eertwegh, 1992). T cells can act as APC if ligands 
are linked to antibodies targeted to surface
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receptors (Wyss-Coray et al., 1992). Presentation 
of peptides has been shown with cytotoxic CD8 + T 
cells (Kos and Mullbacher, 1992). During the 
inflammatory response, cells other than those 
related to the immune system can express MHC class 
II determinants. These include, keratinocytes, 
dermal epithelial cells, synovial fibroblasts and 
chondrocytes, cerebral endothelial cells, astrocytes 
and thyroid follicular cells, although their 
capacity to function as APC has not been extensively 
studied (reviewed by Geppert and Lipsky, 1989).
Internalization, Processing and Presentation of
Ligands
Ligands can be internalized without binding to 
the surface of the cell via fluid phase pinocytosis. 
Proteins internalized by macrophages using this 
process include horseradish peroxidase and mouse 
albumin (Steinman and Cohn, 1972; Schmidtke and 
Unanue, 1971). Most ligands enter the cell through 
receptor mediated endocytosis (reviewed by Geppert 
and Lipsky, 1989). In this process, ligands bind to 
receptors at neutral pH and the complex is 
internalized through clathrin-coated pits (Pearce, 
1987). When ligands are particulate, they are 
internalized by direct phagocytosis into 
phagolysosomes (Geppert and Lipsky, 1989). Some 
receptors can be internalized without ligand. Other 
receptors are not internalized at all. Some free
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ligands appear to enter through coated pits 
(reviewed by Lanzavecchia, 1990). Receptors, upon 
disassociation from ligand in early endosomes, can 
recycle to the cell surface (Schmid et al., 1988). 
FC7RII on macrophages can be recycled when complexed 
to monovalent but not multivalent ligands (Ukkonen 
et al., 1986; Mellman and Plutner, 1984). Depending 
on the concentration and type of extracellular 
ligand, surface expression of receptor can be 
downregulated.
The molecular and biochemical aspects of 
antigen processing for class II MHC molecules have 
been intensively studied (Kourilsky and Claverie, 
1989; Neefjes and Ploegh, 1992; Harding et al.,
1988; Brodsky and Guagliardi, 1991; Geppert and 
Lipsky, 1989; Lanzavecchia, 1990; Van den Eertwegh 
et al., 1992). Class II molecules are heterodimers 
of two membrane glycoproteins: the a chain (33-35 
kDa) and the 0 chain (27-29 kDa). The two class II 
molecules in the mouse making up the la subregions 
are: A (AJ^) and E (E^) and both the a and $ chains 
consist of two extracellular domains, a connecting 
peptide, a transmembrane domain and a cytoplasmic 
tail (Lafuse, 1991).
Much is known about the structure of class II 
MHC molecules. The three dimensional structure for 
the class I molecule HLA-A2 has been resolved 
(Bjorkman et al., 1987). The class I HLA-A2 
molecule contains a peptide binding cleft formed by 
eight antiparallel j3-strands with two a-helices
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outlining the groove. The groove is closed at both 
ends that restricts the size (8-10 AA) of binding 
peptides (Neefjes and Ploegh, 1992). A similar 
structure is predicted for class II molecules (Brown 
et al., 1988). Peptide binding studies and 
mutational analyses support this model (Gorga,
1992). Class II bound peptides can be up to 14 AA 
in length and show heterogeneity at the carboxy 
terminus. This heterogeneity suggests that the 
class II groove may be open at one end (Rudensky et 
al., 1991).
Neefjes and Ploegh (1992) have recently 
reviewed the two pathways by which ligands can be 
processed and effectively associate with the 
appropriate class II molecules. In the first 
pathway ligands are first endocytosed from an 
exogenous source. These ligands are all processed 
via the endocytic pathway and exclusively associate 
with class II MHC molecules. In the second pathway 
(cytosolic) ligands are synthesized endogenously.
MHC class II molecules are assembled in the ER 
and associate with the invariant or y chain which 
targets the heterodimers to the endocytic pathway 
and also blocks the binding of peptides to the 
groove. At the trans-Golgi reticulum the a/3 dimer, 
following a signal from the cytoplasmic tail of the 
invariant chain, enters the endocytic pathway at 
which time the invariant chain is released. The 
incoming ligand which has migrated from coated pits 
through early and late endosomes (during which time
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it has been proteolytically processed) interacts 
with the a/3 dimers in an acidic, peripheral, 
endocytic compartment. The acid pH alters the 
conformation of the class II heterodimer allowing 
degraded peptide to bind to the groove. This 
binding putatively stabilizes the conformational 
structure of the aj8 dimer (Sadegh-Nasseri and 
Germain, 1992). That an acid step in this process 
does occur is supported by the observation that 
treatment of the cell with lysosomotropic agents 
such as chloroguine, primaquine and NH4C1 which 
neutralize acidic compartments and inhibit 
processing (Ziegler and Unanue, 1982). In addition, 
ligand disulfides can be reduced during processing 
(Jensen, 1990, 1991). Once bound, ligand fragments 
are protected from further proteolytic digestion 
(Mouritsen et al., 1992; Donermeyer and Allen,
1989). It has been proposed that the ligand 
peptides are produced within dense lysosomes, then 
recycle back to endosomes to bind MHC molecules 
(Harding et al., 1991).
The binding of the ligand fragment to the la 
restriction element to form the agretopic complex 
is a specific event (Buus et al., 1987a, 1987b;
Sette et al., 1989a, 1989c). Since any individual 
will only have a limited number of different MHC 
molecules, these must be able to bind a large number 
of peptides to insure immunocompetence (Adorini et 
al., 1988b). Therefore, since la cannot distinguish 
between self and nonself, some peptides may bind
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that are not recognized by the T-cell repertoire of 
the host (Schaeffer et al., 1989). This hole in the 
T-cell repertoire can also occur if there are 
deletions in the gene segments arising during 
normal cell development (Nanda et al., 1991). The 
primary function of la molecules is to form 
bimolecular structures with foreign peptides and 
transport them to the surface of the cell via an 
unknown pathway (Allen et al., 1987).
In the cytosolic pathway of antigen processing 
endogenously synthesized ligands can enter the 
endocytic pathway by direct translocation over 
lysosomal membranes or the formation of 
autophagosomes which engulf cytoplasmic ligands 
(Neefjes and Ploegh, 1992). These fuse with 
lysosomal structures and enter the endocytic pathway 
for processing. The biological ramifications of the 
two processing pathways are significant. For 
effective CTL-mediated immunity to viruses, the 
cytosolic pathway is important since this is the 
only pathway that is functional for class I molecule 
binding and subsequent transport of appropriate 
ligands to the cell surface. Expression of some 
influenza virus determinants was only possible by 
endogenous synthesis suggesting that these 
determinants were degraded when presented by 
exogenous virus to the endocytic pathway (Eisenlohr 
and Hackett, 1989).
There are several factors which can influence 
not only the processing of ligands but also the
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presentation of the ligands at the surface of the 
cell. These include: (1) amount of free antigen;
(2) efficiency of capture by APC; (3) concentration 
of class II molecules with available binding sites; 
(4) stability of the bimolecular complex; (5) 
blocking of receptor by antibody; and, (6 ) immune 
complexes (Lanzvacchia, 1990). In a study with hen 
egg-white lysozyme protein, as few as 210-340 
peptide/MHC molecules per cell could activate T 
cells (Harding and Unanue, 1990). This represented 
only 0.1% of the total I-Ak molecules and suggested 
how it was possible to present multiple antigens 
simultaneously even with peptide competition. It 
has been shown that antigen/antibody complexes in 
extreme antibody excess did not activate T cells; 
this hampered proteolytic degradation during 
processing (Manca et al., 1991). This may be a 
mechanism to downregulate the immune response. 
Anti-HA MAB can block influenza virus uptake by APC, 
whereas anti-peptide antibody, which recognizes the 
same determinant as presented, blocks the antigen 
presenting step (Mills, 1988).
Th-Cell Recognition of Class II MHC-Peptide
Complexes on APC: CD4+activation requirements
There has been much interest in the factors 
involved in T-cell activation (for reviews see 
Geppert and Lipsky, 1989; Thomas, 1989; Bierer et 
al., 1989; Altman et al., 1990; Ashwell and
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Klausner, 1990; Jorgensen et al., 1992; Janeway, 
1992). Th cells are activated following recognition 
by the T-cell receptor (TCR) of foreign ligand in 
association with the appropriate, restricted MHC 
class II molecules. Following the formation of this 
trimolecular complex, the Th cell can be activated 
to secrete various lymphokines, proliferate and 
provide help to B cells. The TCR is composed of 
multiple units that function inter and co- 
dependently to activate the T cell following binding 
to the specific complexes on the APC (Janeway,
1992) .
The a and 0 polypeptide chains exist as a 
noncovalently associated heterodimer, and form the 
integral part of the TCR and determine the 
specificity of the binding (Marrack and Kappler, 
1986). Although the genes encoding these 
polypeptides are not as polymorphic as Ig genes and 
cannot undergo somatic mutation (Tonegawa, 1983) , 
random rearrangements, combinatorial association, 
and imprecise joining as well as random nucleotide 
insertion in the a(VaJa) and loci insure
diversity in the T-cell repertoire for recognition 
of MHC-associated foreign ligands (Marrack and 
Kappler, 1988; Blackman et al., 1990). Sequence 
analyses of TCRs following immunization of BALB/c 
mice with a determinant (AA 110-120) of the 
influenza virus HA1 subunit, revealed that 
structurally highly diverse (approximately 70 
different Va/V/? combinations) TCRs can be used for
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recognition (Taylor, A.H. et al., 1990).
Actual activation of the Th cell is a complex 
process. Janeway (1992) envisions the TCR as a 
multicomponent signaling machine. This consists of 
the hypervariable a:/3 heterodimer, the CD3 complex 
with its five invariant polypeptide chains, the CD4 
coreceptor, and CD45. The CD3 is in close but 
noncovalent association with the a:/3 heterodimer and 
may play a role in signal transduction (Altman et 
al., 1990). Two of the invariant chains f and e 
have been shown to activate tyrosine kinases and 
hence T cells by means of their cytoplasmic tails 
independent of the ct:fi heterodimer (Letourneur and 
Klausner, 1991, 1992). The CD4, which is also a 
member of the immunoglobulin gene superfamily, is 
considered to be a coreceptor functioning to 
activate transduced signals (Janeway, 1992). To do 
this the CD4 must physically associate with TCR and
bind the same ligand (Dianzani et al., 1992).
CD45 is the leukocyte common antigen found on 
all cells of haemopoietic origin. It is expressed 
on the surface at a ratio of 1 0 : 1 compared to the 
TCR (Alexander et al., 1992). A mutant T cell 
lacking CD45 and signal transduction for T-cell 
activation, can be activated following transfection 
with CD45 cDNA which restores the CD3-induced
signals (reviewed by Alexander et al., 1992). CD45
has a unique structure with various isoforms which 
appear to have distinct functions or activation 
requirements (Janeway, 1992). The low molecular
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weight isoforms of CD45 are associated with memory 
cells, whereas the isoforms with high molecular 
weight are associated with naive cells. Both the 
CD4 and CD45 are in close physical contact with TCR 
in memory but not naive T cells (Dianzani et al.,
1992). Therefore, it was speculated that CD45 plays 
a regulatory role in signal transduction through the 
TCR (Janeway, 1992).
Other molecules on the surface of Th cells also 
play a role in the interaction between Th cells and 
MHC-ligand complexes. These include: (1) CD2 
(murine CD48, Kato et al., 1992) which binds to its 
ligand on the APC promoting adhesion and Th-cell 
activation (Bierer et al., 1989); (2) leukocyte 
function associated (LFA)-1 which is part of a 
family of homologous proteins called integrins 
(Hynes, 1987), and functions as an adhesion molecule 
binding to intercellular adhesion molecule (ICAM)-l 
on APC; (3) CD28, which is not physically linked to 
the TCR complex, but might be a part of another 
activation pathway (Altman et al., 1990); (4) CD5 
(murine Lyt-1) which may provide for accessory 
activation signals; and, (5) CD6 and CD7, when 
crosslinked by specific MABs, bring about 
intracellular Ca2+ mobilization (Altman et al.,
1990). Four adhesion molecules (B7, ICAM-1, LFA-3, 
and vascular cell adhesion molecule [VCAM]-1) 
expressed on the surface of APC have been shown to 
differentially costimulate T-cell activation (Damle 
et al., 1992).
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Bretscher and Cohn (1970) were the first 
investigators to propose that T-cell activation 
required two signals: one from interaction with 
receptor and another signal from an antigen specific 
cell. A recent study showed that activation of 
memory Th cells only required occupancy of the TCR 
complex, while naive Th cells required TCR 
interaction and an additional signal from the APC 
(Luqman and Bottomly, 1992). Results in mice with 
B7 and a heat stable antigen suggested that these 
ligands could provide the second or costimulatory 
signal from APC (Liu et al., 1992). Another study 
from the same laboratory indicated that infectious 
agents or their constituents can induce APC to be 
costimulatory for Th cells (Liu and Janeway, 1991).
Th-Cell Subsets
Studies using Th-cell clones have identified 
at least two distinct types of Th cells (Thl and 
Th2) based on lymphokine and secreted protein 
profiles (Mosmann et al., 1986; Mosmann and Coffman, 
1989). The major differences between these cell 
types are that Thl clones secrete IL-2, IFNy and 
lymphotoxin (LT), whereas Th2 clones secrete IL-4, 
IL-5, IL-6 and IL-10. Because of these different 
lymphokine patterns, Thl cells appear to correlate 
with DTH; Th2 cells primarily provide help for 
antibody synthesis. Th2 cells are associated with 
IgM, IgA, IgE and IgGl synthesis. Numerous studies
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have confirmed this dichotomy among not only murine 
but also among human Th cells (reviewed by Bottomly, 
1988; Mosmann et al., 1991; Van den Eertwegh et al., 
1992; Sher and Coffman, 1992; Romagnani, 1992).
These studies also suggest that additional 
phenotypes may exist.
Based on the cumulative data, Mosmann et al. 
(1989, 1991) have developed a model for Th-cell 
subset differentiation (Table 3). Mature, naive, 
precursor Th cells secrete only IL-2 after specific 
interaction with antigen on APC. After 
differentiation, these cells for a short time 
secrete several possible lymphokines including the 
ThO pattern. When the host is initially challenged 
with a large antigen burden, either the Thl or Th2 
phenotypes become dominant without having 
intermediate phenotypes. Thl cells, if low in 
number and in the presence of Th2 cells, can help 
with antibody (primarily IgG2a) production; however, 
if in large numbers, Thl cells can kill B cells and 
targets probably by release of LT. In this model, 
short-term memory Th cells retain either Thl or Th2 
secretion profiles, whereas long-term memory Th 
cells secrete IL-2. Some cytokines are 
antagonistic. IFN7 and IL-4 are mutually 
inhibitory; IL-10 inhibits production of IFN7 . 
Therefore, complex interregulatory mechanisms 
control the expressed immune response.
In earlier studies, it was observed that 
immunization of animals to induce antibodies made
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Table 3. Th-cell phenotypes based on cytokine secretion 
profiles*.
Lymphokines
Naive
Th
Early 
ThO and ?b Thl Th2 Thmc
IL-2 + + + - +
IFN7 - + + - -
LT 7 + - -
IL-4 - + - + -
IL-5 - + “ + -
IL-6 7 - + -
IL-10 - + - + -
IL-3 - + + + -
TNFd 7 7 + + -
GM-CSF* - 7 + + -
“Adapted from Mosmann et al. (1989, 1991).
Various lymphokine secretion patterns ([IL-2 , 4, 5],
[IL-2, 4, IFN7 ], and [IL-2, 3, 4, 5, 10, IFN7 ]) may be 
seen following early activation with relevant antigen.
cLong-term memory Th cells.
^NF = tumour necrosis factor
dGM-CSF = Granulocyte macrophage-colony stimulating 
factor.
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the animals refractory to the induction of DTH. 
Asherson and Stone (1962) called this phenomenon 
"immune deviation" and suppressor cells were 
implicated. Current evidence indicates that immune 
deviation could be attributable to preferential 
induction of a Th2 type of response, although the 
Th2 DTH is a Jones Mote type and not the classical 
tuberculin type of DTH.
More recently, a recombinant malaria protein 
induced Thl and CD8+ T cells but no antibody (Siiss 
and Pink, 1992). Various immunogens and antigenic 
fragments could induce one or the other of the 
subset populations (Scott et al., 1988; Street et 
al., 1990). The concentration of antigen and the 
type of APC may influence selection of Th-cell 
subsets (DeKruyff et al., 1992). In addition, a 
synthetic peptide to Leishmania sp, preferentially 
activated Th2 cells (Liew et al., 1990). The logical 
extension to Thl and Th2 induction is the possible 
effectiveness of their immune responses against 
intracellular and extracellular pathogens, 
respectively. Romagnani, (1992) has proposed that 
during the natural immune response with bacteria and 
viruses that induction of 7 IFN by these agents from 
NK cells and mast cells may evoke a Thl type of 
immune response. Janeway (1992) has speculated that 
the compilation of the CD45 low molecular weight 
isoform at different stages of Th cell maturation 
may play a role in determining the final Th cell 
phenotype.
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In Vitro Analysis of Th-Cell Activation
One of the earliest observations on lymphocyte 
transformation in vitro was made by Achard and 
Bernard (1909) when leukocytes from morphine addicts 
were unresponsive to tuberculin stimulation when 
compared to normal individuals. Attempts to study 
leukocytes in cell culture over the next fifty years 
were not very successful (Rich and Lewis, 1932; 
Heilman, 1963). Interest in the development of in 
vitro assays for lymphocyte transformation was 
spurred by a need for an in vitro correlate of DTH 
(Bloom, 1971). Some of these studies indicated that 
transformation was related to the carrier in hapten- 
carrier immunized animals. Mills (1966) found that 
lymphocytes from guinea pigs immunized with a DTH 
inducing antigen underwent transformation in vitro. 
This was subsequently confirmed by Oppenheim (1968).
It was found that B cells and macrophages but 
not T cells would nonspecifically bind to glass 
beads (Rosenthal et al., 1972), cotton wool (Hogg 
and Greaves, 1972), and NW (Eisen et al., 1970). 
Immune guinea pig lymphocytes purified over glass 
beads proliferated in the presence of specific 
antigen (Waldron et al., 1973). The presence of 
macrophages was necessary for lymphoblastogenesis.
In a classic study, Julius et al. (1973) described a 
simple but effective procedure for purifying T cells 
by NW chromatography for in vitro lymphocyte
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transformation assays. This procedure also utilized 
irradiated stimulator cells to reduce background. 
Reproducibility of results were much improved using 
media supplemented with 2-mercaptoethanol (ME), and 
using NW purified T cells from peritoneal exudates 
(Schwartz et al., 1975). A similar procedure using 
lymph node T cells yielded strong and specific 
proliferative responses (Corradin et al., 1977).
Lee et al. (1979) showed by T-cell depletion 
using anti-Thy 1 that the proliferating population 
of cells in lymphoblastogenesis assays was T cells. 
Subsequent observations that these T cells were 
predominantly Th cells and the interest in 
characterizing T-cell epitopes on synthetic 
peptides, once again focused attention on in vitro 
lymphocyte transformation assays as possible 
correlates of the in vivo T-cell response (reviewed 
by Berzofsky et al., 1987; 1988; Milich, 1989). The 
caveat with this analysis is that the proliferative 
response may vary considerably depending on Th-cell 
subtypes involved and the associated lymphokine 
profiles.
Th-Cell Epitopes: Predictive Algorithms
Precise analysis of Th-cell epitopes on 
globular proteins is difficult at best. Therefore, 
since Th-cell epitopes are linear or continuous, as 
determined primarily by analyzing native and 
denatured forms of protein, (reviewed by Livingstone
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and Fathman, 1987, and Milich, 1989), and since the 
minimal size (7 AA) for Th-cell epitopes has been 
determined (reviewed by Livingstone and Fathman,
1987), synthetic peptides, derived from the deduced 
AA sequences of proteins, are ideal for this type of 
analysis. However, for any protein this can become 
a monumental task if a purely empirical approach is 
taken, since many peptides would have to be 
synthesized. Based on a hypothetical virus 
glycoprotein that is involved in important 
biological activities such as NT, one could make 
some decisions on regions for peptide synthesis that 
might include: conserved versus variable domains 
when compared to other virus strains; residue 
changes arising from mutagenic events; residue 
changes following the selection of NT escape 
variants with MABs; binding of MABs of interest to 
protein fragments; and, the immune response in 
animals to these protein fragments as measured in 
lymphoblastogenesis tests (LBTs).
Better decisions could be made for synthetic 
peptide design if one could predict (1) what the TCR 
sees in the peptide/MHC bimolecular complex, and (2) 
the residues that form the specific agretopic 
association between the peptide and the MHC 
heterodimer. Further complicating these protein- 
protein interactions are the hydrophilicity 
requirements for optimal agretopic (la plus ligand) 
and epitopic (TCR plus agretope) associations. To 
this end, various algorithms for predicting T-cell
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epitopes have been developed.
Berzofsky and his colleagues have pioneered the 
development of algorithms for predicting T-cell 
epitopes. Delisi and Berzofsky (1985) were the 
first investigators to suggest that most of the T- 
cell epitopes known at that time were amphipathic 
(i.e. alternating hydrophilic and hydrophobic 
regions of AA) in nature. They proposed that the 
hydrophobic region of the bimolecular complex (la 
plus foreign peptide) had to associate with the 
hydrophobic environment at the cell membrane of the 
APC, while the epitopic residues had to be in a 
hydrophilic mileau in order to interact with the 
TCR. Furthermore, most of these determinants could 
fold as a helices and that some sites were 
segmentally amphipathic, i.e. a very hydrophobic 
region was adjacent to a very hydrophilic region 
(Berzofsky et al., 1987).
These preliminary observations led to an 
analysis of more determinants using an improved 
algorithm (AMPHI) (Margalit et al., 1987). This 
algorithm analyzed AA sequence segments that only 
could fold into an amphipathic a-helix. This was 
based on the assumption that a segment that had 
large "hydrophobic moment", based on a slight 
modification of the Fourier analysis, had the 
potential to fold into an amphipathic a-helix. 
Another important parameter of the AMPHI analysis 
was the selection of a hydrophobicity scale that 
would accurately predict amphipathicity in a-
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helices . The scale of Fauchere and Pliska (1983) 
was selected since it performed best with known T- 
cell sites. In a comparative study by Margalit et 
al. (1987) 18 of 23 known T-cell determinants, 
derived mostly from studies with globular proteins 
but which also included some viruses, were predicted 
using the AMPHI algorithm.
Spouge et al. (1987) took a statistical 
approach to analyze the other possible structural 
correlates of T-cell recognition. These included 
helical properties, segmental amphipathicity, 
conformational propensities and the positioning of 
residues that stabilize a-helices. The results were 
consistent with the observations obtained in the 
AMPHI studies. Immunodominant T-cell determinants 
have strong secondary structural propensities that 
are stable during hydrophobic interaction with class 
II MHC molecules (Berzofsky et al., 1987).
Another T-cell epitope predictive algorithm 
based on empirical and not mathematical observations 
made from known T-cell determinants was developed 
(Rothbard, 1986). The Rothbard motif, like the 
AMPHI model, considers hydrophobic and hydrophilic 
aspects of peptide segments. The motif is defined 
by a pattern of a charged residue or glycine 
followed by two or three hydrophobic residues and 
then a polar residue. Using a larger database to 
further refine the original motif it was found that 
the binding of peptides to both class I and II 
molecules was similar (Rothbard and Taylor, 1988) .
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The interactions involved in the binding of peptides 
to MHC proteins as well as a comparison of the AMPHI 
and motif algorithms have been reviewed (Rothbard 
and Gefter, 1991).
A third algorithm for predicting T-cell 
epitopes has been proposed (Elliott et al., 1987; 
Stille et al., 1987; Reyes et al., 1988, 1990; Lu et 
al., 1990, 1992a, 1992b). This algorithm, the 
strip-of-helix hydrophobicity algorithm (SOHHA), is 
based on the strip-of-helix hydrophobicity index 
(SOHHI). This index was determined by ranking 
peptides by their mean Kyte and Doolittle (1982) 
hydrophobicity values of AA at positions n, n + 4, n 
+7, n + 11, n + 14 and n + 18 in a sequence that 
when coiled as a putative a-helix, the indicated 
residues would be found in an axial strip on one 
side of the helix. This hydrophobic strip might 
stabilize the peptide against the hydrophobic 
surfaces of internal membranes. Hydrophobic strips 
that were found associated with known T-cell 
epitopes were characterized by a highly hydrophobic 
strip adjacent to moderately hydrophilic strips 
containing no prolines. An analysis of selected T- 
cell determinants using the SOHHA, AMPHI and motif 
algorithms found similar predictive results (Reyes 
et al., 1990).
Based on an elegant set of interrelated studies 
on the binding of ligand to la, it was determined 
that some la restriction molecules shared a common 
structural motif (Buus et al., 1987a, 1987b; Sette
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et al., 1988, 1989a, 1989b, 1989c, 1989d, 1990). It 
was also demonstrated by analysis of sequence 
patterns that the binding of la to ligand could be 
predicted. A common motif for the binding of ligand 
to another restriction element was also determined 
(Romero et al., 1991). Sequencing of peptides 
associated with class I MHC has led to more motif 
predictions (Falk et al., 1991). Using this motif, 
a 9 AA peptide was synthesized that was efficiently 
recognized by a T-cell clone to Listeria 
monocytogenes (Pamer et al., 1991). Replacement of 
epitopic residues but not agretopic residues in a 
pigeon cytochrome c synthetic peptide known to 
associate with IAk and IAb, with residues from 
influenza virus hemagglutinin, induced neutralizing 
antibody to virus in the corresponding MHC types 
(Ogasawara et al., 1992).
Efficient analyses of proteins for T-cell 
determinants using synthetic peptides, independent 
of predictive algorithms, have taken various 
approaches. The pepscan method of synthesizing 
peptides on solid polyethylene rods for B-cell 
studies has been very successful (Geysen et al., 
1984, 1987). This method has been adapted for T- 
cell studies where a linker system cleaves the 
peptides from the rods in aqueous solution at 
neutral pH (Maeji et al., 1990). This may be a 
feasible approach for detailed analyses of Th-cell 
determinants on proteins (Gammon et al., 1991).
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Th-cell Epitopes: Structural and Functional
Characteristics
Anderer (1963) made the first observation that 
a peptide could induce an antiviral response. A 
hexapeptide fragment from tobacco mosaic virus when 
coupled to a carrier could elicit virus reactive 
antibodies. Using synthetic peptide technology a 
human Th-cell recognition site within the influenza 
virus haemagglutinin was identified (Lamb et al., 
1982). T-cell studies with synthetic peptides to 
cytochrome c (from various species), hen egg 
lysozyme, hen ovalbumin, and sperm whale myoglobin 
have elucidated much about the structure and 
function of Th-cell epitopes (reviewed by Milich,
1989). Among the findings were: (1) that T cells 
and la interact with different sites on the antigen 
(Hansburg, 1981); (2) determination of minimal 
peptide size for Th-cell stimulation (Schwartz,
1985); (3) factors involved in immunodominance 
(Solinger et al., 1979; Berkower et al., 1984; 
Maizels et al., 1980); (4) that Ir genes could 
control responses to different antigenic 
determinants on the same protein (Berzofsky et al., 
1979); and, (5) structural requirements for peptide- 
Ia interaction (Shimonkevitz et al., 1984). Other 
proteins utilized for Th-cell epitope studies have 
included staphylococcal nuclease, /3-galactosidase, 
and insulin. Each study indicated that the immune 
response to a multideterminant antigen was
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controlled by numerous immune response (Ir) genes 
(reviewed by Milich, 1989).
Numerous studies with synthetic peptides have 
indicated that Th- and B-cell epitopes do not 
overlap (Milich et al., 1985; 1986; Maizels et al,, 
1980; Corradin and Chiller, 1979; Berkower et al,, 
1984; Hurwitz et al,, 1984), while other studies 
indicated that the epitopes do overlap (Cohen et 
al,, 1984; Dietzschold et al,, 1984; Graham et al., 
1989; Barnett et al,, 1989; Kutubuddin et al,,
1992a, 1992b). The presence of multiple restriction 
elements, B-cell epitopes and Th-cell epitopes on a 
peptide 22 AA in length from Murray Valley 
encephalitis virus suggested that Th- and B-cell 
epitopes do overlap (Mathews et al., 1992).
Studies with Th-cell clones have demonstrated 
multiple and distinct recognition specificities 
within a limited region of AA on peptides which 
clustered the epitopes into a single domain (Manca 
et al., 1984; Mills et al., 1986; Cease et al.,
1986; Ffrench et al., 1989). Overlapping Th-cell 
determinants have also been determined using 
lymphoblastogensis (Heber-Katz et al., 1988;
Nicholas et al., 1989). Some studies have shown 
that AA outside of the determinant area can 
influence the expression of the determinant (Hackett 
et al., 1985; Shastri et al., 1986; Gammon et al., 
1987; Anderson et al., 1990; Lamont et al., 1990). 
Both of these observations could be explained by a 
recent study by Gammon et al. (1991) in which
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lysozyme was comprehensively analyzed using a series 
of peptides that walked the protein in single AA 
steps using pin technology. This study elucidated: 
(1) the T-CELL DETERMINANT as the shortest peptide 
(defines minimal epitopic and agretopic residues) 
that stimulates a response of normal magnitude in a 
T-cell clone; (2) the DETERMINANT ENVELOPE which 
includes all the overlapping determinants recognized 
in a continuous stretch of the sequence; and (3) the 
CORE SEQUENCE which consists of all the residues 
shared by all the immunogenic peptides in a region. 
The core sequence itself may not be immunogenic, but 
is overlapped by all the immunogenic peptides in the 
domain.
In replacement analyses with various Th-cell 
determinants, it has been found that the 
substitution of a single residue can profoundly 
affect the antigenicity and immunogenicity of a 
peptide (Suhrbier et al., 1991; Kumar et al., 1990; 
Bodmer et al., 1988). In TCR-binding and MHC- 
binding studies using small replacement sets some 
peptides assume a-helical conformations with the 
epitopic and agretopic determinants being recognized 
separately (Allen et al., 1987; Rothbard et al.,
1989). However, in other replacement studies, 
individual residues are found that adopt 
conformations that are recognized by both the TCR 
and MHC molecules (Anderson et al., 1990; Sette et 
al., 1987; Maryanski et al., 1990; Fox et al.,
1987) .
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Th-Cell Memory
T-cell memory has been the subject of a number 
of recent reviews (Cerottini and MacDonald, 1989; 
Vitetta et al., 1991; Mackay, 1991). Memory T cells 
can be distinguished from naive or virgin T cells 
by: (1 ) responding to specific antigen by 
proliferating; (2 ) providing help for antibody 
induction; (3) phenotypic markers; (4) activation by 
cross-linking TCR-associated molecules; and, (5) 
differential patterns of lymphokine secretion.
Budd et al. (1987) found a direct association 
between the presence of a surface-associated CD4 T- 
cell glycoprotein (Pgp-1 (CD44); Trowbridge et al., 
1982) and cells that had recently been antigenically 
stimulated. Mature but unstimulated CD4+ T cells 
were Pgp-1'. MABs to T-cell surface markers have 
also been able to separate memory CD4+ T cells from 
naive T cells (Reinherz et al., 1982; Akbar et al., 
1988; Byrne et al., 1988; Dianzani et al., 1990). 
Crosslinking of CD2 and CD3 receptors with antibody 
activates memory Th cells (Byrne et al., 1988; 
Sanders et al., 1989).
Among the various isoforms of CD45, the lowest 
weight isoform, which reacts with MAB UCHL-1, is 
associated with memory cells, while the highest 
weight isoform, which reacts with MAB 2H4, is 
associated with virgin T cells (Dianzani et al., 
1990). These authors and Janeway (1992) have 
suggested that memory T cells have an altered
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structure of the molecules associated with the TCR 
complex which is controlled by the low molecular 
weight CD45. This isoform has been found to be 
associated with surface marker phenotypic 
differences (both qualitative and quantitative) that 
differentiate memory from naive T cells (Akbar et 
al., 1991).
Although Thl and Th2 CD4+ cells have distinct 
cytokine synthesis patterns when compared to each 
other or to naive Th CD4+ cells, it has been 
proposed that long-term memory Th cells and naive Th 
cells both have the same cytokine profile - 
secretion of IL-2 (Mosmann et al., 1991). Mackay et 
al. (1992) have suggested that memory and naive T 
cells have different trafficking patterns in the 
blood, lymph nodes and tissues. Memory T cells are 
also not responsive to the superantigen 
staphylococcal enterotoxin B (Lee and Vitetta,
1992) .
How memory Th cells are maintained in vivo 
over-time has not yet been resolved. One 
possibility is that memory T cells are long-lived. 
There is evidence that memory T cells can remain in 
a resting state for more than 30 years (Darby et 
al., 1987). These cells may naturally divide 
(Mackay et al., 1992), or not divide (Orme, 1988) or 
be stimulated periodically by cross-reactive 
antigens (Beverley, 1990). CD8 + memory T cells to 
lymphocytic choriomeningitis (LCM) virus have been 
found to persist in mice for the life span of the
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host (Jamieson and Ahmed, 1989).
Another possibility for the maintenance of 
memory T cells is that sequestered antigen persists 
for long periods of time periodically activating 
memory T cells. Celada (1971) first suggested that 
antigen is required for long-lived memory cells.
More recently, Gray and Matzinger (1991), in 
adoptive transfer studies using hapten-carrier 
primed lymphocytes, also demonstrated that antigen 
is required to maintain T-cell memory.
Macrophages could be involved in the process of 
sequestering antigen (Ellner et al., 1977) or, more 
likely, antigen could persist in FDC (Tew, 1979; Tew 
et al., 1980, 1990). Protective CTL memory to LCM 
virus required persisting antigen (Oehen et al., 
1992). Influenza virus, which induces long-lived 
immunity, however shows no evidence of persisting 
antigen or residual genomic RNA (Eichelberger et 
al., 1991). Despite evidence to the contrary, 
specific, short-lived anti-viral memory Th cells 
have been found in vivo (Roost et al., 1990).
Th-Cell Epitopes: Immunodominance
It has been observed in Th-cell studies with a 
number of proteins that the immune response is 
focused on just a few immunodominant determinants 
(reviewed by Gammon et al., 1987). Th-cell studies 
with hen egg white lysozyme and lysozyme from other 
species, have categorized this response as
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"hierarchial" (Katz et al., 1982; Shastri et al., 
1984; Sercarz et al., 1986a; 1986b). This 
categorization included: immunodominant (reciprocal 
recognition by peptide and protein Th cells of 
protein and peptide, respectively); subdominant 
(peptide Th cells recognize peptide and protein); 
cryptic (peptide Th cells only recognize peptide). 
Adorini et al. (1988a, 1988c), independent of the 
previous studies, made similar observations. The T- 
cell response to pigeon cytochrome c and various 
myoglobins focused on just a few immunodominant 
epitopes (Solinger et al., 1979; Berkower et al., 
1984) .
Another observation made in several studies 
using synthetic peptides is that the peptides 
overexaggerate the number of epitopes that are 
actually functional on the native protein (Milich et 
al., 1986; Gammon et al., 1987; Berzofsky et al., 
1988; Brett et al., 1989; Gammon et al., 1990).
This may be due to (1) a lack of competition for MHC 
with more dominant peptides; (2 ) more molecules or 
copies of epitopes and hence increased density of 
MHC/peptides at surface of APC; and, (3) peptides do 
not have to be processed before associating with MHC 
(Gammon et al., 1987; 1990; Ertl et al., 1991). 
Synthetic peptides probably also separate the 
clusters of determinants recognized by T-cell clones 
in a restricted domain (Berzofsky et al., 1988).
This clustering of epitopes on a protein was 
confirmed in a definitive study of the core and
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determinant epitopes of hen egg-white lysozyme in 
three haplotypes of mice (Gammon et al., 1991). The 
Th-cell response to influenza virus nucleoprotein 
was to the same dominant determinants regardless of 
whether animals were immunized with virus, protein 
or peptide (Gao et al., 1990; Brett et al., 1991b).
In the determinant selection model of 
immunodominance, it was proposed that 
immunodominance was determined by the hierarchy of 
binding affinities of processed peptides for MHC 
molecules (Rosenthal, 1977). Both intramolecular 
and intermolecular competition for MHC class II 
molecules between covalently linked T-cell epitopes 
have been associated with peptide conformation 
influenced by adjacent sequences and immunodominance 
(Perkins et al., 1991; Wang, Y. et al., 1992).
Other studies have also indicated that peptide 
conformation is important for efficient binding to 
MHC (Bhayani and Paterson, 1989; Boyer et al.,
1990b) and intramolecular interactions between AA of 
the peptide may affect the conformation during 
processing (Boyer et al., 1990a). Berzofsky and his 
colleagues have stressed that the amphipathic a 
helical structure with strong conformational 
propensities is important for MHC association and 
immunodominance (DeLisi and Berzofsky, 1985; Cease 
et al., 1986; Spouge et al., 1987; Kurata et al.,
1989).
Since there are limited numbers of different
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MHC molecules in any individual, these molecules 
must exhibit a degenerate type of association in 
order to recognize a wide variety of processed 
peptides (Adorini et al., 1988b). This has been 
demonstrated by blocking of known immunogenic 
peptides with non-immunogenic peptides (Adorini et 
al., 1988a). Therefore, optimal conformation for 
interaction with MHC molecules may influence 
immunodominance. Ability of a peptide to associate 
with multiple MHC types may also be an important 
factor in determining immunodominance (Brett et al., 
1991a). Another factor may be the in vivo half-life 
of peptides which has been shown to be affected by 
flanking sequences (Lamont et al., 1990).
Since single AA substitutions in a synthetic 
peptide can greatly alter the immunodominant 
characteristics of a peptide (Fox et al., 1987; 
Adorini et al., 1988c; Milich et al., 1989), this 
may reflect a gain or loss in immunogenicity 
relative to MHC association or to recognition by Th 
cells. If a stable agretopic complex is formed and 
transported to the surface of the cell, but not 
recognized by Th cells, there is a hole in the T- 
cell repertoire. This is considered to be a major 
factor in immunodominance. Several studies with 
peptides have confirmed proper peptide MHC 
association, but there was a lack of recognition by 
Th cells (Guillet et al., 1987; Kojima et al., 1988; 
Schaeffer et al., 1989). Gammon et al. (1990) have 
proposed that environmental antigens, even in
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specific pathogen free murine colonies and even in 
different mice in the same cage, can dramatically 
affect the T-cell repertoires due to clonal 
selection influence by exogenous antigens.
Th-Cell Epitopes: Associated Antibody Response
Claman et al. (1966) first recognized that the 
presence of T cells is required for a B-cell 
response. Although the hapten-carrier effect had 
been observed for some time, Mitchison (1971) 
provided the first direct evidence in hapten-carrier 
studies that cooperation between two cells with 
distinct determinant specificities was required. 
Subsequently, many studies have shown that the 
interaction between Th and B cells and the release 
of cytokines are the important factors in bringing 
about differentiation of resting B or memory cells 
into actively secreting plasma cells (reviewed by 
Vitetta et al., 1989, 1991; Brown, 1992).
This activation of B cells requires cognitive 
recognition; the mechanisms involved were first 
described by Lake and Mitchison (1976). In order 
for the cognate process to occur the Th and B cell 
epitopes must either be linked within the same 
protein (intramolecular) or structurally linked 
(intermolecular or intrastructural). This was first 
considered to occur via an antigen bridge 
(Mitchison, 1971) between T and B cells; however, 
this has been modified based on the role of B cells
-79-
in antigen processing (Chestnut and Grey, 1981; 
Lanzavecchia, 1985). The current view is that the 
haptenic part of an immunogen is recognized by a B 
cell, processed and presented with peptides of the 
carrier in association with MHC molecules that are 
then recognized by Th cells (Vitetta et al., 1989). 
This activation of B cells may be related to the 
binding of 39 kDa protein on Th cells to CD40 on B 
cells (Noelle et al., 1992). Also, Th and B cells 
may interact on macrophages recognizing their 
respective ligands.
Therefore, it is not surprising in studies with 
synthetic peptides that a Th-cell response to a 
peptide is almost always associated with a B-cell 
response (reviewed by Milich, 1989). Factors that 
may affect a B-cell response with synthetic peptides 
that have functional Th-cell epitopes and the 
appropriate MHC restriction elements are: (1)
orientation of Th- and B-cell epitopes; (2) 
limitations in recognition by the B-cell repertoire 
of the host; (3) lack of a B-cell epitope on the 
peptide, and, (4) differential induction of subsets 
of Th cells (Cox et al., 1988; Levely et al., 1990; 
Milich et al., 1990a, 1990b; Mathews et al., 1991; 
Milich et al., 1989; Mosmann et al., 1991). The 
antibody response to synthetic peptides is to 
continuous determinants, whereas the dominant 
antibody response to a native protein is to 
discontinuous determinants (Van Regenmortel, 1992; 
Laver et al., 1990). Due to the cognate nature of
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the Th- and B-cell immune response, peptides can 
prime for Th cells that will provide help for 
discontinuous determinants on a protein (Milich et 
al., 1987a, 1987b; Ertl et al., 1989; Su et al.,
1990).
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CURRENT APPROACHES FOR VIRAL VACCINE DEVELOPMENT
Immunogen Expression Systems
The AIDS epidemic has been a driving force 
behind developing the knowledge of not only how to 
engineer immunologically sound viral vaccines, but 
also how to rationally approach genetic engineering 
of these potential vaccines and appropriate delivery 
systems. Zanetti et al. (1987) have reviewed the 
immunological parameters that are probably important 
in inducing an anti-viral protective response.
Genetic engineering of effective immunogens has 
involved several approaches (reviewed by Rutgers et 
al., 1990; Tartaglia and Paoletti, 1990; Woodrow,
1990). The use of eukaroytic and prokaroytic cells 
to express viral protein(s), following insertion of 
genes or appropriate vector and purification of the 
expressed product, has been investigated. The most 
successful eukaroytic system to date has been the 
expression of a hepatitis B vaccine from yeast 
(Valenzuela et al., 1982). Insect and mammalian 
cell expression systems have not been as successful.
Use of live, recombinant bacteria to deliver 
desired viral immunogens by the oral route is a 
technique with much promise (reviewed by Schodel, 
1992). Salmonella expressing an influenza 
haemagglutinin epitope or hepatitis surface antigen 
was able to induce an immune response (McEwen et
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al., 1992; Wu et al., 1989). Another possible way 
to deliver immunogens to the mucosal immune system 
by the oral route is in biodegradable microspheres 
(McGhee et al., 1992). Cholera toxin is being 
evaluated as an oral adjuvant (McGhee et al., 1992).
Some other approaches to develop innovative 
methods for vaccines include: (1 ) genetic 
immunization (Tang et al., 1992); (2) hybrid virus 
particles (Michel et al., 1990; (3) RNA virus 
infectious recombinants (Hahn et al., 1992; London 
et al., 1992); 3) hepatitis B core antigen as a 
potent stimulator of a polyclonal B-cell response 
(Milich et al., 1988; Murray, 1988; Francis et al., 
1987; Clarke et al., 1987); (4) live recombinant 
viral vaccines (Tartaglia and Paoletti 1990); (5) 
synthetic peptides (Milich, 1989); (6 ) anti- 
idiotypic immunogens (Dalgleish and Kennedy, 1988) ; 
(7) immunostimulating complexes (iscoms) (Morein et 
al., 1987); and, (8 ) infectious cDNA clones (Davis 
et al., 1989; Kinney et al., 1993).
Recombinant Vaccinia virus as a Vector
The use of Vaccinia (VAC) virus as a suitable 
expression vector for foreign genes was first 
demonstrated by Mackett et al. (1982) and Panicali 
and Paoletti (1982). The molecular biology of VAC 
virus and its immunological applications as a 
vaccine have recently been reviewed (Mackett and 
Smith, 1986; Moss and Flexner, 1987; Tartaglia et
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al.t 1990; Bennink and Yewdell, 1990; Moss, 1992). 
The large size of the VAC virus genome 
(approximately 185 kb) makes homologous 
recombination a sensible approach to creating 
recombinant viruses. Foreign DNA segments up to 
25,000 base pairs have been inserted into the VAC 
virus genome.
One of the most attractive immunological 
aspects of using VAC virus as an expression system, 
is that proteins are processed and glycosylated in a 
normal manner (Moss, 1992). Another important 
factor for vaccine development is that revaccination 
with VAC virus recombinants appears to be successful 
(Tartaglia et al., 1990). In order to reduce 
virulence of some strains of VAC virus, 
investigators have found that deletion or 
modification of certain genes reduces virulence or 
alters host range (Tartaglia et al., 1990).
VAC virus can naturally modulate the host's 
response to infection. VAC virus secretes a soluble 
receptor for IL-1/3 which reduces the inflammatory 
response to the virus (Ray et al., 1992; Spriggs et 
al., 1992; Alcami and Smith, 1992). Myxoma virus, 
which is a Leporipoxivirus related to Shope fibroma 
virus, secretes a receptor for TNF which also might 
reduce the inflammatory response (Upton, 1991). VAC 
virus also secretes a protein that binds to C4b 
which blocks the classical pathway of C' activation 
(Kotwal et al., 1990). Ramshaw and colleagues have 
constructed recombinant VAC viruses expressing
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various cytokines including IL-2, IFN7 , and TNF as 
models to evaluate the role of these molecules on 
virus infection in vivo (Ramshaw et al., 1992). 
Therefore, the use of VAC and other poxviruses 
presents a unique opportunity to study the 
mechanisms of various proteins involved in the 
immune response. Analysis of the immune response to 
various VAC virus encoded proteins has also been 
investigated (Demkowicz et al., 1992).
Glycoproteins from various viruses have been 
expressed in VAC and induce protective immunity in a 
variety of laboratory hosts. Some of the viruses 
investigated include: Friend leukemia virus (Earl
et al., 1986); Herpes simplex virus (Martin and 
Rouse, 1987); Lassa virus (Auperin et al., 1988); 
cytomegalovirus (Jonjic et al., 1988); VEE virus 
(Kinney et al., 1988a, 1988b); Japanese encephalitis 
virus (Mason et al., 1991); and, rabies virus 
(Sumner et al., 1991). VAC virus also shows a wide 
species range. Recombinant VAC VEE viruses have 
been shown to protect horses and monkeys from 
virulent VEE virus challenge (Bowen et al., 1992; 
Monath et al., 1992). Recombinant VAC virus 
immunized monkeys were protected from challenge with 
parainfluenza and hepatitis B viruses (Spriggs et 
al., 1988; Moss et al., 1984). Rinderpest and 
vesicular stomatitis recombinant VAC viruses were 
protective in cattle (Giavedoni et al., 1991;
Mackett et al., 1985). Foxes were protected from 
virus challenge after oral vaccination with a
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recombinant VAC-rabies virus (Blancou et al., 1986).
Other members of the orthopox family of viruses 
have also shown potential as recombinant immunogens. 
Raccoon poxvirus-rabies recombinants induced 
protective immunity in raccoons following oral 
immunization (Esposito et al., 1988). The fusion 
protein of Newcastle disease virus when expressed in 
a fowlpox recombinant virus induced protective 
immunity (Taylor, J. et al., 1990). Although the 
replication of avipoxes is host restricted to 
avians, fowlpox and canarypox recombinant rabies 
viruses were able to induce neutralizing antibody 
and protect mammalian hosts (Taylor J. et al., 1991; 
Baxby and Paoletti, 1992).
The humoral and cellular responses to VAC virus 
recombinants have been extensively studied (reviewed 
by Bennink and Yewdell, 1990). Antibodies to 
expressed viral glycoproteins have binding 
characteristics and biological activities that are 
similar to what is seen following immunization with 
the whole virus. CTL epitopes are also expressed on 
the surface of infected cells; however, few studies 
have used in vitro lymphoblastogenesis as a 
correlate of Th-cell epitope activity.
Synthetic Peptides as Viral Vaccines
The use of synthetic peptides for vaccine 
purposes has been the subject of much research ( for 
reviews see Shinnick et al., 1983; Lerner, 1984;
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Brown, 1984; Arnon, 1986; Steward and Howard, 1987; 
Berzofsky et al., 1987; Berzofsky, 1988; Good et 
al., 1988; Milich, 1989). An effective synthetic 
peptide vaccine for most viruses must be able to 
associate with a variety of MHC molecules and induce 
a Th-cell response of such a magnitude that help 
will be provided for induction of antibody that will 
protect the immunized host from virus challenge. 
Since T-cell epitopes are linear in nature, finding 
the appropriate Th-cell epitopes within a protein 
sequence is less of a problem than finding the 
appropriate B-cell epitopes which are almost always 
discontinuous, and conformationally dependent (Van 
Regenmortel, 1992). Although there are many 
predictive algorithms for continuous B-cell 
epitopes, none give a high degree of correct 
predictions (reviewed by Van Regenmortel, 1992) .
Where there is a three dimensional structure 
available, discontinuous determinants in close 
contact can be synthesized separately and then 
covalently linked (Horsfall et al., 1991). A second 
strategy is to use mimotope synthesis as described 
by Geysen et al. (1986, 1987). This is done by 
starting with a dipeptide and purified MAB and 
increasing the length with the various residues 
until maximal binding is achieved. A third method 
to analyze B-cell epitopes is the construction of 
highly diverse peptide libraries using phages for 
expression of peptides (Cwirla et al., 1990).
Synthetic peptides to a few viruses (human
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deficiency virus, foot-and-mouth, mengo, respiratory 
syncytial, and rabies) where conformation may not be 
as important, have been able to induce neutralizing 
and protective antibodies (Palker et al., 1989; Hart 
et al., 1990; Francis et al., 1990; Muir et al., 
1991; Bourgeois et al., 1991; Dietzschold et al.,
1990). Synthetic peptides to the E2 glycoproteins 
of SF and VEE viruses induce protective but non­
neutralizing antibodies (Hunt et al., 1990; 1991; 
Johnson et al., 1991; Snijders et al., 1992a). 
Protection by CTLs to LCM virus was induced by a 
synthetic peptide (Schulz et al., 1991).
One way to obviate the requirement for B-cell 
epitope conformation is to prime for Th cells with 
synthetic peptides that are capable of providing 
help to conformational B-cell determinants on the 
native virion. Enhanced antibody responses to B- 
cell epitopes on the virus in peptide primed animals 
have been seen with rabies virus (Ertl et al.,
1989), human T-cell lymphotropic virus (Kurata et 
al., 1989), hepatitis B virus (Milich et al.,
1987a), and Murray Valley encephalitis virus 
(Mathews et al., 1992).
In addition to the problems in selecting the 
appropriate T- and B-cell epitopes for peptides for 
vaccine purposes, the orientation of the epitopes 
within the continuous sequence is also of 
importance. This has been observed with respiratory 
syncytial virus (Levely et al., 1990), hepatitis B 
virus (Leclerc et al., 1987), foot-and-mouth disease
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virus (Cox et al., 1988), and measles virus 
(Partidos et al., 1991).
Some synthetic peptides may be ineffective 
vaccine candidates unless a carrier is used. 
Peptides synthesized as a high-density multiple 
antigen peptide may increase immunogenicity. (Tam,
1988). The use of carriers such as keyhole limpet 
haemocyanin and hepatitis B core protein can also 
enhance immunogenicity; however, the best synthetic 
peptide immunogens will be those that induce immune 
Th- and B-cells that can recognize their respective 
epitopes after processing of the native protein.
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AIMS OF THESIS
1.) Investigate in C3H (IAkIEk) mice the specificity 
of the Th-cell response (as determined by in vitro 
LBTs) of the three new world encephalitic 
alphaviruses (VEE [TRD and its vaccine derivative 
TC-83]) , EEE and WEE viruses. Then correlate the 
lymphoblastogenic response with the associated 
antibody response.
2.) Proceed with a logical analysis of the 
functional Th-cell epitopes present on the E2 and El 
structural glycoproteins of primarily TC-83 virus in 
various inbred mice using: a.) recombinant VAC VEE 
(TC-5A) virus expressing the gene products encoded 
by the subgenomic 26S mRNA of VEE virus; b.) 
individual E2 and El glycoproteins separated by SDS- 
PAGE; c.) overlapping 25-mer synthetic peptides to 
the entire extramembranal domain of the E2 as well 
as selected regions of the El glycoprotein; and, d.) 
subunit peptides to the TRD virus amino terminal 
peptide (AA 1-25) which induces a protective 
antibody response in mice.
3.) Analyse the phenotypes of lymphocytes present 
in LBTs by C' depletion and flow cytometry using 
antisera to well characterized T-cell markers. 
Monitor LBT supernatants for the presence of IL-2 as 
an indicator of Th-cell activation.
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4.) Determine if there are any differences in the 
Th-cell response between the TRD and TC-83 viruses.
5.) Ascertain if the VEE glycoprotein Th-cell 
epitopes expressed by the VAC recombinant are 
similar in nature to those expressed by VEE virus.
6.) Determine whether or not distinct Th-cell 
epitopes on the E2 and El glycoproteins are 
interactive when analysed within the context of the 
virion.
7.) Attempt to correlate functional Th-cell 
epitopes with T-cell predictive algorithms.
8.) Map the virus-reactive Th-cell determinants 
primarily on the E2 glycoprotein using synthetic 
peptides and determine which peptides elicit virus- 
reactive antibody in mice.
9.) Determine the extent of genetic restriction to 
various Th- and B-cell elements within the synthetic 
peptides using three strains of mice defining three 
unique haplotypes (C3H, C57BL/6 [IAb] , and BALB/c 
[IAdIEd]) .
10.) Ascertain if Th-cell epitopes on the El and E2 
glycoproteins can prime Th cells in the absence of 
demonstrable antibody.
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ll.) Ascertain if Th-cell epitopes on the El and E2 
glycoproteins can prime for Th cells capable of 
providing help to conformationally dependent B-cell 
epitopes on the virion.
12.) Map the Th- and B-cell epitopes present on 
subunit peptides of the TRD virus amino terminal 
synthetic peptide (VE2pep01, AA 1-25) which induces 
protective antibody.
13.) Determine if single AA interchanges between the 
TRD and TC-83 virus synthetic peptides result in 
differences in Th- and B-cell activation.
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CHAPTER 2
MATERIALS AND METHODS
CELL CULTURES
Vero (African green monkey) and BHK-21 (baby 
Syrian hamster) kidney-derived cell lines were 
routinely made available from the tissue culture 
production facility in this laboratory. These cells 
were grown in minimal essential medium (MEM) (Gibco, 
Grand Island, NY) with heat inactivated (56°C for 30 
minutes) 5-10% foetal bovine serum (FBS) obtained 
from Hyclone Laboratories (Logan, Utah). Medium was 
supplemented with 0.9 g sodium bicarbonate per 
litre, extra L-glutamine (additional 2 mM), 
penicillin G (100 units/ml), and streptomycin (100 
Mg/ml) .
The IL-2 dependent cytotoxic T-cell clone cell 
line (CTLL-2; Gillis and Smith, 1977) of murine 
origin (C57BL/6) was obtained from the American Type 
Culture Collection (Rockville, MD). These cells 
were maintained in RPMI-1640 medium (Gibco, Grand 
Island, NY) with 10% FBS, 2.3 g sodium bicarbonate 
per litre, 1 mM sodium pyruvate, 10 mM Hepes buffer 
and 5 x 10'5M 2-ME) , and antibiotics. Rat T-cell 
growth factor (Owen, et al., 1982), also prepared in
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RPMI 1640, was added as a supplement (25-40% v/v). 
Briefly, this was made by preparing red blood cell 
(RBC) lysed single cell splenocyte suspensions from 
Sprague or Lou rats (Harlan Sprague Dawley, Inc.; 
Indianapolis, IN), and incubating these at a 
concentration of 5 x 105 to 106 cells/ml in RPMI 1640 
medium containing 1-4 jug/ml of concanavalin A (Sigma 
Chemical Co., St. Louis, MO) at 37°C in 5% C02 in air 
for 24-48 hours (HRs). Media was clarified by 
centrifugation at 10,000 rpm for 10 minutes (MIN),
50 mM methyl a-D-mannopyranoside (Sigma Chemical 
Co.) was added to inhibit concanavalin A and 40 ml 
aliquots were frozen at -70°C. Alternatively, rat 
T-cell growth factor was obtained commercially from 
Collaborative Research Inc., (Bedford, MA) and used 
as a 10% supplement to the standard RPMI-1640 growth 
media. All tissue culture reagents except for Hepes 
buffer (Whittaker Bioproducts, Walkersville, MD) 
were obtained from GIBCO BRL (Grand Island, NY).
VIRUSES
The passage histories of the alphaviruses used 
in this study are shown in Table 4. All the VEE 
viruses were plaque purified (cloned) by serial 
transfer of isolated plaques in Vero or primary duck 
embryo cell cultures (France et al., 1979; Kinney et 
al., 1983). The EEE virus was uncloned and WEE 
virus was cloned in Vero cells. The Sindbis virus 
was a suckling mouse brain (SMB) seed. The duck
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Table 4. Passage histories of alphaviruses used.
Virus ------- Strain-------
VEE
subtype
Passage
history*
VEE Trinidad donkey (TRD) IAB GPB1V
TC-83b IAB GPH IV
P676 IC SMB IV
3880 ID SMB IV
Mena II IE SMB3V
78V—3531 IF DE1SMB2V
Everglades (EVE) 2 SM4V
Mucambo BeAn 8 (MUC) 3 SMB4V
Pixuna 35645 (PIX) 4 SMB IV
Cabassou CaAr 508 (CAB) 5 P5SMB1DE
EEE Florida 82V-2137 V
WEE 72V-4768 SHB IV
Sindbis AR339 P14SMB4
*GPB = guinea pig brain; V = Vero; GPH = guinea pig heart; 
SMB = suckling mouse brain; DE = duck embryo; P = passage of 
unknown history; and, SHB = suckling hamster brain.
b This virus was obtained as vaccine lot no. 5-LD-l 
(production date 1-26-68) from Merrell-National 
Laboratories, Division of Richardson-Merrell, Inc., 
Philadelphia, PA.
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embryo cell cultures were provided by our tissue 
culture facility. After cloning, all viruses were 
passed in Vero and/or BHK-21 cell cultures several 
times. Virus seeds were prepared in Vero or BHK-21 
cells and titrated in Vero cells (Kinney, 1988). 
Plaques could be visualized after 48 HRs following 
staining with neutral red.
Viruses were purified by a rate zonal and then 
an isopyknic centrifugation on linear density 
gradients of 3 0% glycerol to 45% potassium tartrate 
(Obijeski et al., 1974; Roehrig et al., 1982). 
Gradient purified viruses were pelleted by 
centrifugation at 39,000 rpm for 3 HRs, resuspended 
in 0.2 M Tris buffer (pH 8.0) and protein 
concentrations were determined using the BIO-RAD 
(Richmond, CA) dye-binding assay kit. Viruses were 
always propagated and purified separately to avoid 
cross-contamination.
VAC virus was the New York City Board of Health 
strain derived from a vial of smallpox vaccine 
(Dryvax, Wyeth Laboratories, Marietta, PA). This 
virus had been cloned in African green monkey 
kidney-derived CV-1 cells. The construction and 
characterization of the recombinant VAC-VEE virus 
expressing the structural glycoproteins encoded by 
cDNA to the virion subgenomic 26S mRNA was performed 
in this laboratory by Dr. Richard M. Kinney (Kinney, 
1988; Kinney et al., 1988a). Briefly, a chimeric 
plasmid was constructed by using restriction enzyme 
Tthllll to release VEE cDNA from the recombinant
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pUC18 plasmid pTC-5. This was then ligated with Eco 
RI linkers into the pGS-62 plasmid Eco RI site 
immediately downstream of the VAC 7.5K early-late 
promoter and mRNA start site between flanking 
sequences from the VAC thymidine kinase gene. After 
transfection of VAC-virus infected CV-1 cells, 
selection of recombinants expressing capsid, El and 
E2 glycoproteins was done in 143B cells. Partial 
purification of VAC and the recombinant VAC-VEE (TC- 
5A) viruses was done in CV-1 cells. The virus 
present in cell lysates from infected cells was 
pelleted by centrifugation for 80 MIN at 15,000 rpm 
through 40% sucrose using a Beckman (Beckman 
Instruments, Inc., Palo Alto, CA) SW27 rotor. Virus 
was resuspended in a small volume of TE buffer (10 
mM Tris hydrochloride [pH 9.0] and 1 mM disodium 
ethylene-diamine tetraacetate), and then processed 
with several freeze-thaw cycles to disassociate 
aggregated virus before storing at -70°C. Titration 
of VAC viruses was done by plaquing in Vero cell 
culture.
PREPARATION OF VEE TC-83 VIRUS El AND E2 
GLYCOPROTEINS
VEE TC-83 virus El and E2 glycoproteins were 
separated by discontinuous SDS-PAGE (Laemmli 1970). 
One millimeter (mm) 10% acrylamide gels prepared 
from a stock acrylamide solution (Protogel; 3 0%
[w/v] acrylamide and 0.8% [w/v] bisacrylamide,
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National Diagnostics, Atlanta, GA) were loaded with 
0.70 to 1.0 mg of disassociated and reduced TC-83 
virus. Gels were run for 4 HRs at 40 mA constant 
current and 4°C to insure that the smaller (35 kDa) 
capsid protein had run off the gel. The separated 
glycoproteins were then processed in one of two 
ways. First, sequential, 3 mm horizontal sections 
from the center two-thirds of the gel were cut 
proceeding from the bottom, up to the region above 
the E2 glycoprotein, based on the relative positions 
of the proteins in comparable gels stained with 
coomassie blue (G250). These sections were placed 
in glass tubes, dispersed into small pieces with 
applicator sticks, 1 to 2 ml of 0.1 M sodium 
phosphate (pH 7.2) added, vigorously vortexed and 
then placed at 4°C overnight. After low speed 
centrifugation (2000 rpm for 10 MIN), clarified 
supernatants were used for El and E2 glycoprotein 
analysis.
The VEE TC-83 virus glycoproteins separated by 
SDS-PAGE gels were alternatively transferred onto 
nitrocellulose (NTC) with a Transphor 
electroblotting unit (Hoefer, San Francisco, CA) .
The procedure was similar to one described by Towbin 
et al., (1979). The transfer was done at 60 V for 
12 HRs at 4°C. The NTC was then stained with gold 
using a kit from Integrated Separation Systems (Hyde 
Park, MA). This procedure consisted of incubating 
and washing the NTC blot in phosphate buffered 
saline (PBS)-Tween 20 (0.3%), rinsing in reagent
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grade H20, placing the membrane in gold-blot reagent 
at room temperature (RT) until proteins were 
adequately stained (3-5 minutes), rinsed again with 
H20, and air dried.
Microparticles of NTC with El and E2 bound- 
glycoproteins were prepared with dimethyl sulfoxide 
(DMSO) (Abou-Zeid et al. , 1987). Briefly, El and E2 
glycoprotein-bound strips (600-800 mm2) were placed 
in 10 x 100 mm screw cap tubes and 2 ml of DMSO was 
added, vigorously vortexed, and the solubilized NTC 
was left at RT for 1 HR. The NTC was precipitated 
with 1 ml of coating buffer (CB, carbonate- 
bicarbonate, pH 9.5) added dropwise to each tube 
with continuous agitation. After centrifugation at 
1500 rpm for 5 MIN, the supernatants were removed.
No further NTC precipitation was observed with the 
addition of more CB to the supernatant. The NTC 
precipitates were washed in PBS, freeze-thawed 
several times to disrupt aggregates, and then frozen 
at -20°C. After thawing, the NTC particles were 
finely pulverized with a Bellco grinder, washed 
several times in PBS and then stored at 4°C in PBS.
COMPUTER ANALYSES
The El and E2 glycoprotein gene sequences of 
both VEE TC-83 and TRD viruses (Johnson et al.,
1986; Kinney et al., 1986, 1989) were analyzed for 
the presence of epitopes that might be important in 
either the T or B-cell immune responses. The B-cell
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predictions were done using the computer program 
Surfaceplot (Synthetic Peptides, Inc., Edmonton, 
Alberta, Canada). This program analyzed 
hydrophilicity (Parker et al., 1986), accessibility 
(Janin, 1979), and molecular flexibility (Karplus 
and Schultz, 1985). A composite analysis using all 
three parameters was used. The stringency for these 
parameters was set at 60% which selects profiles for 
the highest surface potential value.
Three algorithms were used to predict putative 
T-cell epitopes on the El and E2 glycoproteins.
These were the Rothbard motif, (Rothbard, 1986)
AMPHI (Margalit et al., 1987) and SOHHA (Lu et al., 
1991; Stille et al., 1987; Reyes et al., 1988).
The Rothbard motif and the AMPHI analyses were done 
using the Tsites computer program (Medlmmune; 
Gaithersburg, MD). The Rothbard motif is an 
empirical prediction based on charged residues or 
glycine followed by two or three hydrophobic 
residues and then a polar residue. The AMPHI 
prediction is based on the formation of amphipathic 
a-helices, using the Fauchere-Pliska (1983) 
hydrophobicity index for AA. A sequence block 
length of 11 was selected and the threshold for 
amphipathic scores was set at 4. The SOHHA analysis 
was done using a 19 AA window (mean Kyte and 
Doolittle [1982] hydrophobicity values of residues 
at positions n, n + 4, n + 7 ,  n + 11, n + 1 4  and n + 
18 for 5 cycles of a putative a-helix). Positive 
strips (predictive potential for T-cell epitopes)
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had a high hydrophobic value (>2) with at least one 
of 4 adjacent strips scoring more negatively than -1 
and no prolines were present in the 5 strips.
SYNTHETIC PEPTIDES
Starting at the N-terminus of the TC-83 E2 
overlapping (by 5 AA) 25-mer peptides were 
synthesized on an Applied Biosystems (Foster City, 
CA) 430A automated peptide synthesizer using t- 
butyloxycarbonyl chemistry (Hunt et al., 1990). One 
32-mer (VE2pep-19, AA 169-200) was also prepared. 
Peptides were cleaved from the resin with 
hydrofluoric acid and analyzed for purity by 
reverse-phase high-performance liquid chromatography 
by Applied Biosystems. The coupling efficiency was 
monitored by the quantitative ninhydrin test (Sarin 
et al., 1981). The E2 peptides extended through 
residue 3 65, but did not include the C-terminal 
region of the protein which is buried in the virus 
membrane and is highly hydrophobic. Two TRD E2 
peptides (VE2pep01, AA 1-25 and VE2pep05, AA 81-105) 
were synthesized to evaluate residue changes between 
the TRD and TC-83 viruses at positions 7 and 85 
(Johnson et al., 1986). Four smaller subunit 
peptides of the TRD VE2pep01 peptide were also 
prepared. Finally, five peptides, to predicted 
immunogenic regions, were synthesized from the 442 
AA TC-83 El glycoprotein.
All the peptides used in this investigation,
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their coupling efficiencies and their solubility 
characteristics are listed in Table 5. After 
peptides were dissolved in the appropriate buffer or 
acid, the pH of the acid dissolved peptides was 
adjusted, without changing the solubility 
characteristics, to a more alkaline pH (5-7) with 1 
(molar) M Tris (pH 11). Peptides were diluted to 1 
mg/ml in PBS, filtered (0.2/x), and then stored at - 
70°C in 1-2 ml aliquots. Thawed peptides were held 
at 4°C, used for no more than one.week, and were not 
refrozen.
MICE AND IMMUNIZATIONS
C3H/HeNHsd (H-2k) male mice were obtained from 
the Charles River Breeding Laboratories (Wilmington, 
MA) or Harlan Sprague Dawley (Indianapolis, IN). 
C57BL/6NHsd (H-2b) and BALB/cAnNHsd (H-2d) male mice 
were from Harlan Sprague Dawley. All mice were 
received at 3-4 weeks of age and generally used 
between 8 and 16 weeks of age.
Immunization of mice with TC-83, WEE or EEE 
tissue culture seed or purified viruses was always 
done by IP inoculation, without adjuvant, using PBS 
as diluent. Seed viruses with FBS were always 
diluted 10'3 to 10-4 before inoculation to reduce 
background proliferation due to FBS primed T cells. 
Input virus was generally 104 to 105 PFU per mouse. 
Because EEE virus kills adult mice by the IP route, 
mice were immunized twice, two weeks apart, with 20
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Table 5. Synthetic peptides from the TC-83 (E2 and El) and 
TRD (E2) glycoproteins.
Peptides*
Amino
acids
Average coupling 
efficiency
Peptide
solvents1*
VE2pep01 1-25 99.0 HAC
VE2pep01 (TRD) 1-25 98.9 KC1-HC1
VE2pep02 25-45 99.1 BS
VE2pep03 41-65 98.6 BA
VE2pep04 61-85 98.9 BA
VE2pep05 81-105 98.0 KC1-HC1
VE2pep05 (TRD) 81-105 98.0 HAC
VE2pep06 101-125 98.4 BA
VE2pep07 121-145 99.7 KC1-HC1
VE2pep08 141-165 98.5 BS
VE2pep09 161-185 99.0 BS
VE2peplO 181-205 99.1 PBS
VE2pepl9 169-200 98.6 CB
VE2pepll 201-225 99.0 CB
VE2pepl2 221-245 N.D.C HAC
VE2pepl3 241-265 99.2 CB
VE2pepl4 261-285 99.5 CB
VE2pepl5 281-305 99.4 BA
VE2pepl6 301-325 99.1 CB
VE2pepl7 321-345 99.4 BA
VE2pepl8 341-365 99.6 CB
VElpep97-all 97-137 99.0 CB
VElpep97-l 110-137 99.2 CB
VElpepl24 124-155 98.7 CB
VElpep292 292-305 99.7 CB
VElpep321 321-353 99.4 CB
VE2pep01-Sl (TRD) 1-19 99.1 KC1-HC1
VE2pepO1—S2 (TRD) 1-9 99.1 CB
VE2pep01-S3 (TRD) 9-19 99.2d CB
VE2pep01-S4 (TRD) 5-15 99.5 KC1-HC1
‘All peptides were derived from the TC-83 gene sequences 
except where noted with a (TRD) indicating derivation from 
the Trinidad donkey gene sequence.
bDescription of solvents used to solubilize peptides: HAC = 
acetic acid (0.5M); KC1-HC1 = potassium chloride (0.1M)- 
hydrochloric acid (0.2M); BS = borate saline (pH 9.0); BA = 
boric acid (0.5M); PBS = phosphate buffered saline (pH7.2); 
CB * coating buffer (pH 9.5).
CN.D. = Not Done
dNinhydrin assay for one amino acid was not done.
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/xg of /3-propiolactone (BPL)-inactivated virus. 
Briefly, 0.3% (v/v) of BPL was added to 1 mg of 
purified virus in 1 ml Tris buffer (1 mM, pH 8.0) 
and incubated at 4°C for 24 HRs (French and McKinney, 
1964) . Mice were then inoculated with 10s PFU of EEE 
seed virus 5 weeks after the second inoculation of 
inactivated virus. Purified TC-83, WEE and EEE 
viruses were used to immunize mice IP using 4 to 100 
/xg diluted in PBS.
All peptides were inoculated as free peptides, 
although a cysteine residue had been placed at the 
carboxy terminus of each peptide to facilitate 
coupling to carrier proteins. Mice were given one 
or two inoculations (subcutaneously [SC]) in 
Freund's incomplete adjuvant (FIA) with 50 /xg of 
peptide. El or E2 glycoproteins either in aqueous 
form or bound to microparticles of NTC and at 
various estimated /xg concentrations, were also 
inoculated SC in FIA.
VAC and recombinant VAC TC-5A viruses were 
inoculated into C3H mice by intradermal tail 
scarification. Animals were given the inhalation 
anesthetic Metofane (methoxyflurane) Pitman-Moore, 
Inc. (Washington Crossing, NJ) and the anterior, 
dorsal third of the tail was scarified with an 18 
gauge needle. Virus (106 or 108 PFU) in 50-100 /xl 
was spread over the abrasion and allowed to 
partially air dry (1-2 minutes) before returning the 
mouse to his cage.
Mice were bled from 5 to 179 days following
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various immunization regimens with peptides, 
glycoproteins and/or viruses. For phlebotomy, mice 
were anesthetized and eye bled by making a small 
incision with a #11 scalpel in the capillary rich 
region near the outside corner of the eye. Blood 
was collected in Microtainer tubes, (Becton 
Dickinson Rutherford, NJ), allowed to clot, 
microfuged at 10,000 rpm for 5 MIN to permanently 
separate the serum from the RBC by an inert barrier 
material, and then stored at 4°C. All serum 
specimens were given accession numbers.
ENZYME-LINKED IMMUNOSORBENT ASSAY
The antivirus and antipeptide enzyme-linked 
immunosorbent assay (ELISA)s were modifications of 
the original procedure described by Voller et al., 
(1976); Roehrig and Mathews, 1985; Hunt et al.,
1990). The assay parameters of importance were: 
coating wells with a minimum of 1 /xg of antigen at 
4°C overnight; blocking for 1 HR at 37°C with 3% 
normal goat serum in PBS; and, diluting all antisera 
and conjugates in rinse buffer (PBS/tween 20). In 
addition to mouse antisera, PTF-39 (IAB) virus 
rabbit anti-E2 and TRD rabbit anti-El antisera 
(France et al., 1979) were used to detect SDS-PAGE 
eluted or NTC bound TC-83 glycoproteins. All 
antibody conjugates used in this study were alkaline 
phosphatase labeled, goat antibodies (Jackson 
ImmunoResearch Laboratories, Inc., West Grove, PA).
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The anti-mouse conjugates were specific for IgG 
(H+L), IgG Fc fragment and IgM mu chain. The anti­
rabbit was IgG (H+L). All except the mouse IgG 
(H+L) were conjugated as F(ab')2 fragments.
Detection of TC-83 El and E2 glycoproteins 
bound to microparticles of NTC was done using the 
Millititer HA plate filtration system (Millipore 
Corporation, Bedford, MA). These plates have a 
microporous-type of NTC membrane sealed to a 
polystryene plate with 96 wells. The high protein 
binding NTC membrane permitted the use of purified 
virus as a positive control. NTC-bound 
glycoproteins and TC-83 virus were added to wells in 
PBS and incubated for 1 HR at 37°C. Wells were 
rinsed by vacuum aspiration, blocked, rinsed again 
before adding anti-El and E2 rabbit antisera for 1 
HR at 37°C followed by a similar incubation with the 
rabbit anti-IgG conjugate. NTC particles were 
periodically mixed to insure maximum surface area 
exposure to antibody. After addition of 0.1 ml of 
substrate (p-nitrophenyl phosphate, 3 mg/ml], Sigma 
Chemical Co., and 3 M NaOH to stop colour 
development, filtrates were collected by vacuum into 
an ELISA plate and read at 405 nm.
SEROLOGICAL ASSAYS
The details for a varying serum dilution 
constant virus plaque reduction NT assay have been 
described (Mathews et al., 1985). The assay was
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done in Vero cells.
HAI assays were performed essentially as 
originally described by Clarke and Casals (1958) and 
then as modified for microtiter plates by Lennette 
and Schmidt (1969). Sucrose acetone mouse brain 
extracted antigens for TC-83, EEE and WEE viruses 
were obtained from the Arbovirus Diseases Branch of 
this laboratory.
IN VITRO LYMPHOBLASTOGENESIS
The molecular dynamics of in vitro recognition 
of antigen by Th cells resulting in a 
lymphoblastogenic response (Schwartz et al., 1975) 
as well as the important test parameters (Corradin 
et al., 1977; Chain et al., 1987) have been 
investigated. The LBT methodology and rationale 
employed in this study were based upon procedures 
reported by Maizels et al. (1980), and Schmid and 
Rouse, (1983).
Responder Th Cells
Spleens were aseptically removed from immunized 
and unimmunized control mice at least two weeks 
following virus or peptide inoculation. Single cell 
suspensions were prepared in Dulbecco's modified 
Eagle's medium (DMEM) supplemented with 10-15% FBS 
(Hyclone Laboratories) screened in this laboratory 
for low mitogenic activity with murine T-cells. The
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DMEM also contained supplemental 2 mM L-glutamine. 
0.1 mM non-essential AA, 1 mM sodium pyruvate, 1.5 g 
sodium bicarbonate per litre, penicillin (100 
units/ml) , streptomycin (100 /xg/ml) , 10 mM Hepes 
buffer and 5 X 10'5M 2-ME. Hypotonic tris-HCl (17 
mM), ammonium chloride (0.14 M) buffer with the pH 
adjusted to 7.2 with HC1, was used to lyse RBC 
(Mishell and Shiigi, 1980). Care was taken to limit 
the lysis period to 2 MIN to avoid lysing 
lymphocytes.
NW was used to increase the percentage of T 
cells present in splenocyte preparations by removing 
cells bearing surface Ig and Fc receptors (Julius et 
al., 1973; Henry, 1980). Although the exact 
mechanism of adherence of these cells to NW is not 
known, the interaction of the nylon polymer surface 
with FBS Ig must create bonding forces sufficient to 
retard phagocytic types of cells. NW that was 
obtained from Fenwall Laboratories (Deerfield, IL) 
was boiled and acid treated before using. 
Subsequently, scrubbed NW from Polysciences, Inc., 
(Warrington, PA) was used. The NW T-cell separation 
procedure used in this study consisted of adding 0.6 
g of teased, loosely stranded NW packed to displace 
6 ml in a 10 ml syringe and incubated in DMEM for 1 
HR at 37°C in 5% C02 prior to adding 108 splenocytes 
and incubating for another HR. The T cell-enriched 
preparation was eluted using an 18 gauge needle with 
a flow rate of 1 drop/sec until a total volume of 15 
ml was collected. These cells were centrifuged,
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counted and resuspended to 4 X 106 cells/ml in DMEM 
with 2-3% FBS and kept at 4°C until added to 96-well 
flat-bottomed tissue culture plates (Costar). In 
some experiments, eluted cells were passed over NW a 
second or third time to determine the efficiency of 
purification.
Antigen Presenting Cells
Splenocytes from normal, unimmunized mice were 
processed in a similar manner as the responder Th- 
cell preparations but not fractionated over NW.
Cells were adjusted to a concentration of no more 
than 5 X 106 cells/ml DMEM and irradiated (2000 rads) 
from a caesium (137Cs) gamma irradiation source. The 
cells were centrifuged, washed twice and resuspended 
to 2 X 106 cells/ml DMEM with 2-3% FBS and placed at 
4°C until used in the LBT. The APC were used in one 
of two ways. First, purified alphaviruses were added 
in various concentrations (5 or 50 jjlg) to every 107 
APC in 1 to 2 ml of DMEM and adsorbed at 37°C for 3 
to 4 HRs before irradiation. Similarly, VAC virus 
was used to infect APC at a multiplicity of 
infection (MOI) of 5. The second approach was to 
add virus or synthetic peptide to APC in the same 
ratio as the adsorption method but after APC had 
been placed into wells in the assay system. Also, 
in some experiments residual APC present in NW 
purified virus-primed responder Th cell populations 
were evaluated after the addition of purified virus
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to assay wells without any irradiated APC cells. 
Lymphoblastogenesis Test
All samples were tested in replicates of three.
Responder splenocytes enriched for T cells by
passage over NW from either normal (unimmunized),
virus, or synthetic peptide primed mice were added
oo-r^ bcrromed 
to 96-well plates. Each well received 4 X 105
responder cells contained in 0.1 ml of DMEM with 2-
3% FBS and 2-ME. The same volume of infected or
uninfected irradiated APC was added (2 X 105
cells/well). Most experiments utilized uninfected
APC. Antigens were then added to wells at various
concentrations (0.04 to 40 /xg/ml) in 0.05 ml
volumes. This quantity of antigen is similar to
what others have observed for optimal responses in
LBTs (Nicholas et al., 1988; Gao et al., 1989; Ertl
et al., 1989; Milich et al,, 1989). Antigens were
also added to nonimmune T-cell responder wells.
Plates were incubated at 37°C in 5% C02 in air.
Plates were microscopically observed on a daily
basis. Cross-linking of T cells by
phytohemagglutinin (PHA) was observed in a few HRs
and mitogen induced blastogenesis was seen at day 1
and peaked by day 3. Antigen-specific blastogenesis
was not generally present until day 3 and was
optimal by day 4 or 5. Cells were pulsed with 1
/xCurie (Ci) [3H] thymidine (TdR) per well (6.7
Ci/mmol; New England Nuclear, Boston, MA; or ICN
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Radiochemicals, Irvine, CA) in 20 fxl of DMEM for 6- 
24 HRs depending on the status of the cells. The 
plates were frozen and later thawed, and the 
contents of the wells harvested with a PHD cell 
harvester (Cambridge Technology, Cambridge, MA) onto 
either glass fibre filters subsequently placed in 
scintillation cocktail, or Ready Filters (Beckman 
Instruments, Inc., Fullerton, CA) which have a solid 
scintillant incorporated in the glass fibres and can 
be counted directly after drying.
Important assay controls included: test and 
control responders with no antigen; stimulation of 
responder Th cells with an irrelevant antigen; 
addition of a specific T-cell mitogen PHA (Sigma) at 
8 /xg/ml to evaluate test conditions for 
blastogenesis; including known specific-antigen 
responder Th cells; and, PHA stimulation of 
irradiated APC. For peptide LBT, Murray Valley 
Encephalitis peptide 6 (AA 230-251 of the E- 
glycoprotein) was used as an irrelevant peptide in 
all assays (Mathews et al., 1991).
ANALYSES OF LBT RESULTS
The LBT data were generally analyzed and 
presented as the mean counts per minute (CPM) ± 
standard deviation of [3H]TdR incorporation, as a 
stimulation index (SI) or as a more stringent 
stimulation index ratio (SIR). The SI for both 
immunized (test) and non-immune (control) responder
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Th cells were calculated using the following 
formula:
CPM test or control Th-cells + relevant antigen 
CPM test or control Th-cells + media
The SIR was then calculated from the SI results by:
SI (immunized [test]) Th-cells
SIR = --- ------------------ -----
SI (non-immune [control]) Th-cells
Some data were analyzed as adjusted means (T cells 
with virus minus T-cells without virus) ± associated 
standard error. In some cases, the Student's t test 
was used to assess the statistical significance of
the difference between these means. In most 
calculations an SIR >2.0, P <0.05 was considered to 
be positive.
INTERLEUKIN-2 ANALYSIS
Culture supernatants from LBTs were collected 
at various times (days 3, 4 or 5) and stored at - 
70°C. Due to limited volumes of samples, each 
replicate of three from the TC-83, EEE and WEE virus 
comparative analysis was pooled and then assayed in 
duplicate. For these assays, 150 /xl volumes of each 
sample were added to 96-well plates , followed by (2 
X 104) CTLL-2 cells (50 /xl) .
The CTLL-2 cells used in these assays had high
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viability (>95%) and demonstrated IL-2 dependence 
when titrated against known, decreasing 
concentrations of standardized IL-2 preparations. 
These cells were at least IL-2 dependent as anti-IL- 
2 receptor antibody inhibited metabolism of these 
cells in the presence of excess IL-2 derived from 
EL-4 cell supernatants (personal communication Dr. 
Jane E. Allan). Plates were incubated at 37°C in 5% 
C02 in air for 18 HRs and then 1 /zCi of [3H]TdR was 
added/well. Plates were processed 4 HRs later. 
Samples collected from TC-83, VAC and recombinant 
VAC TC-5A virus animals (6 each) and tested 
individually in LBT, were pooled and tested in 
replicates of three.
PHENOTYPIC ANALYSES
T-Cell Depletion
All of the T-cell reactive mouse MAB and C' 
(Low-Tox-M rabbit) used for T-cell depletion in C3H 
(H-2k) mice were obtained from Cedarlane Laboratories 
Limited (Hornby, Ontario, Canada). The MAB 
specificities were for Thy-1.2, Lyt-1.1 (CD5) / and 
Lyt-2.1 (CD8) with the proper allelic form for C3H 
mice. Two antibodies are designated here by both 
the older Lyt genetic nomenclature (Morse et al., 
1987) and the more recent and better accepted 
cluster of differentiation (CD) designations as 
developed by international nomenclature committees.
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T-cell depletions were done both pre- and post- 
LBT. In the pre-proliferation depletion NW-passaged 
T cells were diluted to 107 cells/ml in cytotoxicity 
medium (RPMI 1640 with 25 mM-Hepes and 0.3% bovine 
serum albumin). Antisera were added at a final 
dilution as recommended by Cedarlane Laboratories 
Limited. These dilutions met the manufacturer's 
cytotoxic index values when tested on unfractioned 
C3H splenocytes in this laboratory. The antisera 
and cells were incubated at 4°C for 1 HR with 
periodic mixing. Cells were centrifuged and 
resuspended to the original volume in cytotoxicity 
medium containing 10% (v/v) of freshly rehydrated 
C'. This was incubated for 1 HR in a 37°C bath with 
frequent, gentle agitation of the cells. Treated 
preparations were diluted to 4 X 106 cells/ml based 
on the original cell count and were used in LBT.
In the post-proliferation depletion procedure,
2 X 106 responder T cells in 1 ml of DMEM were added 
to wells (18 mm diameter) in 24-well tissue culture 
plates. Then 1 ml of 2 X 1 06/ral irradiated 
stimulator cells was added to every well. TC-83 and 
VAC viruses in 0.25 ml were added at concentrations 
of 2.5 /xg and 2.5 X 107 PFU respectively. At day 5 
the culture media from wells treated identically 
were harvested, pooled and set aside. Cells from 
each well were washed separately and 0.5 ml aliquots 
of cytotoxicity medium containing the various T-cell 
MABs, were added to each tube of cells. This was 
incubated as described previously, centrifuged and 2
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ml of rabbit C' (1:18) was added to all samples 
except the diluent control. Dilutions of the MABs 
used were based on expected cell numbers after LBT. 
After 1 HR at 37°C, cells were centrifuged, washed, 
resuspended in the original homologous culture 
supernatants, and placed in new 24-well plates.
These were immediately pulsed with 3 /xCi of [3H]TdR 
per well for 5 HRs at 37°C and then harvested and 
counted.
Flow Cytometry
Anti-Thy-l-fluorescein isothiocyanate (FITC), 
anti-Lyt-2-FITC and anti-L3T4 (CD4)-phycoerythrin 
(PE) conjugated were obtained from Becton-Dickinson 
Immunocytometry Systems (San Jose, CA). 
Fluorescein-conjugated affinipure anti-mouse IgG 
(H+L) was from Jackson ImmunoResearch Laboratories 
(West Grove, PA).
NW-passaged non-immune splenocytes and 
lymphocytes collected on day 4 from TC-83 virus 
specific LBT performed in 24-well plates, were 
washed in cold Hank's balanced salt solution 
containing 2% FBS, 20 mM Hepes buffer and 0.1% 
sodium azide (NaN3), counted, and 1 X 106 cells 
placed in small tubes (10 mm X 75 mm). Cells 
centrifuged (1200 X g) for 5 MIN, supernatants 
decanted, and conjugates ( diluted as recommended by 
manufacturer or based on results from preliminary 
experiments) or Hanks' solution were added to give a
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final volume of 50 to 100 /xl. Samples were placed 
at 4°C for 3 0 MIN, then overlaid onto and 
centrifuged through cold FBS containing 0.1% NaN3. 
Stained cells were washed twice in cold PBS and then 
resuspended to 1 ml in cold PBS and filtered through 
a 44 /xm nylon mesh (Small Parts Inc., Miami, FL) . 
Cells were analyzed on a Coulter (EPICS V) single­
argon laser-flow cytometer with filters set for 
single or dual colour analysis by Dr. M. Fox and Ms. 
L. Armstrong, Department of Radiological Health 
Sciences, Colorado State University, Fort Collins, 
CO. Gating light scatter parameters were set to 
exclude dead cell and debris.
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CHAPTER 3
SPECIFICITY OF THE MURINE TH-CELL IMMUNE RESPONSE TO 
VEE AND OTHER ENCEPHALITIC ALPHAVIRUSES.
SUMMARY
The Th-cell immune response to TC-83 virus and 
the antigenically related but distinct EEE and WEE 
viruses was investigated in C3H (H-2k) mice. 
Stimulation of virus-primed Th cells in LBT with 
homologous and heterologous virus gave a 
lymphoproliterative response that was primarily 
virus-specific. This correlated with the antibody 
response which was also virus-specific as measured 
in ELISA using purified virus. The predominant 
proliferating cell type secreted IL-2 and was of the 
Th-cell phenotype Thy-1+, Lyt-l+/2'/ L3T4+. The 
recognition of VEE subtype viruses by TC-83 Th cells 
was similar to the scheme of antigenic 
classification. Cross-priming was observed; TC-83 
virus-primed mice elicited a heterotypic antibody 
response to EEE virus following secondary 
inoculation with WEE virus. The results suggest 
that the immune response to alphaviruses in C3H mice 
is to immunodominant, virus-specific Th-and B-cell 
epitopes after one inoculation with VEE and WEE 
viruses and multiple inoculations with EEE virus.
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INTRODUCTION
The T-cell response is important in alphavirus 
immunity (Griffin, 1986). Adoptive transfer studies 
have shown that T cells are needed to protect mice 
against virulent alphavirus challenge (Rabinowitz 
and Adler, 1973; Peck et al., 1975). Indirect 
evidence for the importance of Th cells in 
alphavirus immunity was shown with Sindbis and 
Semliki Forest viruses (Burns et al., 1975; Jagelman 
et al., 1978; Suckling et al., 1982). Immunized 
nude mice elicited only a transient IgM antibody 
response whereas T-cell competent littermates 
produced IgG and a strong secondary IgG antibody 
response could be induced.
Mullbacher and Blanden (1978), defined the 
limits of genetic restriction for alphavirus CTLs 
within the murine MHC. Alphaviruses elicited CTLs 
are cross-reactive among all serocomplexes 
(Mullbacher et al., 1979, 1986; Wolcott et al., 
1982a, 1982b), and Th cells are required for in 
vitro clonal expansion of alphavirus CTLs (Ashman 
and Mullbacher, 1979).
The T-cell type (CD4+) involved in DTH may also 
be important in the alphavirus immune response.
This has been characterized to a limited degree with 
Semliki Forest virus in mice (Kraaijeveld et al., 
1979a; 1979b). DTH was enhanced in mice treated 
with CYC, and IP but not SC injection of virus 
induced an antibody response.
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Alphavirus in vitro LBTs were first done with 
Sindbis and VEE viruses and indicated that T cells 
recognizing specific antigen are necessary for 
lymphoblastogenesis (Adler and Rabinowitz, 1973; 
Griffin and Johnson, 1973; Marker and Asher, 1976). 
In another study (Aaskov et al., 1983), virus- 
specific proliferative responses were seen with 
three unrelated alphaviruses.
In the present study, the specificity of the 
Th-cell response in C3H mice to three virulent 
encephalitis viruses (VEE, EEE and WEE) was 
investigated. These viruses are serologically 
distinct; however, cross-reactivity and cross­
protection have been observed among unrelated 
alphaviruses from different serocomplexes (Casals, 
1957, 1963; Cole and McKinney, 1971; Fine et al., 
1974; Karabatsos, 1975). The results indicate that 
after inoculation of mice with VEE, EEE or WEE 
viruses, Th cells secreting IL-2 are generated 
against dominant epitopes that are largely virus- 
specific and that provide help primarily to virus 
specific B-cell epitopes.. Preliminary evidence is 
also presented suggesting that TC-83 Th-cell 
epitopes can prime for a heterotypic antibody 
response to EEE virus following challenge with WEE 
virus.
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RESULTS
ELISA Analysis of Viruses. Since VEE viruses 
are known to cause problems via aerosols, all of the 
purified viruses used in this study were analyzed in 
ELISA with virus-specific MABs to confirm that no 
cross-contamination had occurred (Table 6 ). All 
four viruses (TC-83, TRD, EEE, and WEE) were 
recognized only by their respective virus-specific 
MAB. The alphavirus group-reactive MAB (2A2C-3) was 
positive with all four viruses whereas a flavivirus 
reactive MAB (6B6C-1) did not react with the 
viruses.
Antigen Processing Requirements. APCs were 
initially infected with various concentrations of 
TC-83 virus to determine the optimal amount of 
antigen required to induce maximum virus-specific 
lymphoblastogenesis with pre-infected APCs. This 
gave a dose-related response (Table 7). Maximum 
stimulation of TC-83 virus primed Th cells occurred 
between 5 and 50 /xg of virus for 107 NW T-cell 
enriched splenocytes. One /xg of freshly purified 
TC-83 virus is roughly equivalent to 107 PFU (data 
not shown). This corresponded to a relative MOI 
between 5 and 50. A comparable level of virus- 
specific cellular proliferation was seen when 1 /xg 
of virus plus 2 X 105 uninfected APCs were mixed in 
wells (a ratio corresponding to 50 /xg virus and 1 X 
107 APCs) along with virus-primed NW-eluted T cells.
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Table 6 . Analysis of purified viruses in ELISA with 
virus-specific MABs.
MABb
Virus
Specificity
Purified virus*
TC-83 TRD EEE WEE
5B4D-6 TC-83 §j|c 2.7 <2.7 <2.7
1A2B-10 TRD 3.3 >5-4 3.3 <2.7
1B5C-3 EEE 2.7 <2.7 iliii&Jl <2.7
2B1C-6 WEE <2.7 <2.7 <2.7 4,a
2A2C-3 Alpha-group 1 1 1 ill ill IIS
6B6C-1 Flavi-group <2.7 3.0 <2.7 <2.7
*Purified virus (2/xg/well) was used to coat Immulon II 
plates and alkaline phosphatase goat anti-mouse IgG(Fc) 
chain specific was used as the detecting antibody.
bMAB were used as crude ascitic fluids. Origin of MAB 
used: 5B4D-6, TC-83 virus (Roehrig et al., 1982); 1A2B- 
10, synthetic peptide to the N-terminus of TRD virus 
(Roehrig et al., 1991); 1B5C-3, EEE virus (Roehrig et 
al., 1990); 2B1C-6 and 2A2C-3, WEE virus (Hunt and 
Roehrig, 1985); and, 6B6C-1, St. Louis encephalitis 
virus (Roehrig et al., 1983.)
“Antibody log10 geometric mean titre (GMT) . Shaded 
areas represent positive antibody responses.
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Table 7. Stimulation of TC-83 virus-primed, NW 
passaged T cells with irradiated splenocytes infected 
with TC-83 purified virus.
TC-83 virus (jxg/ml) Lymphoblastogenesis
0 5.1 + 1 .6*
4 13.4 + 1.8
20 37.3 ± 3.7
100 38.0 ± 7.5
2 0 0 32.0 ± 13.1
400 26.1 ± 4.4
PHAb 24.3 ± 2.5
*Mean CPM X 103 ± SD of [3H] TdR incorporation into 
cells.
bPHA, phytohaemagglutinin used at a concentration of 8 
/zg/ml.
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Virus stimulated the proliferation of T cells in the 
absence of irradiated APC, albeit at a reduced level 
(data not shown). This indicated that NW 
chromatography did not remove all APCs. Even T 
cells passed twice over NW retained 40% of the LBT 
activity of the same cells with APC. Analysis by 
flow cytometry of NW-passaged nonimmune C3H 
splenocytes indicated that approximately 35% of the 
eluted cells did not express the pan-T-cell marker 
Thy-1 (Table 8 ).
Phenotypes of T Cells. Three approaches were 
used to determine the phenotypes of T cells involved 
in the lyphoproliterative response. When NW- 
passaged T cells from TC-83 or Sindbis virus-primed 
mice were treated with T-cell marker antisera plus 
C', only the C' control or cells treated with anti- 
Lyt-2.1 proliferated in response to TC-83 or Sindbis 
virus stimulation (Table 9). Similar results were 
observed when cells that proliferated in response to 
TC-83 virus after a culture period of 5 days were 
treated with antisera, pulsed for 4 hr with [3H]TdR, 
and then harvested and counted (data not shown).
Both depletion procedures indicated that the cell 
population involved in proliferation was probably of 
the Th cell phenotype Thy-1+, Lyt l+,2', L3T4+.
To substantiate this observation, flow- 
cytometry with fluorophore-conjugated lymphocyte 
marker MABs was performed at day 4 post­
proliferation on TC-83 virus-primed T cells
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Table 8 . Phenotypic analysis pre- and post- 
lymphoblastogenesis of NW-passaged lymphocytes by flow 
cytometry.
Antibodies*
Percentage of stained lymphocytes
Nonimmuneb TC-83C
Anti-Thy-1 65 74
Anti-L3T4 43 50
Anti-Lyt-2 21 20
Anti-IgG N.D.d 20
*Thy-l, Lyt-2, and IgG antisera were conjugated to 
fluorescein isothiocyanate and the L3T4 to 
phycoerythrin.
bLymphocytes from uninoculated C3H mice were labelled 
and phenotyped following NW chromatography.
cLymphocytes were processed from mice four weeks after 
inoculation with 104 PFU of TC-83 virus and placed in 
LBT with homologous virus prior to analysis.
dN.D. = Not Done
-124-
Table 9. Effect of depletion with antisera on 
proliferation of NW-passaged T cells from alphavirus 
primed C3H mice.
Treatment 
(plus complement)b
Virus*
TC-83 Sindbis
Diluent 97.8 ± 13.6C 34.1 ± 2.2
Anti-Thy-1 3.0 ± 3.1 N.D.d
Anti-Lyt-1 3.3 ± 1.0 <1. 0
Anti-Lyt-2.1 92.5 ± 5.1 .20.1 ± 2.5
“Results are from stimulation of virus-primed T cells 
with homologous virus. Splenocytes were processed 
three weeks following inoculation with lCr and 107 PFU 
of TC-83 and Sindbis viruses respectively. T cells 
from unimmunized mice treated similarly were 
unresponsive in LBT.
bAll MABs used were cytotoxic on NW passaged T cells 
and met Cedarlane Laboratories, Inc. cytotoxic index 
values when tested on unfractioned C3H splenocytes 
(data not shown).
‘Values represent adjusted means (T cells with virus 
minus T cells without virus) CPM X 103 of [3H] TdR 
incorporation ± associated standard error following C' 
treatments.
dN.D. = Not Done.
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stimulated with homologous virus (Table 8 ). The 
majority of the Thy-l-positive cells were of the 
L3T4 phenotype. Incubation of T cells from the same 
NW preparations but without TC-83 virus resulted in 
loss of cell viability at day 4 as determined by 
trypan blue exclusion. Dual colour analysis using 
anti-L3T4-PE and FITC-labelled anti-Lyt-2.1 showed 
that mutually exclusive cell populations were 
present with less that 1% of the cells staining with 
both conjugates. The proportions and actual 
percentages of phenotypes present in the normal 
preparation after NW chromatography, determined by 
flow cytometry, were almost identical to those in 
the TC-83 virus samples after proliferation (Table 
8) .
Th-Cell Responses. The specificity of the 
immune response (both cellular and humoral) was 
evaluated at various days after inoculation of C3H 
mice with TC-83, EEE or WEE viruses. LBTs for mice 
primed to any one virus over time were performed in 
single experiments. Both homologous and 
heterologous purified viruses were used to stimulate 
the virus-primed Th cells. The TC-83 virus-primed 
Th cells primarily recognized the virulent parent 
TRD and the vaccine-derived TC-83 viruses (Fig. 2a). 
The lower response to TRD virus stimulation at day 7 
may indicated that early in the immune response Th 
cells were preferentially recognizing the virus used 
for immunization. The maximum lymphoproliterative
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Ficmre 2. Lymphoproliferative response over time 
of (a) TC-83, (b) EEE and (c) WEE virus-primed and 
pooled (three to six mice per virus group) NW 
purified responder T cells. Stimulator cells were 
uninfected or infected with 50 /xg of
purified viruses TC-83 [|^|j , TRD £^§j|] ,
WEE [[ [] , or EEE • Bars represent the
mean CPM values of3replicates ± S.D.
Incorporation of [3H] TdR into nonimmune control T 
cells incubated with infected stimulator cells was 
<2 X 103 CPM.
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response occurred at day 14. There was a cross­
reactive response to EEE virus that constituted 
about one third of the maximum [3H]TdR incorporation 
when compared to the VEE viruses. WEE virus was not 
recognized in LBT by TC-83 virus Th cells. The EEE 
virus proliferative response was evaluated in mice 
inoculated with BPL-inactivated virus before 
inoculation with live virus. An EEE virus-specific 
blastogenic response was seen despite increased 
background proliferation at days 7 and 14 (Fig. 2b). 
The LBT with mice inoculated only with the BPL- 
treated EEE virus was also virus specific with a SI 
of 14 with homologous virus but only 2.1 with TC-83 
virus. When WEE virus-primed Th cells were 
stimulated with the various viruses, the 
lymphoproliterative response on days 7 and 21 was 
primarily to the homologous virus (Fig. 2c). High 
background proliferation with the day 14 samples 
negated the WEE Th-cell response.
B-Cell Responses. When antisera from all mice 
used in the proliferation studies plus additional 
animals bled between days 35 and 54 post­
immunization were evaluated by ELISA using purified 
virus as substrate, the results paralleled those 
seen in the LBT (Fig. 3). There was a significant 
homologous antibody response to all the viruses used 
for immunization. Low level cross-reactivity was 
seen between the EEE and VEE viruses. The WEE virus 
B-cell response was virus-specific, and mice
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Ficrure 3. Endpoint ELISA titres of mouse serum 
specimens collected at time intervals corresponding 
to the T-cell assays and tested against purified 
viruses TC-83 [ H ]  , EEE and WEE |j |j
Bars represent mean values of four to six sera for 
each virus ± S.D.
-130-
1500
X
0)
L.
■Hlai 100
■H
<
0)
J
LU 50
7 14 21 54 7 14 21 35 7 14 21 42
VEE EEE WEE 
Days after virus inoculation
-131-
immunized with EEE or TC-83 virus did not cross- 
react with WEE virus.
IL-2 Analysis. The presence of elevated levels 
of IL-2 is a sensitive indicator of CD4+ T-cell 
activation and hence Th-cell activity (Vitetta et 
al., 1989). T cells from mice immunized with 100 /zg 
of TC-83, EEE or WEE viruses 48 days earlier were 
analyzed in LBT, and supernatants were harvested at 
72 hours and assayed for IL-2 activity with CTLL-2 
cells (Table 10). Elevated levels of IL-2 
correlated with a strong lymphoblastogenic response 
of Th cells to homologous but not heterologous virus 
stimulation. EEE virus was recognized albeit weakly 
by TC-83 and WEE virus-elicited Th cells in LBT, but 
the corresponding IL-2 values were not elevated.
Recognition of VEE Subtype Viruses by TC-83 
Virus Th Cells. To further analyse the 
lymphoblastogenic response among more closely 
related alphaviruses, various VEE subtype viruses, 
as antigenically classified by Young and Johnson 
(1969) using short incubation HAI assays, were used 
to stimulate TC-83 seed virus-primed Th cells (Table 
11). The magnitude of the Th-cell response 
correlated with the B cell antigenic relatedness 
except for Everglades (subtype II) virus.
B-Cell Response Following Secondary 
Inoculation. Mice primed with TC-83 seed virus,
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Table 10. Comparison of the lymphoblastogenic response and IL- 
2 production after homologous and heterologous stimulation of 
T cells from mice primed with purified alphaviruses.
Responder T cells from mice primed with 
Virus* Assay TC-83 EEE WEE
TC-83 LBT 34.6 + 2. 9b 4.4 + 1.9 5.8 + 2.6
IL-2 7.6 + 1.2C 0.8 + 0.13 0.1 + 0.07
EEE LBT 10.1 + 4.5 28.9 + 2.0 11.6 + 1.9
IL-2 0.4 + 0.04 13.3 + 2.0 1.8 + 0.4
WEE LBT 2.8 + 0.8 4.1 + 1.0 29.0 + 1.8
IL-2 0.2 + 0.02 0.3 + 0.1 6.0 + 0.9
None LBT 4.7 + 1.5 3.5 + 1.5 4.3 + 1.1
IL-2 0.2 ± 0.05 0.6 + 0.2 1.5 + 0.1
•Stimulator splenocytes not preinfected; purified virus added 
to wells at time of assay.
bLBT values represent mean CPM X 103 ± SD of [3H] TdR 
incorporation into NW purified T cells.
Relative IL-2 levels expressed as mean CPM X 103 ± SD of 
[3H]TdR incorporated into CTLL-2 cells.
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Table 11. Stimulation of TC-83 virus-primed T cells 
with various VEE subtype viruses*.
Virus
Strainb Subtype Lymphoblastogenesisc
TC-83 IA 67.0 ± 5.8
PTF-39 IB 95.7 + 9.3
P676 IC 46.4 + 3.3
3880 ID 28.6 + 4.2
Mena II IE 38.0 + 5.2
Everglades II 72.4 + 1 0 . 8
Mucambo III 23.2 + 2 . 1
Pixuna IV 24.8 + 5.7
*Mice used in LBTs had been inoculated with 104 PFU 
of TC-83 seed virus four weeks earlier.
bStimulator splenocytes not preinfected; purified 
virus (1 /Ltg) added to wells at time of assay.
°Values represent mean CPM X 103 ± SD of [3H] TdR 
incorporation. Background of responder T cells 
from TC-83 virus immunized mice incubated without 
virus was 1.1 ± 0.2 mean CPM X 103 ± SD.
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were given a secondary inoculation with homologous 
and heterologous viruses, bled 14 days later, and 
pooled sera were tested for biological and binding 
activity using HAI, NT and ELISA (Table 12). As 
expected, HAI and NT activity were seen with the 
homologous TC-83 virus both in the control and in 
the TC-83 and TRD virus groups with strong 
corresponding ELISA titres with some cross­
reactivity with EEE but not WEE virus. The two TC- 
83 virus-immunized mice which survived EEE virus 
challenge produced EEE reactive HAI, NT and ELISA 
antibodies. A strong heterotypic antibody response 
to EEE virus was seen, however, from WEE virus 
secondary inoculation of TC-83 virus-primed mice.
WEE virus-reactive HAI and ELISA antibodies were 
also induced.
DISCUSSION
Specificity of the Th-and B-Cell Responses.
The present study shows that inoculation of mice 
with VEE, EEE or WEE viruses results in Th-cell and 
B-cell responses that are primarily virus-specific. 
The T-cell phenotypes identified and the presence of 
elevated levels of IL-2 in culture supernatants from 
LBT positive samples indicate that the Th cell is 
the primary cell type present in
lymphoblastogenesis. Low level T-and B-cell cross­
reactivity was observed between VEE and EEE viruses, 
but neither cross-reacted with WEE virus. These
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Table 12. Biological and binding activity of pooled sera frc 
TC-83 virus-primed mice given a secondary challenge with 
various alphaviruses.
Inoculation groups* Antigens
Primary Secondary Assayb TC-83 WEE EEE
TC-83 None HAI 3.4° 1.3 1.3
NT >3.2 <1.7 <1.7
ELISA 4.9 <3.0 3.6
TC-83 TC-83 HAI 3.4 1 . 0 1.9
NT >3.2 <1.7 <1.7
ELISA 5.1 <3.0 3.8
TC-83 TRD HAI >4.0 1 . 0 1.3
NT >3.2 <1.7 <1.7
ELISA 5.1 <3.0 3.5
TC-83 WEE HAI >4.0 2 . 2 l§pe
NT >3.2 <1.7 SSI
ELISA 5.0 4.0 4 7*
TC-83 EEEd HAI 3.4 1.3 2 . 8
NT >3.2 <1.7 2 . 0
ELISA 5.1 <3.0 4.7
•Tissue culture derived seed virus (106 PFU) was used for both
the primary and secondary inoculation of mice.
bAntigens used for HAI and ELISA were sucrose-acetone 
extracted mouse brain and purified virus respectively. NT 
titres were based on 70% plaque reduction.
cLog10 geometric mean titres of pooled sera (2-5 per group).
dOnly 2/5 survived EEE virus challenge.
S t lo -d e d  JLndL.co^Tc GteoaJVeci ine-revoltp»C cMr\>r< b o>cJ Y
v e T o  fEE oivuL/ij*
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data support early serological observations on these 
viruses using HAI and CF assays with polyclonal 
antisera (Casals, 1963), and NT (Karabatsos, 1975; 
Calisher et al., 1980). VEE, EEE and WEE viruses 
are clearly distinguishable on the basis of NT which 
separates them into distinct antigenic complexes 
(see Table 1 in literature review). Sindbis virus, 
the prototype alphavirus and a member of the WEE 
virus antigenic complex, was able to prime Th cells 
in C3H mice that recognized Sindbis but not TC-83 
virus (unpublished observation). Griffin and 
Johnson (1973) found marked proliferation of T cells 
from lymph nodes and spleens of BALB/c mice after 
primary and secondary inoculations with Sindbis 
virus; however, no heterologous stimulation was 
done. Aaskov et al. (1983) observed a virus- 
specific lymphoproliferative response with the 
antigenically unrelated alphaviruses Ross River, 
Getah and Sindbis.
The antigenically more closely-related VEE 
subtype viruses were recognized by TC-83 virus- 
primed Th cells to varying degrees that correlated 
with the antigenic classification scheme proposed by 
Young and Johnson (1969) based on kinetic HAI using 
spiny rat antisera. The one exception was to 
Everglades (II) virus which was recognized in LBT by 
TC-83 virus-primed Th cells as well as the 
homologous and the closely related PTF-39 (IB) 
viruses (Table 10). However this antigenic 
relationship was not unexpected because Everglades
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virus is readily NT with rabbit antisera prepared to 
the E2 glycoproteins of both IA and IB subtype 
viruses (Kinney et al., 1983). To determine whether 
binding antibody might place Everglades virus closer 
to the IA and IB viruses, single inoculation TC-83 
virus mouse antisera in ELISA against all the VEE 
subtype viruses gave a reactivity pattern 
characteristic of the HAI classification (data not 
shown).
Molecular Correlates of Alphavirus Th- and B- 
Cell Epitope Specificity. The specificity of the 
alphavirus lymphoproliferative response may be 
related to the El and E2 glycoproteins which are 
present on the surface of the virion in the form of 
a heterodimer spike in which the glycoproteins are 
structurally closely associated (Harrison, 1986; 
Schlesinger and Schlesinger, 1986), and are 
important in the immune response (Roehrig, 1986). 
Comparison of amino acid sequence homology on the El 
of several alphaviruses (EEE, VEE, Ross River, 
Sindbis and SF) showed that VEE and EEE viruses were 
the most closely related (Chang and Trent, 1987). 
Comparison of percent sequence homology on the E2 
showed VEE/EEE >WEE/EEE >VEE/WEE (Hahn et al.,
1988). These sequence relationships correlated with 
the Th and B cell responses with VEE, EEE and WEE 
viruses.
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Immunological Correlates of Alphavirus Th- and 
B-Cell Epitope Specificity. The E2 glycoprotein is 
less conserved than the El and E2 B-cell epitopes 
expressed on the virion are mostly virus-specific 
and are involved primarily in the biological 
functions of HA and NT (Roehrig, 1990). The El B 
cell epitopes generally have broader reactivity 
patterns and are biologically less active (Roehrig, 
1990) . The specificity of both the Th and B-cell 
responses to TC-83, EEE and WEE viruses seen in this 
study suggest that the E2 glycoprotein may be 
responsible for the immunodominant response seen.
This is in marked contrast to several studies 
which agree uniformly that the CTL response to 
alphaviruses is cross-reactive (Mullbacher et al., 
1979, 1986; Wolcott et al., 1982b). The El 
glycoprotein has been implicated as the target 
antigen for alphavirus CTL using a temperature- 
sensitive mutant of Sindbis virus (Wolcott et al., 
1985). Although Berbaru and Sindbis viruses showed 
complete CTL cross-reactivity, antisera to these 
viruses were virus-specific for blocking CTL- 
mediated lysis of infected target cells (Mullbacher 
et al., 1979). This suggested that the specific B- 
cell epitopes expressed on infected cells were in 
close proxmity to CTL target peptides so that 
antibody binding to the cells would sterically block 
CTL-target interaction. Liu and Mullbacher, (1989) 
showed that B cells could provide help for in vitro 
generation of CTLs to influenza virus. Therefore,
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antigen presenting B cells may process and present 
both El and E2 peptides and activate the appropriate 
ThcrL“ and ThB-cell precursors. Unfortunately, VEE, 
EEE and WEE viruses have not been evaluated for CTL 
activity.
Significance of Cross-Priming and Cross- 
Protection in Alphavirus Immunity. Casals (1963) 
observed no basic change in the expected HAI 
reactivity pattern of antisera from mice receiving 4 
to 6 IP inoculations of homologous alphaviruses.
When TC-83 virus-primed mice were challenged with 
TC-83 or TRD viruses there was no change in the 
specificity of the binding and biological antibody 
response (Table 12). Despite this apparent 
specificity of the antibody response, cross­
protection has been repeatedly observed among 
alphaviruses not serologically related (Casals,
1963). Mayaro virus-immune mice were protected from 
challenge with WEE and EEE viruses; EEE virus-immune 
mice survived challenge from Semliki Forest virus; 
and, Chikungunya inoculated mice were resistant to 
challenge with VEE virus (Casals, 1963).
Convalescent sera from this latter group showed 
broad HAI reactivity with a variety of unrelated 
alphaviruses which was not present before challenge. 
The rapid appearance and elevated antibody titres 
were characteristic of an anamnestic response.
These results suggest that priming to alphavirus Th- 
cell epitopes can occur without a concomitant B-cell
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response. This was also suggested in the present 
study when the challenge of TC-83 virus-primed mice 
with WEE virus elicited a strong heterotypic 
antibody response to EEE virus. Wolcott et al. , 
(1982b) observed T- and B-cell cross-priming between 
Sindbis and Semliki Forest viruses.
A homotypic and not a heterotypic B-cell 
response was seen when EEE virus was used as the 
challenge virus. Since EEE virus uniformly kills 
adult mice by the peripheral challenge route, it was 
of interest that 40% of the TC-83 virus-immune mice 
survived EEE virus challenge. This is in agreement 
with what Hearn and Rainey (1963) and Cole and 
McKinney (1971) observed with these viruses in 
cross-protection studies in guinea pigs and hamsters 
respectively, however, protection was not 
reciprocal. Hamsters immunized with EEE virus were 
not protected from virulent VEE virus challenge. 
Furthermore, hamsters inoculated sequentially with 
VEE-WEE or WEE-VEE viruses demonstrated levels of 
protection to EEE virus challenge that were 
significantly greater that hamsters inoculated with 
either VEE or WEE viruses (Cole and McKinney, 1971).
The events involved in cross-priming and cross­
protection with alphaviruses are complex and are yet 
to be resolved but must involve the B cell which is 
the predominant APC in a secondary immune response 
(Chestnut and Gray, 1981). Possible alteration of 
Th- and B- cell epitopes could occur by a process of 
negative selection as proposed by Ozaki and
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Berzofsky, (1988). They suggested that the binding 
by the B cell capture antibody to its respective 
determinant on the antigen with subsequent 
internalization could then alter how the peptides 
are processed. This masking of epitopes could 
result in the dominant expression of usually 
subdominant epitopes. Alternatively, the cross­
priming/protection events may involve the 
differential induction of subsets of Th cells 
resulting in preferential activation of the B- or 
CTL-cellular compartments (Mosmann et al., 1986).
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CHAPTER 4
MURINE TH-CELL IMMUNE RESPONSE TO RECOMBINANT 
VACCINIA VEE TC-83 VIRUS
SUMMARY
The Th-cell immune response following primary 
immunization of C3H (H-2k) mice with a recombinant 
VAC virus (TC-5A) expressing the TC-83 virus 
structural proteins (capsid, El and E2) was compared 
to the response induced by the TC-83 virus. Both 
low dose (106 PFU) and high dose (108 PFU) TC-5A 
virus immunized mice assayed individually in in 
vitro LBTs elicited Th cells that strongly 
recognized both VAC and TC-83 viruses. CD4+ T-cell 
activation was confirmed by post-LBT phenotypic 
analysis and by elevated levels of IL-2 found only 
in culture supernatants from positive virus-induced 
LBTs. The TC-5A virus induced antibody that bound to 
TC-83 virus albeit at lower titres than antibody 
from TC-83 virus-immune mice. VEE virus subtypes 
were recognized similarly by Th cells and antisera 
from TC-5A and TC-83 virus immunized mice. The 
results indicate that the TC-5A and TC-83 viruses 
induced a comparable and qualitatively similar Th- 
cell immune response in mice to the TC-83 virus 
structural glycoproteins.
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INTRODUCTION
The use of VAC virus as a vector for the 
expression of foreign DNA gene products has received 
considerable attention. Much emphasis has been 
placed on the development of anti-microbial vaccines 
(Tartaglia et al., 1990) as well as investigating 
immunological mechanisms (Moss and Flexner, 1987) 
and expression of various cytokines (Ramshaw et al., 
1992).
The first alphavirus antigens to be vectored by 
VAC virus were Sindbis virus structural 
glycoproteins (Rice et al., 1985). The structural 
glycoproteins were expressed. Immunization of 
cattle with this recombinant VAC Sindbis virus 
elicited anti-Sindbis neutralizing antibody (Franke 
et al., 1985).
As a possible alternative to the live, 
attenuated TC-83 virus vaccine, a recombinant VAC- 
VEE virus (TC-5A) was constructed expressed the 
structural proteins (capsid, El, E2) encoded by cDNA 
to the virion subgenomic 26S mRNA was constructed 
(Kinney et al., 1988a). Characterization of El and 
E2 glycoprotein B-cell epitopes on TC-5A virus 
infected cells with a battery of VEE MABs indicated 
that the epitopes were expressed in a manner similar 
to that in VEE virus-infected cells. Immunization 
of mice with the TC-5A virus elicited NT antibody 
and protection from virulent VEE virus challenge 
(Kinney et al., 1988b). Subsequent investigations
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in monkeys and horses showed that the TC-5A virus 
was also able to induce protective immunity in these 
species (Monath et al., 1992; Bowen et al., 1992).
In the present study, the Th-cell immune 
response in C3H (H-2k) mice to the TC-5A virus was 
investigated as a corollary to the B-cell epitope, 
protection and challenge studies. The results 
suggest that the Th-cell immune response to the 
recombinant VAC virus (TC-5A) expressing the TC-83 
virus structural glycoproteins is similar to that 
seen with the TC-83 virus (Mathews and Roehrig,
1989).
RESULTS
Th-Cell Immune Response to VAC, Recombinant VAC 
(TC-5A) and TC-83 Viruses. It was previously shown 
that C3H (H-2k) mice immunized with TC-83 virus 
elicited a virus specific in vitro lymphoblastogenic 
response (Mathews and Roehrig, 1989). When splenic 
T cells were collected from C3H mice 18 days 
following inoculation with either 104 PFU IP with TC- 
83 virus or 108 PFU intradermal (ID) with VAC virus 
and assayed in LBT, there was a strong 
lymphoproliferative response to homologous but not 
to heterologous virus (Fig. 4). This was remarkably 
uniform in all 6 mice from each virus group. This 
might be expected from parenteral inoculation with 
TC-83 virus infection which is more systemic and 
widely disseminated (LeBlanc et al., 1978), whereas
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Ficrure 4 . Lymphoproliferative response of TC-83 and
VAC virus-primed Th cells from individual mice.
Stimulator cells were uninfected , or
infected with TC-83 [ ^ H j  , or TRD |J
purified virus (50 jig/101 cells) or infected with VAC
virus (5 X 107 PFU/107 cells) . Bars
3
represent the mean CPM values of*replicates ± S.D
S.D.
-146-
00
X
n
O VACCINIA
QC
" O
I—
I
00
50
40
30
20
10
TC-83
-147-
replication of VAC virus following ID administration 
is local with the generation of a typical vaccinial 
lesion (Mackett and Smith, 1986) . TC-83 virus Th
cells recognized both homologous and TRD viruses 
equally well, and there was no cross-stimulation 
between the VEE and VAC viruses.
f Th cells harvested from spleens of mice on day 
18 following immunization with either 106 or 108 PFU 
of the recombinant TC-5A virus recognized both VEE 
and VAC viruses (Fig. 5). There was no discernible 
difference in the lymphoproliferative response 
between the low and high dose immunization groups.
A comparative analysis using the mean LBT results 
from the six individual mice for each group showed 
that the VAC proliferative response was similar in 
both the VAC and TC-5A immunized animals (Fig. 6 ). 
However, the magnitude of the proliferative response 
to TC-83 virus in TC-5A immunized mice was 
approximately one third less than in the TC-83 
virus-immunized mice. Th cells from TC-83 and TC-5A 
immunized mice did not recognize EEE or WEE viruses.
IL-2 and Phenotypic Analyses of VAC and TC-5A 
Virus-Induced Th Cells. When pooled culture 
supernatants from the LBTs were assayed for the 
presence of IL-2 using CTLL-2 cells, the presence of 
elevated levels of IL-2 correlated with an elevated 
LBT response (Table 13). Interestingly, the amount 
of IL-2 present in the TC-5A LBT supernatants 
stimulated with VAC and VEE viruses was similar,
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Ficrure 5 . Lymphoproliferative response of low dose
(1 x 106 pfu) and high dose (1 x 108 PFU) of TC-5A
virus-primed Th cells from individual mice.
Stimulator cells were uninfected [ i j j j j j ]  , or
infected with TC-83 [|^H] ' or TRD [l l]
purified virus (50 jig/107 cells) or infected with VAC
virus (5 X 107 PFU/107 cells) . BarsL J ^
represent the mean CPM values of^replicates ± S.D.
TC-5A HIGH DOSE
TC-SA LOW DOSE
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Ficrure 6 . Comparative lymphoproliferative analysis 
of Th cells from TC-83, VAC and TC-5A virus 
immunization groups in response to stimulation by 
various viruses. Stimulator cells were uninfected 
/ or infected with TC-83 [iHij ,
TRD |j || , EEE [^ = j ] , or WEE [||||]] purified
virus (50 /xg/107 cells) or infected with VAC virus 
[M i l ] (5 x 107 PFU/107 cells) . The results for 
each bar represent the mean LBT value from six 
individually tested mice ± S.D.
TC-83 VACCINIA LOW DOSE HIGH DOSE UNIMMUNIZED
TC-5A TC-5A
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although the LBT response of TC-5A Th cells to VAC 
virus was considerably greater. The correlation 
between elevated levels of IL-2 and positive 
lymphoblastogenesis suggested that Th cells had been 
specifically activated in all three Th-cell 
responder groups.
Post-proliferation depletion experiments using 
specific T-cell antisera and complement confirmed 
that the Th-cell phenotype (Lyt-1; CD4+) was the 
predominant proliferating population of lymphocytes 
(Fig. 7) . The incorporation of [3H]TdR into both TC- 
83 virus stimulated TC-83 and TC-5A virus 
lymphocytes was dramatically reduced following 
treatment with anti-Thy-1 and anti-Lyt-1 (CD4+) 
antisera. Incorporation of [3H]TdR into lymphocytes 
was not altered by anti-Lyt-2 (CD8+) antisera. T 
cells from unimmunized mice were unresponsive to TC- 
83 virus stimulation as maximum [3H]TdR incorporation 
was <300 CPM. The magnitude of the TC-5A virus 
lymphoproliferative response was less than the TC-83 
virus response, but the depletion profiles were 
similar. The IL-2 and phenotypic results correlated 
with previous observations with TC-83 virus (Mathews 
and Roehrig, 1989).
Antibody Response to TC-83 Virus. Individual 
sera, collected from the low and high dose TC-5A 
virus immunized mice, were tested in ELISA on TC-83 
virus (Fig. 8) . These were compared to pooled sera 
from TC-83 virus immunized mice. Antisera from TC-
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Ficrure 7. Post-lymphoproliterative analysis of T- 
cell phenotypes present in TC-83 and VAC TC-5A 
virus-immune, NW chromatographed splenocytes. T 
cells were treated with C' and T-cell antisera 
following five days of in vitro stimulation with TC- 
83 virus, and subsequently pulsed with [3H]TdR as 
described in the Materials and Methods.
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Fiqure 8. ELISA analysis on TC-83 virus of 
individual serum specimens from both the low and 
high dose TC-5A immunization groups as well as 
pooled sera (n=6) from TC-83 virus-immunized mice.
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5A mice recognized TC-83 virus albeit at titres 
approximately twenty-fold less than the positive 
control. As a negative control, pooled sera (n=6) 
from VAC immunized mice were unreactive with TC-83 
virus (<1:100). TC-5A immunized A/J (IAkIEk) mice 
elicited similar antibody titres to TC-83 virus 
(Kinney et al., 1988b). It is of interest that 
animals 1 and 6 in the low dose group were low 
titred while their corresponding lymphoblastogenic 
results were positive (Fig. 5) .
Recognition of VEE Subtype Viruses by TC-5A 
Virus Th Cells and Antisera. It was previously 
shown (Mathews and Roehrig, 1989) that Th cells from 
TC-83 virus immunized C3H mice recognized the 
antigenically closely related VEE subtype viruses in 
a manner similar to the classical antigenic 
classification determined with polyclonal single 
inoculation spiny rat antisera in kinetic HAI assays 
(Young and Johnson, 1969). When TC-5A Th cells were 
stimulated with the various VEE subtype viruses, a 
similar pattern was seen despite differences in the 
magnitude of the LBT and increased background when 
compared to the TC-83 virus results (Table 14). The 
highest LBT responses were to the IAB and Everglades 
(II) viruses which correlated with the TC-83 LBT 
results. Antisera from TC-83 and TC-5A immunized 
mice both showed similar patterns of recognition of 
B-cell epitopes on the VEE subtype viruses (Table 
15) .
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Table 14. Stimulation of TC-83 and TC-5A virus-immune 
Th cells with a battery of VEE subtype viruses.
Lymphoblastogenesis
Virus* Subtype TC-83 TC-5A Nonimmune
None 1.1 + 0. 2b 6.8 ± 0.7 3.1 + 1.1
TC-83 IA 67.5 + 5.9 29.0 + 2.7 5.5 + 0.6
PTF IB 95.8 + 9.3 42.3 + 3.3 4.5 + 1.5
P676 IC 46.4 + 3.2 22.8 ± 2.2 2.7 + 0.7
3880 ID 28.6 + 4.2 23.8 ± 2.4 4.7 + 1.0
Mena II IE 37.9 + 5.2 21.9 ± 4.4 4.8 + 0.9
78V-3531 IF 22.4 ± 2.7 22.8 ± 3.2 6.1 ± 1.0
Everglades II 72.4 + 10.8 38.9 ± 5.0 7.0 ± 2.0
Mucambo III 23.2 ± 2.1 24.1 ± 1.2 8.8 + 0.7
Pixuna IV 24.8 + 5.7 24.0 + 2.9 4.9 + 0.7
Cabassou V 20.3 + 5.0 22.4 + 0.8 5.6 + 1.2
‘Stimulator splenocytes not preinfected; purified virus 
(1-2 /zg) added to wells at time of assay.
bLBT values represent mean CPM X 103 ± S.D. of [3H] TdR 
incorporation into NW chromatographed T cells.
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Table 15. ELISA reactivity of antisera from TC-83 and TC- 
5A virus-immunized mice with various VEE subtype 
viruses.
Antisera*
TC-•5A
Virus Subtype TC-83 1 2 3 4
TC-83 IA 3. 8b 3.5 3.2 3.2 2.9
P676 IC 3.2 3.2 2.9 3.2 2.6
Mena II IE 3.5 3.5 3.2 2.6 2.6
78V—3531 IF 2.9 2.9 2.3 2.6 <2.3
Everglades II 3.5 3.2 2.9 3.2 2.6
Mucambo III 3.2 3.5 2.6 2.6 2.6
Pixuna IV 2.9 2.6 2.3 2.3 <2.3
Cabassou V 3.5 2.9 2.6 2.3 2.3
*C3H Mice were immunized with either TC-83 virus (104 PFU) 
intraperitoneally, or TC-5A virus (108 PFU) by tail 
scarification, and sera were collected at day 21. TC-83
virus sera were pooled (n=4); representative TC-5A virus 
antisera were tested individually.
Values represent log10 geometric mean titres.
DISCUSSION
Evaluation of the Th-Cell Immune Response to 
TC-5A Virus. Most of the VAC virus expression 
systems for structural glycoproteins to other 
viruses have often used induction of neutralizing 
antibody and protection of immunized animals from 
virus challenge as important parameters to evaluate 
the authenticity of the expressed product (reviewed 
by Tartaglia et al., 1990; Mackett and Smith, 1986). 
This is a logical approach to ascertain the vaccine 
potential of the expressed glycoproteins.
Evaluation of the cellular immune response to these 
proteins is also important. Much has been done with 
the induction of CTLs and the recognition by CTLs of 
the expressed product on the surface of VAC virus 
infected target cells, but surprisingly little is 
known about the Th-cell immune response to VAC 
vectored virus glycoproteins (Bennink and Yewdell, 
1990; Tartaglia et al., 1990). This may be related 
to problems with antigen processing using infectious 
VAC virus or interference due to endogenously 
encoded VAC virus proteins (Bennink and Yewdell, 
1990). These problems seemed to be obviated in the 
current study by preinfecting the APC population 
with VAC virus. The addition of VAC virus directly 
to wells containing the NW enriched Th cells plus 
APC resulted in increased background (data not 
shown).
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Fidelity of the TC-5A Virus-Induced Th-Cell 
Immune Response to the TC-83 Virus Structural 
Glycoproteins. A previous study with TC-83 virus 
showed that the CD4+ Th-cell was the predominant 
cell type present after virus-specific 
lymphoblastogenesis (Mathews and Roehrig, 1989).
CD4+ activation was associated with elevated levels 
of IL-2. In the present investigation, TC-5A virus 
induced a CD4+ T-cell immune response to the TC-83 
virus structural glycoproteins that was determined 
by in situ T-cell depletion experiments with anti- 
CD4+ antisera plus complement. CD4+ T-cell 
activation was also associated with elevated levels 
of IL-2.
Th cells from both TC-83 and TC-5A virus 
immunized mice recognized TC-83 virus structural 
proteins with similar specificity and in a 
qualitatively similar manner; however, the magnitude 
of the lymphoproliterative response was consistently 
greater with Th cells from TC-83 virus-primed mice. 
This may be related to a higher frequency of memory 
Th cells in the TC-83 immunized mice probably due to 
a heightened immune response resulting from a 
systemic infection, whereas the TC-5A virus probably 
only induced an immune response at the site of 
injection with involvement of the regional lymph 
nodes. This quantitative difference in the immune 
response was also reflected in binding antibody 
levels from TC-83 and TC-5A virus-immunized mice.
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Kinney et al., (1988b) observed lower HAI and NT 
titres in antisera from TC-5A virus-immunized when 
compared to TC-83 virus antisera.
Th-Cell Epitope Relationships Among the VEE 
Subtype Viruses. Th and B cell reactivity patterns 
with the VEE subtype viruses provided further 
support for the authenticity of the TC-83 virus 
structural glycoprotein immune response to TC-5A 
virus. The strongest LBT responses with both 
viruses were with the antigenically closely related 
IABC viruses and Everglades (II) virus. It is of 
interest that Everglades (II) virus, based on its 
recognition by TC-83 virus glycoproteins in LBT, is 
more closely related to the IABC viruses than the 
3880 (ID) and Mena (IE) viruses. Similar 
observations of antigenic relatedness between the 
IABC and Everglades viruses were found in epitope 
mapping experiments with anti-E2 MABs (Roehrig and 
Mathews, 1985) . A critical site (E2C) for HA and 
virus infectivity was found in the same spatial 
location on all four viruses. This is substantiated 
by recent sequencing studies which have found the 
structural glycoproteins of 3880 (ID) virus to be 
more closely related to TRD virus than either 
Everglades (II) or Mena (IE) viruses based on fewer 
AA differences (Kinney et al., 1992a, 1992b;
Sneider et al., 1993).
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Potential Efficacy of the TC-5A Virus as a 
Vaccine Candidate. Inoculation of mice (Kinney et 
al., 1988b), monkeys (Monath et al., 1992) and 
horses (Bowen et al., 1992) with the TC-5A virus has 
resulted in the induction of neutralizing antibody 
and the hosts were protected from virulent virus 
challenge. These results indicated that a strong Th 
cell immune response had been induced. The present 
investigation supports these results; TC-5A virus 
induced Th cells in C3H mice that strongly 
recognized TRD and TC-83 (IA) VEE viruses in LBT and 
this was associated with a demonstrable antibody 
response from most of the TC-5A virus immunized 
mice. Furthermore, peripheral blood mononuclear 
cells (PBMCs) and lymphocytes from lymph nodes of 
TC-5A virus immunized horses and monkeys 
respectively recognized IA VEE viruses in LBTs (data 
not shown). Priming of the T-cell compartment in 
horses without a concomitant antibody response was 
observed (Bowen et al., 1992). This was similar to 
some of the mice in the low dose TC-5A group in the 
present study where high Th-cell responder mice had 
low levels of anti-TC-83 virus binding antibody.
Overall, the results with the TC-5A recombinant 
VAC virus in a variety of species demonstrate the 
effectiveness of this virus at inducing protective 
immunity to virulent VEE virus challenge. Adequate 
priming of the Th-cell compartment was found to be 
as important as the presence of significant levels 
of neutralizing antibody in these studies.
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As an alternative to the possible side effects 
caused from the replication of most poxviruses in 
mammalian tissues, a case for mammalian directed 
vaccines in poxvirus vector research has been made 
for the avipoxviruses which only replicate in avian 
species (Baxby and Paoletti, 1992). A recombinant 
canarypox-rabies virus was just as efficacious as a 
VAC-rabies virus at similar dosages in protecting 
mice (Taylor et al., 1991). The use of a 
nonreplicating poxvirus-TC-83 virus immunogen would 
give more flexibility to the route of immunization 
and hence the induction of mucosal immunity which 
was a problem with ID immunization in mice (Kinney 
et al., 1988b).
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CHAPTER 5
LYMPHOBLASTOGENIC AND IMMUNOGENIC ANALYSES OF THE 
TH-CELL EPITOPES ON THE El AND E2 GLYCOPROTEINS OF
TC-83 VIRUS.
SUMMARY
The El and E2 structural glycoproteins of TC-83 
virus were separated by SDS-PAGE and the Th-cell 
epitopes were analyzed. Th cells from TC-83 virus 
primed C3H (H-2k) mice recognized both the El and E2 
glycoproteins in LBT, and El Th cells were positive 
in LBT with both TC-83 virus and El glycoprotein. 
Mice primed with the El and E2 glycoproteins 
immobilized on microparticles of NTC elicited an 
enhanced antibody response to both glycoproteins and 
TC-83 virus following secondary inoculation with TC- 
83 virus. Mice primed with El or E2 glycoproteins 
showed kinetic differences compared to controls in 
their IgM response following challenge with TC-83 
virus; IgM levels were more elevated at day 5 and 
remained elevated in most animals at day 14. The 
results suggest that Th-cell epitopes on both the El 
and E2 glycoproteins are important in the immune 
response to TC-83 virus.
>
INTRODUCTION
Pedersen and Eddy (1974) were the first 
investigators to separate the TC-83 virus El and E2 
glycoproteins using PAGE. Subsequent analysis of 
these glycoproteins showed that determinants 
important in inducing NT, HAI and protective 
antibody were located on the E2 but not the El 
(Pedersen and Eddy, 1974) . These results were 
supported by analysis of the El and E2 glycoproteins 
of Sindbis virus separated by column isoelectric 
focusing, although the HAI activity was associated 
with the El (Dalrymple et al., 1976). More detailed 
studies with various VEE subtype virus strains using 
isoelectric focusing gave further evidence that the 
E2 glycoprotein was the centre of biological 
activity on the virus (France et al., 1979; Kinney 
et al., 1983). Mapping of B-cell determinants on 
the VEE virus El and E2 glycoproteins with MABs has 
precisely defined critical sites involved in 
important biological activities on the E2 as well as 
mechanisms involved in NT and protection (reviewed 
in Roehrig, 1990). In addition, a non-neutralizing 
MAB to the El glycoprotein was shown to passively 
protect mice from virulent VEE virus challenge 
(Mathews and Roehrig, 1982). By sequence analysis, 
the El of TC-83 and other VEE virus strains has been 
found to be more conserved than the E2 (Johnson et 
al., 1986; Hahn et al., 1988; Kinney et al., 1992a, 
1992b).
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In contrast to the extensive B-cell analyses, 
very little is known about the cell mediated 
immune response to the El and E2 glycoproteins. 
Because of the cross-reactive nature of the CTL 
response (Mullbacher et al., 1979; Wolcott et al., 
1982b) and the lysis of target cells infected with a 
ts mutant of Sindbis virus expressing only the El 
(Wolcott et al., 1985), the El has been implicated 
as important in the CTL response. The serocomplex 
specificity of the alphavirus Th-cell immune 
response (Aaskov et al., 1983; Mathews and Roehrig, 
1989) suggests that the E2 may be involved. Despite 
the indirect experimental results, the importance of 
the El and E2 in the cellular immune response to 
alphaviruses has not been addressed. Recently, 
cloned SF virus E2 protein fragments, expressed in 
E. coli from recombinant plasmids, were able to 
induce DTH and stimulate proliferation of SF virus- 
primed Th cells in vitro (Snijders et al., 1992b).
In the present investigation, the Th-cell 
epitopes present on the El and E2 glycoproteins of 
TC-83 virus were analyzed in LBT and priming 
experiments. The results suggest that both 
glycoproteins have Th-cell epitopes that are 
important in the immune response to TC-83 virus.
RESULTS
Lymphoblastogenic Analysis of the El and E2 
Glycoproteins. Although coomassie blue staining of
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the El and E2 glycoproteins was done to approximate 
the position of the proteins in SDS-PAGE gels, the 
relative purity of the soaked out samples was 
determined in ELISA with rabbit anti-El and anti-E2 
sera (Table 16). These results are representative 
of a typical analysis. Samples 3 and 4 were 
considered to be pure El; sample 7 was considered to 
be pure E2. Estimation of protein concentrations in 
these samples was done by comparing the ELISA 
optical densities (OD) derived from known nanogram 
amounts of purified TC-83 virus in wells to the OD 
of various dilutions of the glycoproteins.
Therefore, an OD of 2.1 with both 250 ng of TC-83 
virus and a 1:32 dilution of E2 would extrapolate to 
8 jug/0.1 ml in the undiluted E2 sample.
When the El and E2 were analyzed in LBT, both 
glycoproteins were recognized by Th cells from TC-83 
virus-primed C3H (H-2k) mice (Table 17) . This 
indicated that Th cells specific for both 
glycoproteins were induced in mice following 
inoculation with TC-83 tissue culture derived seed 
virus. In a reciprocal manner, both TC-83 virus and 
El were recognized by El Th cells. E2 immunized 
mice were not evaluated in LBT because of either a 
poor antibody response or one that was heterotypic.
El and E2 Th-Cell Epitopes Prime Mice for an 
Enhanced Antibody Response Following Challenge with 
TC-83 Virus. Several inoculations of mice with the 
El and E2 glycoproteins (3 - 10 /zg per inoculation)
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Table 16. Immunological analysis using ELISA of TC-83 virus El an 
E2 glycoproteins soaked out of SDS-PAGE gels.
Samplesb
Rabbit antisera and sample dilutions*
Anti-E2 Anti-El
8 16 32 64 8 16 32 64
1 0.19 0.09 0.09 0.09 0.10 0.10 0.11 0.11
2 0.15 0.09 0.12 0.15 0.14 0.12 0.12 0.12
3 0.08 0.09 0.08 0.08 2.46 ■ l l 2.22 f j j ig c
4 0.14 0.18 0.14 0.10 2.30 2.23 §§|| g i l l
5 2.25 1.66 § |g i| 1 1 1 ! 2.31 2.05 2.54 0.86
6 i l l ! 2.52 2.50 2.76 ;o'.‘54 0.44 0.26 0.16
7 2.42 2.24 2.23 1.21 0.19 0.16 0.13 0.11
8 0.50 0.32 0.20 0.15 0.11 0.11 0.10 0.11
“Optical densities were determined at 405nm using alkaline 
phosphatase labelled goat anti-rabbit IgG(h+l) antiserum as the 
detecting antibody.
bSections cut from bottom region (1) to top region (8) of gel.
cShaded regions represent positive reactions (>2x above background) 
with the respective antiserum.
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Table 17. Analysis of the lymphoblastogenic response 
to the El and E2 glycoproteins.
Assay Antigen Nanograms
Responder T 
TC-83
cells*
El
1 TC-83 1000 19. lb
100 8.2
10 4.1
2 TC-83 1000 7.5 2. 8C
100 4.9 1.2
10 1.5 1.0
El 500 1.4 1.3
3 TC-83 1000 5.9 2. 9d
100 4.6 1.1
El 800 8.9 3.7
200 3.8 3.4
50 1.5 1.3
4 TC-83 1000 13.4
100 4.1
10 2.2
E2 300 2.4
150 1.5
*The splenocytes from two mice were pooled and 
processed for each responder T-cell group.
bStimulation Index.
°E1 mice received 2 inoculations with 6fiq of 
glycoprotein; ELISA antibody log10 GMT (3.5) to El was 
32-fold greater than to E2.
dEl mice received 3 inoculations with 6/zg of 
glycoprotein; ELISA antibody log10 GMT (4.7) to El was 
40-fold greater than to E2.
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were generally required to elicit detectable 
antibody as measured by ELISA (data not shown). To 
determine if the Th-cell compartment of the immune 
system had been primed in El and E2 immunized mice 
in the absence of antibody, control and glycoprotein 
immunized mice were inoculated with 50 nq of 
purified TC-83 virus. The IgM and IgG response to 
TC-83 virus was evaluated in these mice on days 0,
5, 7 and 14 (Fig. 9). On day 5 one of six E2 primed 
mice had a strong secondary IgG response. The IgM 
response in most of the El and E2 mice was enhanced 
at day 5 when compared to the controls and persisted 
in most animals at titres higher than the controls 
on day 14.
Selected El and E2 antisera from Fig. 9 were 
tested in ELISA on both glycoproteins, EEE and WEE 
viruses to ascertain the specificity of the antibody 
response following TC-83 virus challenge (Table 18). 
At day 5 the elevated IgM titres in all four of the 
glycoprotein primed mice had ELISA reactivity that 
was associated with TC-83 virus but not the 
glycoproteins. Serum from the one E2 animal 
eliciting an anamnestic IgG response only recognized 
TC-83 virus. None of these 5 day sera were reactive 
with either EEE or WEE viruses. At day 14 one El 
mouse had significant antibody to both TC-83 virus 
and El. At day 14 there was increased IgG 
reactivity with EEE virus in all the samples tested.
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Figure 9. IgG and IgM antibody response in 
individual control [ ], El [ ^ ] /  and
E2 [ ] primed mice at various times following IP
inoculation with 50 fig of TC-83 virus. Sera were 
tested in ELISA using TC-83 virus as antigen.
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Immunological Evaluation of the El and E2 
Glycoproteins Immobilized on Microparticles of 
Nitrocellulose Glycoproteins immobilized on 
microparticles of NTC have been reported to 
stimulate Th cells in LBT (Abou-Zeid et al., 1987). 
To determine if this methodology might have some 
application to the El and E2 glycoprotein studies, 
various concentrations of PHA were dotted onto NTC, 
microparticles were prepared as described in the 
Materials and Methods, and NW purified T cells were 
stimulated with soluble and NTC prepared PHA (Fig. 
10). Although NTC-bound PHA was able to induce T- 
cell proliferation, it took eight times more of the 
NTC-bound PHA to obtain comparable [3H]TdR 
incorporation when compared to soluble PHA. The 
decreased incorporation values at the higher 
concentrations of soluble PHA reflect cell death by 
day four when the cells were pulsed and harvested 
following strong visual proliferation early in the 
experiment.
Subsequently, El and E2 bound to NTC were 
converted into microparticles using DMSO as 
described in the Materials and Methods, and 
antigenically evaluated in ELISA using membrane 
filtration plates (Table 19). NTC bound 
glycoproteins were added to wells at estimated 
amounts corresponding to the TC-83 virus based on 
data extrapolated from radiolabelled El and E2 that 
remained after SDS-PAGE, blotting and DMSO 
processing. Both El and E2 were detected using
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Ficrure 1 0 . Comparison of T-cell lymphoblastogensis 
induced by soluble PHA [ ■ ]  and PHA bound to 
microparticles of NTC [ ^ 3 -
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glycoprotein specific antisera, however, at 
concentrations tenfold or more, less than predicted. 
Background OD results suggested that both the El and 
E2 NTC preparations may not have been homogenous.
TC-83 primed Th cells from both C3H (H-2k) and 
BALB/c (H-2d) mice proliferated in the presence of 50 
ng of TC-83 virus (SI of 2.6 and 4.4 respectively) 
while the Th cells from both strains of mice were 
unresponsive to an estimated 500 ng of the El, E2 
and E1/E2 NTC preparations. C3H mice that had 
received two inoculations with an estimated 2 and 
1/xg of the El and E2 NTC preparations respectively 
were evaluated for Th cell activity in LBT and 
immunogenic priming experiments. Th cells from El 
and E2 NTC immunized mice did not proliferate in the 
presence of 1000 ng of TC-83 virus while virus- 
primed Th cells had a SI of 3.2. However, when the 
remaining NTC El and E2 primed mice were boosted 
with 40/xg of TC-83 virus and subsequently bled on 
days 5 and 22, the antibody response to virus and 
glycoprotein indicated that priming of Th cells had 
occurred (Table 20). Both the E2 and El NTC mice at 
day 22 had high titred IgG antibody to both 
glycoproteins as well as to virus. There was an 
enhanced IgM response to virus in the El NTC mice at 
day 5.
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DISCUSSION
Biological and Functional Relevance of the El 
and E2 Glycoprotein Th-Cell Epitopes. It has been 
previously shown that C3H (H-2k) mice immunized with 
TC-83 virus elicited Th cells that primarily 
recognized VEE virus in LBT (Mathews and Roehrig, 
1989). The specificity of the proliferative results 
indicated a possible dominant role for the E2 rather 
than the El. It has been shown with T-cell clones 
to the nucleoprotein of influenza virus that the 
same Th-cell epitopes were dominant whether 
immunization was with infectious virus or 
glycoprotein (Brett et al., 1991b). In the present 
study, following immunization with TC-83 virus, Th 
cells recognized both the El and E2 in LBT. This 
suggested that immunization with native virus 
elicited Th cells to functional Th-cell epitopes on 
both the El and the E2. This is the first direct 
observation of Th-cell activity on both the El and 
E2 of any alphavirus. Snijders et al. (1992b) used 
recombinant SF virus E2 protein fragments to induce 
proliferation of SF virus Th cells in LBT. Purified 
proteins from other viruses have also been analyzed 
for Th-cell activity. These include the VP1 capsid 
protein of poliovirus (Kutubuddin et al,, 1992a), 
the 1A protein of respiratory syncytial virus 
(Nicholas et al., 1988), and the influenza virus 
nucleoprotein (Gao et al., 1990). It is of interest 
that the Th-cell epitopes on the VP1 capsid protein
-186-
of poliovirus mapped to the same region of the 
protein as epitopes involved in virus NT (Kutubuddin 
et al., 1992b).
The biological importance of the Th-cell 
epitopes on both glycoproteins was observed when El 
Th cells were able to recognize TC-83 virus in LBT 
and when both El and E2 primed mice elicited an 
enhanced antibody response following inoculation 
with purified TC-83 virus. Priming in these animals 
occurred without a detectable glycoprotein or virus 
associated antibody response. Similar priming of 
the Th-cell compartment was previously observed in 
recombinant VAC TC-83 virus vaccinated horses (Bowen 
et al., 1992). Other proteins have been shown to 
prime for Th cells without a concomitant antibody 
response (Suss and Pink, 1992; Fox et al., 1989).
Immunological Appraisal of the El and E2 
Glycoptoteins Immobilized on Nitrocellulose. SDS- 
PAGE separated polypeptides from various 
microorganisms and transferred to NTC have been used 
to stimulate Th cells in LBT (reviewed in Lamb et 
al., 1988). Most of these studies used NTC sections 
for Th-cell stimulation while Abou-Zeid et al.
(1987) converted NTC into microparticles with DMSO. 
All of these studies utilized human PBMCs or human 
T-cell clones and accessory cells were required. No 
murine-related studies have been published. In the 
present investigation, excess TC-83 virus or El and 
E2 glycoproteins dotted or blotted onto NTC and used
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as sections or immobilized on microparticles of NTC 
were apparently not processed in any form and were 
not recognized by TC-83 virus Th cells. Only PHA- 
NTC microparticles were able to induce 
lymphoblastogenesis by crosslinking T cells albeit 
at higher concentrations than required for soluble 
PHA. It has been previously shown that PHA 
polypeptides immobilized on NTC caused proliferation 
of human PBMCs (Laurent et al., 1985.
C3H mice immunized with El and E2 NTC- 
microparticles elicited a strong and equivalent 
antibody response to both El and E2 as well as to 
virus following secondary inoculation with TC-83 
virus. This indicated that either the El or E2 was 
able to prime Th cells which provided help for both 
the homologous or heterologous protein or that the 
NTC preparations were not homogeneous. Help for 
antibody responses to B-cell epitopes on viral 
proteins not used for priming has been shown for 
hepatitis B virus (Milich et al., 1987b), and 
influenza virus (Scherle and Gerhard 1986, 1988).
In addition, the El NTC-primed mice had elevated IgM 
titres to TC-83 virus, and the anti-virus titre in 
both groups of glycoprotein primed mice was two-fold 
higher to virus than the control mice.
Priming and B-Cell Response Characteristics of 
Individual and Virion Associated El and E2 
Glycoproteins. The apparent paradox of B-cell 
priming by the El and E2 glycoproteins in the
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absence of antibody may be due to the presence of 
two functionally separate B-cell precursors (Linton 
et al,, 1989; Klinman and Linton, 1990; Vitetta et 
al., 1991). Upon stimulation with antigen, one 
precursor differentiates into a memory cell but does 
not secrete antibody; the other differentiates into 
a plasma cell and secretes Ig. Subimmunogenic 
concentrations of TC-83 virus will also prime for an 
enhanced antibody response following subsequent 
virus challenge (unpublished observation).
Therefore, the differences seen in the antibody 
response to subimmunogenic or immunogenic doses of 
TC-83 virus or the individual glycoproteins may be 
partially due to differences in induction of these 
B-cell precursors.
The El and E2 glycoproteins were also able to 
prime for an elevated IgM response. The reason for 
this is not known; however, it has been shown that 
memory B cells can be induced that simultaneously 
express two or more isotypes - including IgM 
(LaFrenz et al., 1986; Vitetta et al., 1991). Also, 
the nucleocapsid of hepatitis B virus can induce 
elevated levels of IgM through a T-cell independent 
mechanism ( Milich et al., 1986).
It was observed in this study that antisera 
from C3H mice, given a single inoculation of TC-83 
virus, were primarily reactive in ELISA with virus 
but not the El or E2 glycoproteins. This suggested 
that the antibody response was to conformationally 
dependent B-cell epitopes on the virus. Conversely,
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glycoprotein antisera recognized both virus and 
glycoprotein (data not shown). These reactivity 
patterns may be of value in future studies, since 
this appears to differentiate linear from 
conformationally dependent B-cell epitopes.
Vaccine Potential of the El and E2 
Glycoproteins. The El and E2 glycoproteins derived 
from SDS-PAGE are not by themselves strong inducers 
of a B-cell response. In the present study, the El 
was qualitatively more immunogenic than the E2 based 
upon the requirement for fewer inoculations with 
comparable amounts of protein to elicit an antibody 
response. Dalrymple et al. (1976) made a similar 
observation with the Sindbis virus El and E2 
separated by isoelectric focusing. Three to four 
injections of rabbits elicited antibody to El; 
however, 14 injections of E2 were necessary for a 
significant antibody response. Nevertheless, both 
glycoproteins appear to be biologically relevant 
since they are able to prime for an enhanced 
antibody response to TC-83 virus. The results from 
the present study suggest that the appropriate 
linear residues from these glycoproteins may be of 
value in vaccine studies; therefore, synthetic 
peptides may be able to prime mice for a protective 
anamnestic immune response following challenge with 
virulent VEE virus.
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CHAPTER 6
TH-CELL ANALYSIS OF SYNTHETIC PEPTIDES OF THE E2 AND 
El GLYCOPROTEINS OF VENEZUELAN EQUINE ENCEPHALITIS
VIRUS.
SUMMARY
Overlapping synthetic peptides primarily of the 
entire extramembranal domain of the TC-83 virus E2 
and selected regions of the E2 and El of TRD and TC- 
83 viruses respectively were analyzed for Th-cell 
recognition and antibody induction in three strains 
of mice representing three haplotypes. T-cell 
epitopes were predicted in 23 out of 26 peptides by 
one or more of three unique algorithms. NW-passaged 
splenic Th cells from mice immunized with peptide in 
Freund's incomplete adjuvant were analyzed in 
lymphoproliterative assays. Peptide reactive Th 
cells were induced by 25 out of 26 peptides in one 
or more haplotypes of mice. Genetic restriction was 
observed and positive LBT was generally associated 
with a concomitant anti-peptide antibody response as 
measured in ELISA. Only 6 peptides were recognized 
by TC-83 virus Th cells; Th cells from 7 peptides, 
including El-97 (AA 97-137), were stimulated by 
either or both TC-83 and TRD viruses. Peptides TRD 
E2-01 (AA 1-25) and TC-83 E2-13 (AA 241-265), 
previously shown to be important in inducing 
protective antibody, were among the peptides that
-191-
elicited Th cells that recognized virus in LBT. The 
results map important dominant and subdominant Th- 
cell epitopes on both the El and E2 glycoproteins, 
and show that a single residue change involved in 
protection can alter Th-cell and B-cell epitope 
specificity.
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INTRODUCTION
T-cell epitopes are sequential and not 
conformational. This was first shown by Gell and 
Benacerraf (1959) when proteins elicited DTH with 
similar specificity using either native or denatured 
antigens. The linear nature of T-cell epitopes has 
subsequently been confirmed in many different 
laboratories using various types of proteins 
(reviewed in Livingstone and Fathman, 1987;
Berzofsky et al., 1987). Synthetic peptides, 
therefore, are well suited for studies to 
investigate the basic immunology of T-cell epitopes. 
A logical extension of these studies was to the 
possible use of synthetic peptides for vaccine 
purposes in general (Lerner, 1984; Laver and Air, 
1985; Arnon, 1986), and for viruses (Brown, 1984) in 
particular.
Synthetic peptides prepared from the deduced 
amino acid sequences of the structural glycoproteins 
from many viruses have been analyzed for T- and B- 
cell activity. Some of the viruses studied include 
influenza (Gao et al., 1989), herpes simplex (Heber- 
Katz et al., 1988), Hepatitis B (Milich et al., 
1987a, 1987b), rabies (Ertl et al., 1989), 
respiratory syncytial (Nicholas et al., 1989), foot- 
and-mouth disease (Francis et al., 1990), human T- 
cell lymphotrophic virus type 1 (Kurata et al., 
1989), Murray Valley encephalitis (Mathews et al., 
1991), poliovirus (Kutubuddin, et al., 1992a,
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1992b), and human immunodeficiency virus (Hart et 
al., 1990). The results indicate that the same Th 
cells that respond to virus can be induced with 
synthetic peptides. Synthetic peptides are 
generally poor inducers of neutralizing antibody/ 
since many of these epitopes are conformationally 
dependent. However, some synthetic peptides, where 
conformation is less important for the expression of 
epitopes involved in NT, have been shown to elicit 
neutralizing antibody (e.g. foot-and-mouth disease 
virus, Francis, 1990; hepatitis B virus, Neurath et 
al., 1986; and Mengo virus, Muir et al., 1991).
The antigenic, immunogenic and protective 
properties of various TC-83 and TRD virus E2 
glycoprotein synthetic peptides have been previously 
published (Hunt et al., 1990, 1991; Johnson et al., 
1991). Analysis of the E2 glycoprotein was 
emphasized because of its important involvement in 
NT and protection (Roehrig, 1990). Antipeptide and 
antiviral antibodies were induced by several 
peptides; none neutralized virus. However, peptides 
to the amino terminus of the E2 of TC-83 and TRD 
viruses (VE2pep01, AA 1-25) and one from TC-83 virus 
VE2pepl3 (AA 241-265) (see Table 21) were 
biologically relevant. Antibody induced by these 
peptides was able to protect mice from virulent 
virus challenge. The Th-cell immune response to 
these peptides was not addressed, although previous 
characterization of the Th-cell immune response to 
VEE virus suggested a possible dominant role for the
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E2 protein (Mathews and Roehrig, 1989) . Colinear 
synthesis of Th and B cell epitopes from the E2 of 
SF virus induced antibody in mice that did not 
neutralize virus but was protective (Snijders et 
al., 1992a).
In the present study the originally 
characterized VEE peptides and other overlapping 
peptides synthesized from the remaining 
extramembranal region of the E2, and peptides 
synthesized from putatively important domains on the 
El were investigated for Th-cell activity. This 
involved prediction of T-cell epitopes using various 
algorithms, induction of peptide and virus reactive 
Th cells in three haplotypes of mice, and 
correlation of Th cell activity with the associated 
antibody response. The results indicate that most 
of the peptides induced peptide reactive Th cells 
and antibody and genetic restriction was observed. 
Those E2 peptides important in protection and one El 
synthetic peptide predominantly defined the few 
regions of the glycoproteins that induced virus- 
recognizing Th cells.
RESULTS
Prediction of T-Cell Epitopes within the E2 and 
El Sequences of TRD and TC-83 Viruses. The
subgenomic 26S mRNA encoding the structural 
glycoproteins for both the virulent parent TRD virus 
and its attenuated vaccine derivative TC-83 virus
-195-
have been sequenced (Kinney et al., 1986, 1989; 
Johnson et al., 1986). The deduced AA sequences of 
the E2 of these viruses, including the 5 non­
conservative residue changes that occurred during 
the attenuation process, are shown in Fig. 11. Also 
included are T-cell epitope predictions using three 
algorithms (AMPHI [Margalit et al., 1987],
Rothbard's motif [Rothbard, 1986] and the strip of 
helix hydrophobicity algorithm [SOHHA] [Stille et 
al., 1987]). For the AMPHI analysis, a sequence 
block length of 11 was selected and the threshold 
for amphipathic scores was set at 4. The SOHHA 
analysis used a moving 19 AA window, and positive 
strips were determined as described in the Materials 
and Methods. The Lys to Asn change at position 7 
resulted in a reduced AMPHI segment on the TC-83 E2. 
A predicted AMPHI epitope on the TRD E2 at positions 
86-90 was lost on TC-83 following the His to Tyr 
substitution at position 85; however, new sites were 
predicted following the Val to Asp and the Thr to 
lie shifts at residues 192 and 296 respectively. An 
AMPHI segment defined by residues 194-196 and a 
hydrophobic strip at position 282 are predicted on 
TC-83 but not TRD virus. In general, clusters of 
predicted T-cell epitopes were found in both the 
amino and carboxyl terminal regions as well as 
within AA 140-170 and 210-250.
Fig. 12 shows the deduced AA sequences of the 
El for both TRD and TC-83 viruses. The substitution 
of an lie for Leu at position 161 was the only
-196-
Ficrure 11. Predicted T-cell epitopes on the E2 
glycoproteins of TRD and TC-83 viruses. TRD E2 
sequence is represented by single letter codon 
designations for amino acids. Solid dots within the 
TC-83 sequence indicate amino acid sequence identity 
with TRD virus. T-cell epitopes for both proteins 
were predicted using the AMPHI algorithm (A), the 
Rothbard motif (R) and the strip of helix 
hydrophobicity algorithm (H). Differences in 
predictions between the two viruses are shown by 
duplicate algorithm rows; the TC-83 row is in lower 
case type.
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TRD
TC-83
TRD
TC-83
TRD
TC-83
TRD
TC-83
TRD
TC-83
TRD
TC-83
TRD
TC-83
TRD
TC-83
10 20 30 40 50 60
STEELFKEYKLTRPYMARCIRCAVGSCHSPIAIEAVKSDGHDGYVRLQTSSQYGLDSSGN
.....N..................................................
AAAAAA AAAAAAA AAAA
aaaa aaaaaaa aaaa
RRRR RRRR RRRR RRRR
H
70 80 90 100 110 120
LKGRTMRYDMHGTIKEIPLHQVSLHTSRPCHIVDGHGYFLLARCPAGDSITMEFKKDSVT
......................Y................................ R
AAAAAAA AAAA
aaaaaaa
RRRR RRRR RRRR
H H H H H H
130 140 150 160 170 180
HSCSVPYEVKFNPVGRELYTHPPEHGVEQACQVYAHDAQNRGAYVEMHLPGSEVDSSLVS
AAAAAAAAAAAAA AAAA
RRRRR RRRRR
H H H H H
190 200 210 220 230 240
LSGSSVTVTPPVGTSALVECECGGTKISETINKTKQFSQCTKKEQCRAYRLQNDKWVYNS
......... D.............................................
AAAAAAAAAAAAAAAAA 
aaa aaaaaaaaaaaaaaaaa
RRRR RRRR RRRRR
250 260 270 280 290 300
DKLPKAAGATLKGKLHVPFLLADGKCTVPLAPEPMITFGFRSVSLKLHPKNPTYLTTRQL    . . .1 ....
AAAAAAA
RRRRRRRR
H
h  h
310 320 330 340 350 360
ADEPHYTHELISEPAVRNFTVTEKGWEFVWGNHPPKRFWAQETAPGNPHGLPHEVITHYY
AA AAAA AAA AAAAAAAAAAAAAAAA
RRRRRRRR RRRRR RRRRRRRRRR RRRRRRR
370 380 390 400 410 420
HRYPMSTILGLSICAAIATVSVAASTWLFCRSRVACLTPYRLTPNARIPFCLAVLCCART
AAAAAA AA AAAAA AAA
R RRRRR
ARA 
• • •
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Ficrure 12. Predicted T-cell epitopes on the El 
glycoproteins of TRD and TC-83 viruses. TRD El 
sequence is represented by single letter codon 
designations for amino acids. Solid dots within the 
TC-83 sequence indicate amino acid sequence identity 
with TRD virus. T-cell epitopes for both proteins 
were predicted using the AMPHI algorithm (A), the 
Rothbard motif (R) and the strip of helix 
hydrophobicity algorithm (H).
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TRD
TC-83
TRD
TC-83
TRD
TC-83
TRD
TC-83
TRD
TC-83
TRD
TC-83
TRD
TC-83
TRD
TC-83
10 20 30 40 50 60
YEHATTMPSQAGISYNTIVNRAGYAPLPISITPTKIKLIPTVNLEYVTCHYKTGMDSPAI
AAAAAA
RRRR RRRRR RRRR
H H H
70 80 90 100 110 120
KCCGSQECTPTYRPDEQCKVFTGVYPFMWGGAYCFCDTENTQVSKAYVMKSDDCLADHAE
AAAA AAAAAAA AAAAA
RRRRR R
130 140 150 160 170 180
AYKAHTASVQAFLNITVGEHSIVTTVYVNGETPVNFNGVKLTAGPLSTAWTPFDRKIVQY
..................................... I..................
AAA AAAA AAAAA AAAA
RRR RRRR RRRRR RRRR
H H H H H
190 200 210 220 230 240
AGEIYNYDFPEYGAGQPGAFGDIQSRTVSSSDLYANTNLVLQRPKAGAIHVPYTQAPSGF
AAA AAAAAAAAAA AAAA
RRRR RRRR RRRR RRRRR RRRR
H H
250 260 270 280 290 300
EQWKKDKAPSLKFTAPFGCEIYTNPIRAENCAVGSIPLAFDIPDALFTRVSETPTLSAAE
AAAAAAA AAAAAAA AAAA
RRRRR RRRRR
H H
310 320 330 340 350 360
CTLNECVYSSDFGGIATVKYSASKSGKCAVHVPSGTATLKEAAVELTEQGSATIHFSTAN
AAAAA
RRRR RRRR RRRRRRRR
H
370 380 390 400 410 420
IHPEFRLQICTSYVTCKGDCHPPKDHIVTHPQYHAQTFTAAVSKTAWTWLTSLLGGSAVI
AAAAAAA AAAA
RRRRR RRRRR
430 440
IIIGLVLATIVAMYVLTNQKHN
AAAAAAA
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change and this was a conservative one. Predicted 
T-cell epitopes were not as clustered on the termini 
as on the E2, but regions with the strongest 
predicted activity included AA 115-135, and 160-290.
Synthetic Peptides. The sequences of the 26 
peptides analyzed in this study as well as predicted 
T-cell epitopes are listed in Table 21. Most of the 
peptides are 25-mers with a five AA overlap and are 
from the deduced AA sequence of the E2 of TC-83 
virus. Also synthesized were the TRD virus VE2pep01 
and VE2pep05 to compare residue changes at positions 
7 and 85 respectively. Based on predicted T-cell 
sites, 5 El peptides were also synthesized. A 
cysteine residue was included at the carboxy- 
terminus of each peptide to facilitate the coupling 
of carrier proteins if necessary. With few 
exceptions, most of the peptides have one or more 
predicted T-cell epitopes. High AMPHI scores were 
seen in peptides VE2pep01 TC-83 and TRD, 04, 07, 08, 
11, 13 and VElpep97 and subunit peptide 97-1. Most 
of these peptides also had elevated SOHHI values. 
Rothbard's motif epitope was predicted in 20 out of 
26 peptides. It is of interest that the Lys to Asn 
change in VE2pep01 reduced the magnitude of the 
AMPHI segment score in the amino terminal epitope in 
the TC-83 peptide.
A composite analysis was then performed on the 
E2 and El using the Surfaceplot computer program 
which predicts regions of hydrophilicity (Parker et
Ta
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al., 1986), accessibility (Janin, 1979), and 
molecular flexibility (Karplus and Schultz, 1985) 
(Fig. 13 and 14). Most of the peptides were 
positioned within putative B-cell epitope domains.
As indicated by the diamonds, two peaks on the TRD 
virus E2 were lost and two nascent ones appeared on 
the vaccine derived TC-83 virus following the AA 
changes that occurred during the attenuation 
process. Also, it is of interest that the E2 is 
more hydrophilic than the El based on surfaceplot 
area comparisons.
Synthetic Peptide Th-Cell Eptiope Aanlysis in 
Mice. This laboratory has previously shown with VEE 
virus, using flow cytometry and standard T-cell 
depletion methods, that CD4+ T cells are an absolute 
requirement for an in vitro lymphoblastogenic 
response (Mathews and Roehrig, 1989). To analyze 
the VEE synthetic peptides for functional Th-cell 
epitopes in LBT, inbred mice representing three 
distinct strains and haplotypes were used. Since 
the VEE virus Th-cell studies had been done in C3H 
(H-2k) mice, the synthetic peptide experimental 
rationale was to first evaluate all the peptides for 
Th-cell activity in C3H mice. Those peptides that 
did not induce peptide recognizing Th cells in C3H 
mice were subsequently analyzed in C57BL/6 (H-2b) 
mice and, if still negative, evaluated in BALB/c (H- 
2d) mice. Some peptides of interest were assayed 
with all three haplotypes.
-204-
Ficrure 13. Surfaceplot computer program composite 
analysis (hydrophilicity, accessibility and 
molecular flexibility) of the VEE TRD and TC-83 
virus E2 glycoproteins for putative B-cell regions. 
The parameters for stringency were set at 60%. The 
location of the E2 synthetic peptides is shown by 
numbered bars. E2 glycoprotein peaks present on one 
but not the other virus are indicated by open (TC- 
83) and closed (TRD) diamonds respectively.
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Ficrure 14. Surfaceplot computer program composite 
analysis (hydrophilicity, accessibility and 
molecular flexibility) of the VEE TRD and TC-83 
virus El glycoproteins for putative B-cell regions. 
The parameters for stringency were set at 60%. The 
location of the El synthetic peptides is shown by 
numbered bars.
-207-
9 n | B A  e o e j j n s
Am
in
o 
ac
id 
nu
m
be
r
-208-
When Th cells from all of the peptide immunized 
C3H mice were stimulated with homologous peptide in 
LBT, 20 out of 26 peptides elicited a SIR of >1.7;
18 had a SIR of >2.0, and 6 had a SIR of >4.0 (Table 
22). Peptides that were nonresponsive were then 
assayed in C57BL/6 mice; 3 of the 6 induced a SIR of 
>3.0. Two (VE2pep04 and 17) of the three remaining 
nonresponder peptides were strongly recognized by 
their respective Th cells in BALB/c mice. VElpep292 
was the only peptide not to induce peptide Th cells 
in any of the three haplotypes of mice.
Genetic restriction of the proliferative 
response was observed. Although not every peptide 
was analyzed in all the mouse strains, several 
peptides were able to associate with MHC class II 
gene products from two or more haplotypes.
To determine the peptide epitopes that may be 
dominant within the context of the virion, all of 
the peptides were tested for reactivity with TC-83 
virus-immune Th cells. Positive SIR were seen with 
the TC-83 and TRD VE2pep01 and TC-83 VE2pepl9 
peptides in C57BL/6 mice, TRD VE2pep05 in C3H mice, 
TC-83 VE2pep07 in BALB/c mice, and TC-83 VE2pepl6 in 
both C3H and BALB/c mice.
Another parameter of Th-cell dominance is the 
recognition by peptide Th cells of native virion 
epitopes following processing by APC. This is an 
important requirement for peptides to be considered 
for vaccine studies. Peptides TRD VE2pep01, TC-83 
and TRD VE2pep05, TC-83 VE2pep03, 04, 13 and
-209-
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VElpep97 all elicited Th cells in mice that 
recognized virus in at least one haplotype of mice. 
Only TRD peptides VE2pep01 and 05 demonstrated 
reciprocal Th-cell reactivity with virus; both 
peptide and peptide elicited Th cells demonstrated 
reactivity similar to virus and virus elicited Th 
cells (Table 22).
Synthetic Peptide B-Cell Response in Mice.
Since the induction of IgG is a strong indicator of 
Th-cell activity (Vitetta et al., 1991), and since 
in vitro lymphoblastogenesis may not always 
elucidate Th-cell function (Mathews et a!., 1991), 
the VEE peptides were also tested for antibody 
induction in mice (Table 23). The region of the E2 
defined by peptides VE2pep07-VE2pepll (AA 121-225) 
strongly associated with the la gene products of C3H 
(H-2k) mice while the rest of the protein, except for 
VE2pepl6 (AA 301-325) , was not B-cell immunogenic in 
C3H mice. Clustering of the peptide Th-cell epitope 
induced B-cell response was also seen in C57BL/6 (H- 
2b) mice. The amino terminal peptides induced a 
strong antibody response while the region defined by 
AA 50-250 did not. BALB/c (H-2d) mice responded to 
both amino and carboxyl terminal peptides. VE2pepl6 
and VElpep97 elicited antibody in all three 
haplotypes of mice. When antisera from each of the 
various B-cell responder groups were pooled and 
tested for reactivity on TC-83 virus, only antibody 
from VE2pep02, 08, 13, 16, 17 and VElpep97 immunized
fa
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e 
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mice strongly recognized virus. This recognition 
was haplotype dependent.
Comparative Analyses of Predicted Versus Actual 
Th- and B-cell Epitopes on the synthetic Peptides.
A summary of the VEE synthetic peptide data 
describing predicted T and B cell epitopes, and Th- 
cell epitopes defined by LBT and antibody induction 
is shown in Table 24. Every peptide except for 
VE2pep06, 14, and 15 is predicted to contain one or 
more Th-cell epitopes. Upon functional analysis, 
however, these latter three peptides were found to 
have Th-cell epitopes. VElpep292 contains a 
predicted AMPHI segment, but was both Th- and B-cell 
negative. All of the E2 peptides had functional 
peptide-reactive Th-cell epitopes in one or more 
haplotypes of mice. Recognition of VEE virus by 
peptide Th cells was not associated with any 
particular predictive algorithm. Putative 
prediction of B-cell epitopes using the Surfaceplot 
analysis was sometimes, but not always, associated 
with an antibody response. The TC-83 and TRD 
VE2pep05 peptides did not elicit a strong antibody 
response and this correlated with the Surfaceplot 
prediction. In general, positive Th-cell LBT was 
associated with a concomitant antibody response, but 
there were several exceptions. Antipeptide antibody 
induction without an associated Th-cell LBT response 
was seen only with VE2pepl6 (AA 301-325) in C57BL/6 
mice.
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DISCUSSION
Appraisal of T-Cell Epitope Predictive 
Algorithms. All three of the T-cell epitope 
predictive algorithms (AMPHI, Rothbard motif and 
SOHHA) used in this study take into consideration 
that most immunogenic peptides have both hydrophobic 
and hydrophilic characteristics. This amphipathic 
characteristic enables the hydrophobic part of the 
peptide to associate with the MHC molecules on the 
APC to form the agretope, while the hydrophilic part 
of the peptide interacts with the T-cell receptor to 
form the epitope (Spouge et al., 1987). The 
algorithms predicted a degenerate type of T-cell 
response with the VEE peptides as 20, 17 and 13 out 
of a total of 26 peptides were predicted to contain 
T-cell epitopes by the Rothbard motif, AMPHI and 
SOHHA analyses respectively. The peptide Th-cell 
response did correlate with the predictive 
algorithms as all but one peptide were LBT positive. 
However, the algorithms overpredicted the important 
peptide Th-cell recognition of virus or virus Th- 
cell recognition of peptide which occurred with only 
11 out of 26 peptides. All eleven of the virus- 
positive peptides were predicted to be T-cell 
positive by one or more algorithms, but no 
particular, unique algorithm pattern could be 
discerned.
The primary limitation of the described
-218-
algorithms is that they do not take into account the 
polymorphism of the MHC so that predicted sites may 
be immunogenic in one MHC type but not another.
This was seen with the VEE peptides (Table 24).
Since there are so many exceptions to T-cell epitope 
predictive algorithms without regard for MHC, some 
investigators are still stressing the importance of 
the empirical methodology for T-cell analysis of 
synthetic peptides (Gammon et al., 1991). Recently, 
studies have resolved some of the MHC predictive 
hurdles with the development of agretopic motifs for 
binding to class II MHC molecules of some MHC types 
(Sette et al., 1989b; Ogasawara et al., 1992).
Immunodominant E2 and El Th-Cell Epitopes. T
lymphocytes recognize a limited number of 
immunodominant antigenic sites on any given protein 
(Benjamin et al., 1984). Factors that may 
contribute to dominance are the MHC of the host, 
affinity of peptide residues to form the agretope, 
conformational propensities related to intrinsic 
structural features of the antigenic sites and 
antigen processing (Berzofsky et al., 1987; 1988; 
Rosloniec et al., 1990; Sette et al., 1990). 
Immunodominant synthetic peptides readily induce Th 
cells that recognize native protein and/or are 
recognized by native protein derived Th cells 
(Gammon et al., 1987). Peptide Th-cell recognition 
only of itself is considered to be cryptic (Gammon 
et al., 1987) and many of the VEE peptides elicited
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a cryptic response (Table 24). It has been observed 
that synthetic peptides tend to overexaggerate the 
number of Th-cell determinants on a protein (Milich 
et al., 1989).
Three types of complex immunodominant 
reactivities were seen in this study with some of 
the VEE synthetic peptides (Table 24). These 
immunodominant patterns are summarized in Table 25. 
TRD VE2pep01 and TC-83 VE2pep05 were reciprocally 
dominant. TC-83 VE2pep01, 07, 16, and 19 peptides 
were recognized by virus Th cells, but peptide Th 
cells did not recognize virus. This indicates that 
these peptides define epitopes that are dominant 
following immunization with virus, but immunization 
with peptide induces Th cells that recognize a 
different epitope that is apparently not well 
expressed on virus infected APC. This observation 
may be related to overlapping Th-cell epitopes with 
various specificities (Berzofsky et al., 1988; 
Ffrench et al., 1989). Conversely, Th cells induced 
by peptides TC-83 VE2pep03, 04, 13, TRD VE2pep05 and 
VElpep97 recognized virus, but virus Th cells were 
not stimulated by peptide. This suggested that the 
peptides elicit Th cells that recognize their 
epitopes in the context of the APC expressed virion, 
but that these epitopes are not dominant following 
immunization with virus. Competition between 
molecules for MHC peptides (Adorini et al., 1988b), 
or the amount of peptide at the surface of APCs 
(Gammon et al., 1987) could account for these
-220-
Table 25. Three patterns of immunodominant Th-cell 
reactivities among the VEE virus synthetic peptides.
Lymphoblastogenic analysis
Peptide
Peotide Th Virus Th
Peptide Virus Peptide
VE2pep01 (TRD) HI ill
VE2pep05 (TC-83) r 2.* 1 ill
VE2pep01 (TC-83) n§ <1 . 0 ill
VE2pep07 wgk <1.0 gig
VE2pepl9 SB <1.0 Z>3>
VE2pepl6 IS <1.0 m
VE2pep03 Bill III <1 . 0
VE2pep04 33.7 Si <1.0
VE2pep05 (TRD) 3.8 Si 1.2
VE2pepl3 lllll 1.4
VElpep97 111 Si <1 . 0
•Values represent SIR. Shaded areas are considered to 
be CP *£0 *ojr)
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observations.
Although the peptides listed in Table 25 
probably account for the majority of immunodominant 
regions on the E2 of TC-83 virus, more may be 
revealed if tested in other MHC types. Also, some 
Th-cell epitopes may have been missed if they span 
two peptides and are larger than the peptide 
overlaps. In addition, more peptides would be 
required in order to define the determinant 
boundaries on the immunodominant peptides (Gammon et 
al., 1991).
B-Cell Response as a Correlate of Th-Cell 
Activation. Th-cell epitope studies of synthetic 
peptides with various viruses have sometimes 
correlated the association between T- and B-cell 
responses (Milich et al., 1987a, 1987b; Hart et al.,
1990), the LBT response (Ertl et al., 1989; Gao et 
al., 1990) or just the B-cell response (Neurath et 
al., 1985; Francis et al., 1990) to peptides. Since 
the proliferative response may not always correlate 
with the antibody response (Mathews et al., 1991), 
both of these parameters of Th-cell activation were 
evaluated with the VEE peptides. Evaluation of Th- 
cell activation by the B-cell response in C3H mice 
without LBT would have grossly underestimated the 
number of Th-cell epitopes as only nine of twenty 
LBT positive peptides had a corresponding anti­
peptide antibody response. This may have been due 
to a limitation of the B-cell repertoire with these
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peptides in C3H mice as most were antibody positive 
when tested in the remaining haplotypes of mice. 
Peptides VE2pep04, 06, 12 and VElpep292 and 321 did 
not elicit antibody in any haplotype. Only 
VElpep292 was LBT negative indicating that the other 
four peptides may not have had functional B-cell 
epitopes in the three strains of mice used.
There was considerable variation in the 
recognition of TC-83 virus in ELISA by pooled anti­
peptide sera (Table 23). Epitopes ranged from 
cryptic to fully expressed. Strong anti-virus 
reactivity was seen with peptides VE2pep02, 08, 13, 
16, 17 and VElpep97. Peptide VE2pepl3 is of 
biological importance, since immunized NIH-Swiss 
mice were protected from TRD virus challenge 
(Johnson et al., 1991). It is also of interest that 
peptides VE2pepl6 (AA 301-325) and VElpep97 (AA 97- 
137) elicited strong anti-peptide antibody responses 
in all three haplotypes of mice, whereas the anti­
virus activity was strong in C3H mice, intermediate 
in C57BL/6 mice and negative in BALB/c mice. These 
resuits suggest that different B-cell epitopes were 
recognized in each haplotype.
Effect of a Single Residue Change on Th and B 
Cell Fine Specificity. TC-83 and TRD VE2pep01 
peptides (AA 1-25) both induce an antibody response 
in NIH-Swiss and BALB/c mice that protects mice from 
TRD virus challenge (Hunt et al., 1990). The TRD 
peptide VE2pep01 is considered to be more potent
-223-
since fewer inoculations are required for maximum 
protection (Hunt et al., 1990). The only difference 
between the two peptides is at position 7 where Lys 
in TRD has been substituted for an Asn in TC-83 
virus. These peptides were not immunogenic in C3H 
mice, but both peptides elicited antibody to peptide 
and virus in BALB/c mice as well as peptide reactive 
Th cells. However, in C57BL/6 mice, elicited Th 
cells with the TRD but not the TC-83 virus peptide 
recognized both viruses in LBT. This suggested that 
the Lys is necessary for the epitopic configuration 
required to induce Th cells reactive with both 
viruses. This may be related to alpha-helical 
conformational propensities as described by Spouge 
et al., (1987). Since both peptides were able to 
stimulate TC-83 virus Th cells, this indicates that 
epitopes common to both peptides and distal to the 
substitution may also be functional. Antisera from 
both peptides were tested on TC-83 but not TRD 
virus. TC-83 virus was recognized by antisera from 
the TC-83 but not the TRD peptide indicating that B- 
cell recognition was affected by the residue change. 
Similar observations were previously made when the 
TRD VE2pep01 peptide induced antibody in BALB/c and 
NIH Swiss mice that reacted to higher titre with TRD 
than with TC-83 virus (Hunt et al., 1990)
Differences in both peptide and virus-related 
Th- cell activity were noted with the TC-83 and TRD 
VE2pep05 peptides (AA 81-105) where a His to Tyr 
change occurred during the attenuation of TRD to TC-
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83 virus. The TC-83 peptide induced a much stronger 
peptide-related proliferative response in C57BL/6 
mice than did the TRD peptide. Just the opposite 
was observed in C3H mice. The equivalent 
recognition of TRD virus by Th cells from both 
peptides indicated that epitopes not affected by the 
residue change were functional. However, TC-83 
virus Th cells were only stimulated by the 
homologous peptide and TRD peptide Th cells were 
reactive with TC-83 virus. These complicated 
results suggest that multiple MHC restricted 
epitopes are involved and that an AA substitution 
may or may not alter how epitopes are expressed.
-225- 
CHAPTER 7
ANALYSIS OF THE TH- AND B-CELL DETERMINANTS ON A 
SYNTHETIC PEPTIDE FROM THE AMINO TERMINUS OF VEE TRD 
VIRUS THAT INDUCES PROTECTIVE ANTIBODY IN MICE.
SUMMARY
A synthetic peptide (VE2pep01) comprised of the 
first 25 AA of the amino terminus of VEE TRD virus 
has previously been shown to induce protective 
antibody in both NIH swiss and BALB/c mice (Hunt et 
al,, 1990). In the present study, the full-length 
TRD peptide plus four overlapping subunit peptides 
(SI to S4) of VE2pep01 were analyzed in C3H (IAkIEk) , 
C57BL/6 (IAb) and BALB/c (IAdIEd) mice for induction 
of both Th-cells and antibody as measured in LBT and 
ELISA respectively. Peptide TC-83 VE2pep01 was also 
analyzed. This peptide differs from the TRD peptide 
only at position seven where the Lys in the TRD 
peptide has been substituted by an Asn in the TC-83 
peptide. Genetic restriction of the Th-cell 
response to various peptide elements was observed. 
All peptides were essentially not immunogenic in C3H 
mice. A dominant Th-cell epitope in peptide S3 (AA 
9-19) associated with both IAb and IAdIEd molecules 
and induced Th cells that recognized homologous as 
well as other peptides containing this sequence.
Only SI of the four subunit peptides induced 
antibody. The anti-Sl antibody failed to react with
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any of the other three subunit peptides. However, 
the full-length TRD and TC-83 peptides elicited 
antibody that identified at least one B-cell epitope 
on each of the smaller peptides. In IAdIEd mice TRD 
VE2pep01 elicited antibody that reacted with 
homologous peptide and S2 (AA 1-9) but not TC-83 
VE2pep01. This antibody also recognized TRD virus. 
The results suggest that a dominant Th-cell epitope 
is present within S2 (AA 9-19) , and that adjacent AA 
as well as the residue at postion seven may be 
important in both Th- and B-cell activation.
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INTRODUCTION
An effective vaccine must associate with the 
MHC of the host and elicit memory T and B cells that 
can be recalled in a secondary type of immune 
response upon subsequent experience with the native 
or related antigens (Vitetta et al., 1991). The 
efficacy of the immune response to most viral 
vaccines is often determined by the presence of 
antibody that will neutralize virus or protect the 
host from virulent virus challenge (Brown, 1984).
An essential process for antibody synthesis is the 
activation of Th cells by T-cell epitopes that are 
cognately linked on the same molecule 
(intramolecular) or structurally linked 
(intermolecular or intrastructural) to B cell 
epitopes within the context of the virion (Lake and 
Mitchison, 1976).
Although the protective immune response to some 
viruses is probably CTL mediated (Oehen et al.,
1992) , and CTLs are possibly important in the immune 
response to certain other viruses (Rosenberg and 
Fauci, 1990), the presence of pre-existing antibody 
to epitopes involved in NT and/or protection is 
critical for VEE virus immunity (Roehrig, 1990). 
Non-neutralizing MABs to the El of VEE virus 
(Mathews and Roehrig, 1982), Sindbis virus 
(Schmaljohn et al., 1982) and WEE virus (Hunt and 
Roehrig, 1985) have been shown to passively protect 
mice from virus challenge. Non-neutralizing
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antibodies to the E2 of SF virus were protective 
(Grosfeld et al., 1989). Non-neutralizing 
antibodies elicited following immunization of mice 
with synthetic peptides (VE2pep01) to the amino 
terminus of the E2 of TRD and TC-83 virus protected 
mice from TRD virus challenge (Hunt et al., 1990). 
Passive transfer of antibody to the TRD VE2pep01 
peptide also protected mice (Hunt et al., 1991). In 
addition, a MAB to the same peptide was also 
protective (Roehrig et al., 1991; Hunt et al.,
1991). Therefore, non-NT antibodies to both the El 
and E2 of VEE virus have been shown to be protective 
and suggest that synthetic peptides defining these 
B-cell epitopes in association with the appropriate 
Th-cell epitopes, could be likely candidates for an 
effective synthetic peptide vaccine to VEE virus.
In this study, overlapping subunit peptides (SI 
[AA 1-19]; S2 [AA 1-9]; S3 [AA 9-19]; and S4 [AA 5- 
15]) of the TRD VE2pep01 (AA 1-25) were analyzed for 
antibody induction and Th-cell activity in three 
strains of mice representing three different 
haplotypes. Th-cell epitopes were predicted in TRD 
VE2pep01 by each of three unique algorithms.
Complex T-B cell interactions elucidated distinct B- 
cell epitopes on all of the subunit peptides and 
important MHC restricted Th-cell epitopes mapped to 
both the carboxy and amino terminal regions of the 
VE2pep01 peptide. The Lys at position 7 appears to 
define an important B-cell epitope.
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RESULTS
Synthetic Peptides. The sequences of the TRD 
VE2pep01 and subunit peptides are listed in Table 
26. The strategy for synthesis of the overlapping 
subunit peptides was to evaluate immunogenicity 
within discrete regions of the amino terminus using 
peptides nine to nineteen AA in length. Also 
included is the sequence of TC-83 VE2pep01 which is 
derived from the attenuated vaccine variant strain 
of TRD virus. The only difference between the two 
peptides is at position 7 where Lys in TRD VE2pep01 
has been substituted for an Asn in TC-83 VE2pep01. 
Also shown are predicted T-cell epitopes using the 
Rothbard motif (Rothbard, 1986) and AMPHI (Margalit 
et al., 1987) algorithms. Two of each are predicted 
in the full-length peptides. The residue change in 
the TC-83 peptide resulted in a decreased AMPHI 
segment in the amino terminal epitope. A third 
algorithm, SOHHA (Stille et al., 1987) was also used 
to predict T-cell epitopes on the TRD peptides 
(Fig.15). Although not shown, the SOHHA profile for 
TC-83 VE2pep01 was identical to that for the TRD 
peptide. Two hydrophobic strips that weakly met the 
criteria for the SOHHA start at residues 9 (Tyr) and 
13 (Arg). A strongly hydrophobic strip is found at 
position 20 (He) .
Th-Cell Epitope Analysis. Splenocytes were 
harvested from C3H (IAkIEk) , C57BL/6 (IAb) and BALB/c
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Table 26. Sequences of TRD peptide VE2pep01 and subunit peptides 
as well as TC-83 VE2pep01.
Peptides AA Sequence*
VE2pep01 (TRD) 1-25 N-STEELFKE¥KDTRP¥M&RCIRCAVG-Cvs-C
VE2pep01 (TC-83) 1-25 N-STEELFNl*lrRP^TOii^CAVG-Cys-C
VE2pepol (TRD)-SI 1-19 N-STEELFKEYKfcTRPYMARC-Cvs-C
VE2pep01 (TRD)-S2 1-9 N-STEELFRE^-Cys-C
VE2pep01 (TRD)-S3 9-19 N-iilTRPfiiA&f-Cys-C
VE2pep01 (TRD)-S4 5-15 N-lSliiiTRPY-Cys-C
•Predicted Rothbard motif epitopes are underlined; predicted AMPH 
segments are shaded.
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Fiqure 15. Strip of helix hydrophobicity plot for 
the TRD VE2pep01 synthetic peptide (AA 1-25) for 5 
cycles of an alpha helix. The postions of the 
subunit peptides are indicated by labelled 
horizontal bars.
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(IAdIEd) mice four to six weeks after immunization 
with a single inoculation of peptide (50 fig) in FIA. 
T cells were collected following NW chromatography 
and assayed in LBT for recognition of a battery of 
related antigens (Table 27). All of the peptides 
except for S2 (AA 1-9) were not immunogenic in C3H 
mice and S2 Th cells only reacted with TC-83 virus. 
There was no induction of peptide or virus reactive 
antibody.
In C57BL/6 mice a variety of Th-cell epitope 
reactivity patterns was observed. Peptide S3 (AA 9- 
19) defined a major Th-cell epitope that was 
recognized by Th cells from both TC-83 and TRD 
VE2pep01 peptides, SI (AA 1-19) and homologous S3 
peptide. Th cells from S3 primed mice reciprocally 
recognized the same peptides. TC-83 VE2pep01 had the 
same reactivity pattern as S3 suggesting that the 
same Th-cell epitope was dominant in the full-length 
peptide. Th cells elicited by TRD VE2pep01 (AA 1- 
25) recognized TRD virus, the full-length peptides, 
and S3. Th cells primed by peptide SI were only 
reactive with S3 (AA 9-19). This suggested that the 
6 additional residues at the carboxy terminus plus 
the Lys at position 7 activated a Th-cell epitope 
important in recognition of virus, since Th cells 
from TC-83 VE2pep01 immunized mice were not reactive 
with virus.
In BALB/c as in the C57BL/6 mice Th-cell 
activity was noted with peptide S3. Either an 
additional Th-cell epitope or a cumulative effect of
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Table 27. Lymphoblastogenic analysis of the Th-cell epitopes on the VEE 
virus E2 amino terminal peptides following primary immunization of C3H, 
C57BL/6 and BALB/c mice.
Th cells from TC-83 virus and peptide immune mice
Mice
Stimulating
Antigens
TC-83
virus
VE2pep01
(TC-83)
VE2pep01
(TRD) SI
C3H TC-83 IS. 3* £1.0 £1.0 1.4
TRD £1.0 £1.0 1.0
VE2pep01 (TC-83) £1.0 £1.0 £1.0 £1.0
VE2pep01 (TRD) £1.0 £1.0 £1.0 £1.0
SI £1.0 £1.0 £1.0 £1.0
S2 1.5 1.2 £1.0 1.1
S3 £1.0 £1.0 £1.0 £1.0
S4 £1.0 £1.0 £1.0 £1.0
S2 S3 S4
C57BL/6
BALB/c
TC-83
TRD
VE2pep01 (TC-83) 
VE2pep01 (TRD)
51
52
53
54
3.0
2.2
3.2
2.3 
1.9
£1.0
1.8
£1.0
£1.0
£1.0
4.1
5.2 
4.7 
1.4
111
£1.0
1.7 £1.0
2.3 £1.0
2.2 £1.0
3.B £1.0
1.7 1.1
1.6 £1.0
4 1
1.9 1.3
TC-83 HI £1.0 £1.0 III
TRD 1.9 £1.0 1.1 £1.0
VE2pep01 (TC-83) £1.0 M 1.9
VE2pep01 (TRD) 1.4 9.4 6.7 14.1
SI £1.0 4.S* 11.3
S2 £1.0 £1.0’ £1.0 1.3
S3 £1.0 1.4* 2*0* 1.3
S4 £1.0 £1.0 1.5 £1.0
; 2:3 £1.0 £1.0
£1.5 £1.0 £1.0
£1.0 £1.0 £1.0
Oi—1VI £1.0 £1.0
£1.0 £1.0 £1.0
1.1 £1.0 1.1
£1.0 £1.0 £1.0
£1.0 £1.0 £1.0
£1.0 £1.0 £1.0
£1.0 £1.0 £1.0
£1.0 2.3 £1.0
1.8 £1.0
£1.0 3.4 £1.0
1.2 £1.0 £1.0
£1.0 ■*•3 £1.0
£1.0 £1.0 1.8
2.7 3.0 £1.0
1.8 3 :0 £1.0
£1.0 2,7 £1.0
1.8 %:a 1.7
£1.0 3.0 £1.0
£1.0 £1.0
£1.0 2*3 £1.0
£1.0 £1.0 £1.0
•Values represent SIR derived from LBT using pooled T cells from 3-6 mice. 
Values marked with an * are SI; SIR were not calculated due to erroneous 
results with cells from unimmunized controls. SIR and SI £2.0 are shaded.
bBoxes denote that >50% of mice used for LBT within that immunization group 
had ELISA antibody log10 GMT of >2.6 on homologous antigen.
-235-
other Th-cell epitopes resulted in a very strong LBT 
response when SI (AA 1-19) primed Th cells were 
stimulated by SI or the full-length TRD but not the 
TC-83 peptide. TRD VE2pep01 elicited Th cells that 
were primarily reactive with homologous peptide 
whereas TC-83 VE2pep01 induced Th cells recognized 
both the TRD and TC-83 VE2pep01 peptides as well as 
peptide SI. This suggested that induced Th cells 
from these peptides may be recognizing different Th- 
cell epitopes. It is also of interest that both S2 
and S3 Th cells were reactive with virus while Th 
cells from TRD VE2pep01 did not recognize virus.
B-Cell Epitope Analysis. Sera from peptide 
and TC-83 virus responding mice from each haplotype 
were assayed for recognition of virus, TC-83 
VE2pep01 and TRD VE2pep01 as well as the subunit 
peptides (Table 28). Among the peptides, only TC-83 
VE2pep01, TRD VE2pep01 and SI (AA 1-19) were able to 
induce B-cell responses in C57BL/6 and BALB/c. C3H 
mice were refractory for antibody induction or 
recognition by TC-83 virus antisera.
In both C57BL/6 and BALB/c mice the 
substitution of Lys for Asn at position 7 altered 
the specificity of the resultant antibody. In 
C57BL/6 mice, antisera from TC-83 VE2pep01 reacted 
with homologous peptide, TRD VE2pep01, SI, and 
peptide S3 (AA 9-19). Antisera from TRD VE2pep01 
and SI (AA 1-19) only reacted with homologous 
peptide and each other but not S3 or TC-83 VE2pep01.
Ta
bl
e 
28
. 
EL
IS
A 
re
ac
ti
vi
ty
 
of 
VE
E 
vi
ru
s,
 
VE
2p
ep
01
 
(T
C-
83
/T
RD
) 
an
d 
su
bu
ni
t 
pe
pt
id
es
 
wi
th
 
an
ti
se
ra
 
fr
om
 
TC
-8
3 
vi
ru
s 
an
d 
pe
pt
id
e 
im
mu
ni
ze
d 
mi
ce
.
-236-
4
to
H►QW
•o
0)m
3
10
0)
TJi-l+J04 
0) 
0«
4J
0)JG
•P
C>im
•0e<d
m
0)
(0au
•*H
>
o O O o o O O O o o O. • « • • « • • SSS • • •
CO CM CM CM CM CM CM CM CM W& CM CM CM
V V V V V V V V V V V
o O o sim O O O O sp o O Om • • • • • • • • • •
CO CM CM CM CM CM CM CM CM CM CM
V V V V V V V V V V
O O O o O o O o o PI O OCM • • • • • • • • • • •
co CM CM CM CM CM CM CM CM CM $! CM CM
V V V V V V V V V V V
pH O O O m SB*; O O m sag w® oCO • • • Wit*: • • •
CM CM CM $9$ **§ Wi CM CM WM CM
V V V V V V
rH
O
cu­ o O n w® m m o O !p Pi W® ol) q • • I:-*** • • •
cu2 CM CM ill Pi il $S3 CM CM $1 Pi CMCM H V V V V
5 -
pH
o m
CUC0 O O o o o O O iP o o O0) 1 • • • •tvife • • • • • • •
CUO CM CM CM CM CM CM CM Ssi CM CM CMCM EH V V V V V V V V V
O mi m O O O **3 o m oq • SI:**; • • • • • • •
2 CM ma CM CM CM CM Icrii CM isl CM CME-i V Al V Ai V V
CO A...00 mm o n O O O O o O o1 • ¥S»S • • • • SiS • • • •
O CM MS CM CM CM CM CM CM CM CM
Eh V V V V V V V V
_ _ - L
n n
00 — 00 —i
O S O §
Eh Eh Eh EH
id a) 0) w " 0)
0 G c c
a) 3 pH pH 3 pH pH 3
ID 1 O O
P O O g
iH Ol 04 g 04 04 g
v m iH n 0) 0) iH m a) <0 iH
G 00 1 00 04 04 1 00 04 04 1
< i G i CM CM G I CM CM G
O 0 O P pH 0 U & pH 0H G Eh > > CO G Eh > > CO c
VO
'■"s. O
hJ —
0) OQ CQ
o rn r-
•r| n in s
• S O U OQ
00
-p (0
O 3
•0
0)•O
idJG
(0
c
0)(UA
d)
>
id£
vo
CM
Al
(0a>u
4JiH
-P
>»
TJO.Q••H
-PG
id
0)
>
(0oCU
so
O'o
>1TJOJQ
+»
c
id
4J
Ga>
a<u
Uo<a>u
CD
a)
3H
*
-237-
This suggested that the Lys at 7 position is 
critical for expression of a dominant B-cell epitope 
within the context of the first nineteen AA but not 
the first nine (S2) or five to fifteen (S4), and may 
overlap part of the B-cell epitope on S3. A third 
reactivity pattern was observed in C57BL/6 mice with 
TC-83 virus antisera which, among the battery of 
peptides, only reacted with TRD VE2pep01.
In BALB/c mice, at least four unique B-cell 
epitopes were elucidated within the various 
peptides. These were: (1) S3 (AA 9-19) and (2) S4 
(AA 5-15) defined by TC-83 VE2pep01 antisera; (3) SI 
(1-19) reactivity with homologous, TRD VE2pep01, and 
TC-83 VE2pep01 antisera; and, (4) S2 (AA 1-9) 
recognized by TRD VE2pep01 antisera. TRD VE2pep01 
antibodies were also reactive with TRD but not with 
TC-83 virus or the TC-83 VE2pep01 peptide. The 
reactivity patterns in (1) and (3) were also seen in 
C57BL/6 mice.
DISCUSSION
TRD VE2pep01 and Subunit Peptides Define 
Multiple Th-Cell Epitopes. A summary of the TRD
VE2pep01 and subunit peptides that induced a LBT 
response in one or more of the three strains of mice 
representing three distinct haplotypes is shown in 
Fig. 16. Low, intermediate and high responder 
patterns were observed along with genetic 
restriction of the Th-cell response. Peptide S3
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Ficrure 16. MHC restriction analysis of functional 
Th-cell epitopes on TRD VE2pep01 and subunit 
peptides in three strains of mice representing three 
haplotypes. Th-cell epitopes were defined by Th- 
cell recognition of either virus or peptide or both. 
Th-cell activation, as measured by the SIR, was
2.3-4.1, and 5.7-14.1 respectively. Rectangle 
represented by dotted lines in C57BL/6 mice 
indicates that the entire VE2pep01 was required for 
the expression of the carboxy-terminal epitope.
graded as low [ ], intermediate [
or high [ ] based on SIR values of 1.8-2.0
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C3H IAkIEk
S2
STEELFKEYKLTRPYMARCIRCAVG
C57BL/6 IA
S4
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VE2pep01l
STEELFKEYKLTRPYMARCIRCAVG
BALB/c I^ IE d
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STEELFKEYKLTRPYMARCIRCAVG
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defined a dominant Th-cell epitope that would 
associate with IAb and IAdIEd MHC class II molecules 
but not with IAkIEk. A Th-cell epitope defined by 
the carboxy-terminal 6 AA of TRD VE2pep01 was only 
functional in IAb mice. A dominant Th-cell 
epitope(s) in peptide SI was restricted to IAdIEd 
mice. Genetic restriction in inbred mice has been 
regularly observed with synthetic peptides (Ertl et 
al., 1989; Gao et al., 1989).
The strong and IAdIEd restricted LBT response 
induced by peptide SI may represent a cumulative 
effect of the Th-cell epitopes in peptides S2 and S3 
or the overlap between the peptides may define an 
additional epitope. The SI peptide may be a part of 
a determinant envelope which includes overlapping 
Th-cell epitopes present in a continuous stretch of 
a sequence (Gammon et al., 1991). Peptides S2 and 
S3 have discrete Th- and B-cell determinants; 
however, neither peptide was able to induce 
antibody. Antibody to these peptides was only 
induced when these peptides formed part of a larger 
peptide. This should not be related to minimal B- 
or Th-cell size as Geysen et al. (1988) have shown 
the minimal B-cell determinant to be five AA in 
length. Numerous investigators have found that 
peptides defining minimal T-cell epitopes contain 8 - 
14 residues (reviewed in Kourilsky and Claverie, 
1989). Therefore, the overlap between peptides S2 
and S3 may constitute an important Th-cell epitope.
-241-
B-Cell Response as Related to Th-Cell 
Induction. It has been shown that multiple 
immunizations of mice with the TRD and TC-83 
VE2pep01 peptides elicit antibody that is reactive 
with virus (Hunt et al., 1990; 1991). In the 
present study, antibody to these full-length 
peptides and SI (AA 1-19) defined at least one B- 
cell epitope on each of the four subunit peptides of 
TRD VE2pep01 (Table 27). A dominant theme in the 
antibody response in both the C57BL/6 (IAb) and 
BALB/c (IAdIEd) mice was the activation of S3 (AA 9- 
19) reactive Th cells. In IAb mice this appeared to 
be the only anti-peptide Th cell that was associated 
with antibody induction, although the Asn/Lys shift 
in the TRD VE2pep01 and SI immunized mice altered 
the specificity of the induced antibody. Single AA 
interchanges within a B-cell epitope have been shown 
to affect B-cell specificity with influenza virus 
(Webster et al., 1982; Stark and Caton, 1991).
In IAdIEd mice the single AA interchange at 
position seven altered B-cell specificity. Antibody 
to TRD VE2pep01 recognizes determinants in SI and S2 
but does not bind to TC-83 VE2pep01. The S2 
antibody was reactive with TRD but not TC-83 virus. 
Single AA substitutions have been shown to alter 
both Th- and B-cell recognition (Barnett et al.,
1989; Graham et al., 1989). These substitutions may 
affect T- and B-cell specificity by altering how the 
relevant immunogenic peptide binds to MHC (Kurata 
and Berzofsky, 1990), altering the orientation of
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the epitopes within the peptide (Cox et al., 1988), 
or changing the fine specificity for recognition by 
Th and B cells (Milich et al., 1990a).
A Single Amino Acid Defines a B-Cell Epitope 
that may be Important in Protection. During the 
attenuation of the virulent TRD virus to its vaccine 
derivative TC-83 virus by serial passage in 
embryonic guinea-pig heart cell culture (Berge et 
al., 1961), five nucleotide changes in the E2 gene 
produced five non-conservative AA substitutions 
(Johnson et al., 1986). One of the substitutions 
was at position seven where the Lys in TRD virus was 
replaced with an Asn in TC-83 virus. Subsequently, 
synthetic peptides prepared to the amino terminal 
25 AA of both viruses were found to induce antibody 
that would protect BALB/c and NIH swiss mice from 
TRD virus challenge (Hunt et al., 1990). The 
antibody elicited following TRD peptide immunization 
was more efficient at protecting mice than antibody 
from TC-83 peptide immunized mice. Passive transfer 
of anti-TRD VE2pep01 antibody also protected mice 
from virus challenge (Hunt et al., 1991). Also, a 
Mab (1A2B-10) prepared to the TRD confers protection 
(Roehrig et al., 1991).
In the present study, immunization of BALB/c 
mice with TRD VE2pep01 but not TC-83 VE2pep01 
elicited antibody to an epitope in S2 (AA 1-9) that 
would also bind to TRD virus. This may be a major 
B-cell epitope involved in protection, since an
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octomer (AA 3-10) of the TRD peptide is recognized 
in solution by the 1A2B-10 Mab (A.R. Hunt personal 
communication). Further evidence for the importance 
of this region of the peptide was the lack of 
protection afforded by carrier-induced antibody to 
S3 and S4 while antibody from SI immunized mice was 
protective (A.R. Hunt personal communication).
Although immunization of BALB/c (IAdIEd) mice 
with TRD VE2pep01 elicits antibody that will bind to 
TRD virus, the LBT data suggest that TRD VE2pep01 
elicited Th cells will not recognize virus.
Challenge of control and TRD VE2pep01 immunized NIH 
swiss mice with TRD virus induced comparable levels 
of anti-viral IgM and neutralizing antibody over a 
five day period indicating that no secondary 
response had occurred in the peptide immunized mice 
(Hunt et al., 1991). However, in C57BL/6 (IAb) mice 
immunized with TRD VE2pep01, a secondary antibody 
response after TRD virus challenge might be 
expected, since TRD VE2pep01 primed Th cells 
recognize TRD virus in LBT (Table 2). The caveat is 
that the elicited antibody from IAb mice does not 
recognize virus. Based on the results in this 
study, TRD VE2pep01 primed C3H (IAkIEk) mice would 
not be expected to survive virulent virus challenge.
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CHAPTER 8 
GLOBAL DISCUSSION
Specificity of the VEE Virus Th- and B-Cell 
Responses Following Virus Inoculation. The virus- 
specific Th- and B-cell responses seen in this study 
following either primary or secondary immunization 
of mice with VEE virus suggest that the E2 rather 
than the El glycoprotein is the target immunogen. 
This is based on evidence that the El is more 
conserved than the E2 as shown by sequence data and 
hence more cross-reactive; and, MABs to the E2 are 
more specific and biologically active than MABs to 
the El (Roehrig, 1990).
VEE virions, following immunization or initial 
replication in permissive cells, are probably 
captured by mlg on B cells specific for E2 
determinants that are conformational and expressed 
on the surface of the virion. These B cells are 
subsequently activated by Th cells that are also 
virus-specific following processing and presentation 
of glycoprotein peptides (Lanzavecchia, 1985). This 
preferential pairing of B cells expressing antibody 
to conformationally dependent B-cell epitopes and Th 
cells with similar specificity has been termed 
"directional help" (Manca et al., 1985; Celada and 
Sercarz, 1988) . In this situation the B cell choses 
the type of Th cell with which it wants to be 
associated. Secondary immunization with homologous
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virus preferentially activates the same set of B 
cells. This would suggest that cross-protection 
observed between antigenically unrelated 
alphaviruses may partly be attributed to 
differential expression of cross-reactive 
determinants on the surface of various alphaviruses. 
This could be demonstrated in virus capture ELISA 
assays using a variety of anti-E2 and E-l MABs.
Although the specificity of the CTL response to 
VEE virus has not been determined, studies with 
other alphaviruses uniformly agree that the cross­
reactive El glycoprotein is the primary target 
antigen (Mullbacher et al., 1979; Wolcott et al., 
1982a; 1985). Both the El and E2 glycoproteins are 
expressed on the surface of VEE virus-infected cells 
as detected with MABs in indirect immunofluorescence 
assays (Kinney et al., 1988b). However, the E2 may 
already have conformational attributes which would 
interfere with optimal association with MHC class I 
molecules, whereas the El polypeptides may not be 
under such restrictions until terminal maturation 
events occur. These events could be analysed in CTL 
assays using virus, glycoprotein and synthetic 
peptide induced CTLs.
Cross-Help Among El and E2 Glycoprotein-Induced 
Th Cells. The results from this study suggest that 
both El and E2 primed Th cells can provide help to 
conformational B-cell epitopes on the virion. B 
cells that capture virions via anti-E2 epitopes
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process, and probably present, both El and E2 
peptides in association with class II MHC molecules. 
Therefore, an animal host with primed El Th cells 
should recognize El determinants on B cells specific 
for E2 glycoprotein conformational determinants and 
provide help. This was demonstrated in the present 
investigation. This type of cognate help would be 
considered as intermolecular (Lake and Mitchison, 
1976). In support of this suggestion, help for B- 
cell responses to the influenza haemagglutinin has 
been provided by structurally associated but 
separate proteins (Scherle and Gerhard, 1986; 1988). 
A feasible approach to investigate this further 
would be to synthesize chimeric E1-E2 synthetic 
peptides. If the appropriate determinants were 
included, co-recognition of an E1-E2 epitope by a 
specific Th cell may be possible. Also, such 
chimeric peptides would have the potential to 
generate help for both alphavirus B and CTL 
precursor cells.
Priming Characteristics of the El and E2 
Glycoproteins. Both the El and E2 glycoproteins 
were able to prime Th cells without a concomitant 
antibody response. A lack of B-cell immunogenicity 
with these glycoproteins, particularly with the E2 
glycoprotein, was observed in an early study with 
Sindbis virus (Dalrymple, 1976). It may be that the 
frequency of B-cell precursors to linear epitopes 
may be less than those to conformational epitopes.
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This makes biological sense and has consequences for 
vaccine development, since most foreign proteins, 
when first introduced into the immune system, are 
probably in their native state. The priming of Th 
cells without induction of antibody is an important 
observation, since traditional approaches to 
efficacy of viral immunogens has relied on the 
presence of biologically relevant antibody as the 
sole indicator of the host's immune status.
Results showing that the El and E2 
glycoproteins primed Th cells for an antibody 
response to conformational B-cell epitopes on the 
virion is important for VEE virus vaccine 
development. Since the biologically important B- 
cell E2 epitopes on VEE virus are conformational, 
synthetic peptides to VEE virus have not been able 
to induce neutralizing antibody or highly efficient 
protective antibody (Hunt et al., 1990; 1991).
Future investigations with VEE virus synthetic 
peptides should include extensive priming and 
challenge virus experimentation. The resulting 
antibody should be tested for biological activity 
and glycoprotein specificity. Also, the kinetics of 
the secondary antibody response should be 
investigated, since survival of an individual 
infected with virulent VEE virus may depend on the 
rapid appearance of neutralizing antibody.
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Development of a VEE Virus Synthetic Peptide 
Vaccine. In this study it was demonstrated that 
both the El and E2 glycoproteins contain important 
VEE virus-reactive Th-cell epitopes. This was shown 
when both glycoproteins were recognized by VEE virus 
Th cells and immunodominant E2 and El synthetic 
peptides were found that could induce Th cells that 
would recognize VEE virus. Many of the VEE peptides 
readily induced antibody in one or more haplotypes 
of mice which is in contrast to the rather poor 13- 
cell immunogenicity of the El and E2 glycoproteins 
shown in this and other studies. This may be 
related to the number of copies of epitopes, e.g. 1 
/Ltg of a 25-mer E2 synthetic peptide would have 
approximately 17 more copies of a particular B-cell 
or Th-cell epitope than 1 jttg of E2 glycoprotein. 
Other factors involved with enhanced immunogenicity 
of synthetic peptides would be the nascent 
appearance of new epitopes that would not be 
affected by distal factors within the context of the 
glycoprotein, and the lack of peptides that might be 
more competitive for la. Although most of the 
peptides were able to induce good anti-peptide 
antibody, most did not induce strongly reactive 
anti-VEE virus antibody.
The tools are now available to construct an 
effective VEE virus synthetic peptide vaccine. This 
vaccine should include the following T- and B-cell 
elements: (1) AA that can associate with multiple 
MHC class I and II restriction elements; (2) B-cell
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epitopes that will induce non-neutralizing but 
protective antibody; (3) Th-cell epitopes to both 
the E2 and El glycoproteins that will activate ThB 
and Thctl respectively; and (4) Th-cell epitope(s) for 
Th cells active in providing help to conformational 
B-cell epitopes on a challenge VEE virus. Such a 
vaccine would have a wide host range, induce non­
neutralizing but partially protective antibody, and 
induce ThB and Thctl so that an appropriate protective 
anamnestic response would follow VEE virus 
challenge.
A Single AA Interchange Can Affect the 
Specificity of both the Th- and B-CELL Responses.
The Lys to Asn shift at position seven of the E2 
amino terminal E2 peptide VE2pep01 during the 
attenuation of TRD to TC-83 virus affected the 
specificity of both the Th and B-cell response.
This and the fact that various MHC restriction 
elements, and multiple Th and B cell epitopes were 
present within a single peptide defined by only 25 
AA suggest that very complex immunological events 
can occur within a very small domain and 
interpretations of derived immunological data must 
be made with care. If not properly evaluated and 
monitored, these interactive factors may actually 
enhance virus disease in a vaccine intended for 
protection (Oehen et al., 1991).
One of the primary limitations of immunological 
studies with synthetic peptides, or even entire
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structural proteins of viruses, is that the results 
derived may not accurately detail immunologic 
functions within the context of the complete virion. 
The construction of an infectious cDNA clone for VEE 
virus will enable anti-VEE virus T- and B-cell 
analyses that were not previously possible (Kinney 
et al., 1993). Such studies may include: (1) the 
effect of single or multiple AA interchanges on the 
immune response; (2 ) making changes within a domain 
to correspond to important Th and B cell 
determinants on other alphaviruses such as EEE and 
WEE; and, (3) using synthetic peptide technology in 
conjunction with the infectious VEE clone to 
accurately evaluate T and B cell epitopes, effect of 
conformation on the immune response, effect of 
peptides distal to epitopes recognized by immune 
response, and the epitopic nature of epitopes that 
will induce Thl and Th2 immune responses.
Th-Cell Response to a Recombinant VAC VEE TC-83 
Virus. This study and previous investigations with 
the TC-5A recombinant virus suggested that the 
immune response and induced protective immunity in 
various animal species was similar to that seen with 
TC-83 virus (Kinney et al., 1988a, 1988b; Monath et 
al., 1992; Bowen et al., 1992). Due to the large 
size of the VAC genome, cDNA for the 26S mRNAs of 
EEE and WEE viruses could also be inserted creating 
a trivalent vaccine expressing the structural 
glycoproteins of all three viruses.
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It is of interest to speculate as to how 
efficacious the same cDNAs might be if inserted into 
a canarypox virus which has a limited host range for 
replication and, yet, can express recombinant rabies 
proteins in mice sufficiently to induce protection 
(Taylor, J et al., 1991). Also, intranasal or oral 
routes could be considered for immunization, since 
these would induce good mucosal immunity which was a 
limiting factor following peripheral inoculation of 
the TC-5A virus in mice (Kinney et al., 1988b). 
Another interesting approach with VAC virus 
recombinants in VEE virus studies would be to 
introduce genes defining various cytokines to 
evaluate their influence on the immune response to 
VEE virus (Ramshaw et al., 1992).
Bioethical Considerations. A better 
understanding of the anatomy of the immune response 
to VEE and other alphaviruses will permit 
investigators to evaluate the protective efficacy of 
synthetic peptides, recombinant viruses and 
infectious cDNA clones without challenging animals 
with virulent viruses. The factors that will allow 
such decisions to be made include: (1 ) presence of 
neutralizing antibody; (2 ) in vitro immunological 
recall where Th cells recognize the virulent form of 
virus; (3) in vivo immunological recall to an 
altered form of the virulent virus; and (4) 
comparison of antibody reactivity profiles on a 
battery of synthetic peptides between sera taken
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from subunit immunized animals before challenge that 
were protected from virus challenge, and compared to 
sera from animals inoculated with immunogens of 
possible vaccine potential.
CONCLUSIONS
Overall, this thesis has generated much 
information about the Th-cell response induced by 
VEE virus which has important consequences for 
vaccine development. However, this is only one arm 
of the cellular immune response. In particular, the 
CTL response to VEE virus requires detailed study, 
as has been alluded to in this discussion. The 
availability of infectious cDNA clones of VEE virus 
enables a detailed study of the role of particular 
AA of the virus in immunity. Finally, a number of 
proposals have been made in this thesis about 
conformational and linear epitopes on the El and E2 
glycoproteins. Ultimately, understanding the 
interaction of the immune response with these 
glycoproteins will only come following determination 
of the three dimensional structure of these 
proteins.
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RAW DATA: Tables 29, 30 and 31 contain the CPM for
assay replicates as well as means and s.d. used for 
the SIR analysis as shown in Table 22. Tables 32, 33 
and 34 contain similar data used for the SIR analysis 
as shown in Table 27.
STATISTICAL ANALYSIS: The statistical program EPISTAT
was used to compare raw data using the Student's t test 
(two tailed). EPISTAT is a statistical package designed 
for the analysis of small data sets. The program was 
written by: Tracy L Gustafson, M.D.
1705 Gattis School Road
r~
Round Rock, Texas 78664
STATISTICAL SIGNIFICANCE: P values as shown in Tables 35
to 40 were generally derived from comparing replicates of 
three from test samples (responder Th cells + relevant 
antigen) to replicates of test samples incubated without 
relevant antigen (media). Replicates were analysed as 
independent and not paired variables. These data were, 
of course, used to calculate the original stimulation 
indices. Derivation of the SIR values is described in 
the Materials and Methods; however, due to the normalization 
of background proliferation using SIR, SIR values were never 
greater than SI and were often lower than SI.
COMMENTS: There was a strong association between an SIR of
>2.0 and a P value of <0.05 as 78 of 93 SIR values >2.0 were 
statistically significant. Several of the SIR values not 
considered to be significant were on the border. In addition, 
several SIR values <2.0 were found to be statistically 
significant (P <0.05). These results were similar to what we had 
previously observed in a study with synthetic peptides to Murray 
Valley encephalitis virus (Mathews et al., 1991). Where 
differences between SIR values >2.0 and statistical significance 
were observed, the Tables (22 and 27) and associated text have 
been appropriately modified.
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Table 35. Statistical significance of lymphoblastogenic results of
VEE synthetic peptides as evaluated in C3H mice.
Peptide
Responder 
Th cells
Stimulator
antigen SIR* p value
VE2pep02 Peptide Peptide 2.0 0.052
VE2pep05 (TC-83) Peptide Peptide 2 . 1 0.15
VE2pep05 (TC-83) Peptide TC-83 2. 6 0.007
VE2pep05 (TC-83) Peptide TRD 3.7 0 . 0 0 2
VE2pep05 (TRD) Peptide Peptide 3.8 0.007
VE2pep05 (TRD) Peptide TRD 3.2 0 . 0 0 0 2
VE2pep07 Peptide Peptide 3.8 0 . 0 1
VE2pep08 Peptide Peptide 2 . 8 0.0005
VE2pep09 Peptide Peptide 3.3 0 . 0 0 2
VE2peplO Peptide Peptide 1.8 0 . 0 2
VE2pepl9 Peptide Peptide 2.4 0.004
VE2pepll Peptide Peptide 4.0 0 . 0 1
VE2pepl2 Peptide Peptide 14.7 0.000009
VE2pepl3 Peptide Peptide 12.9 0.006
VE2pepl3 Peptide TC-83 2.4 0.09
VE2pepl4 Peptide Peptide 2 . 1 0.03
VE2pepl5 Peptide Peptide 2.9 0.04
VE2pepl6 Peptide Peptide 2. 8 0.004
VE2pepl6 TC-83 Peptide 2 . 1 0 . 1 1
VE2pepl8 Peptide Peptide 1 1 . 6 0.003
VElpep97 Peptide Peptide 4.8 0 . 0 0 0 2
VElpep97 Peptide TC-83 2.3 0.0004
VElpep97-l Peptide Peptide 6 .0 0 . 0 0 0 0 0 1
VElpepl24 Peptide Peptide 2 . 1 0 . 0 0 1
VElpep321 Peptide Peptide 2 . 0 0.008
aThe SIR values were obtained from results presented in Table 22
(pg. 210-211).
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Table 36. Statistical significance of lymphoblastogenic results of
VEE synthetic peptides as evaluated in C57BL/6 mice.
Peptide
Responder 
Th cells
Stimulator
antigen SIR" p value
VE2pep01 (TC-83) Peptide Peptide 5.1 0.007
VE2pep01 (TC-83) TC-83 Peptide 3.3 0.0007
VE2pep01 (TRD) Peptide Peptide 3.8 0.09
VE2pep01 (TRD) Peptide TC-83 1.7 0 .02
VE2pep01 (TRD) Peptide TRD 2.3 0.00003
VE2pep01 (TRD) TC-83 Peptide 2.3 0 . 0 0 2
VE2pep05 (TC-83) Peptide Peptide 4.9 0 . 0 1
VE2pep05 (TRD) Peptide Peptide 1.7 0 . 2 1
VE2pep06 Peptide Peptide 3.3 0.00005
VE2pep07 Peptide Peptide 14.0 0 . 0 0 2
VE2pepl9 Peptide Peptide 5.0 0 . 0 0 2
VE2pepl9 TC-83 Peptide 2.3 0.054
aThe SIR values were obtained from results presented in Table 22
(pg. 2 1 0 -2 1 1 ).
*
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Table 37. Statistical significance of lymphoblastogenic results of
VEE synthetic peptides as evaluated in BALB/c mice.
Peptide
Responder 
Th cells
Stimulator
antigen SIR* p value
VE2pep01 (TC-83) Peptide Peptide 5.5 0.003
VE2pep01 (TRD) Peptide Peptide 3.8 0.0007
VE2pep03 Peptide Peptide 15.1 0.004
VE2pep03 Peptide TC-83 1.9 0 . 2 1
VE2pep04 Peptide Peptide 38.7 0.0004
VE2pep04 Peptide TC-83 3.6 0 . 0 1
VE2pep05 (TC-83) Peptide Peptide 3.9 0.03
VE2pep05 (TC-83) Peptide TRD 1.7 0 . 0 2
VE2pep05 (TRD) Peptide Peptide 3.5 0 . 0 0 2
VE2pep06 Peptide Peptide 2 . 0 0 . 0 1
VE2pep07 Peptide Peptide 4.1 0.0008
VE2pep07 TC-83 Peptide 2 . 8 0 . 0 0 2
VE2pepl5 Peptide Peptide 7.2 0 . 0 1
VE2pepl6 Peptide Peptide 6.9 0 .02
VE2pepl6 TC-83 Peptide 3.3 0.04
VE2pepl7 Peptide Peptide 3.2 0.04
VElpep97 Peptide Peptide 8.3 0 . 0 0 1
aThe SIR values were obtained from results presented in Table 22 
(pg. 2 1 0 -2 1 1 ).
Table 38. Statistical significance.of lymphoblastogenic
results of the E2 amino terminal 01 and subunit peptides
in C3H mice.
Responder 
Th cells
Stimulator
antigen SIRa p value
TC-83 virus TC-83 virus 15.3 0 . 0 1
TC-83 virus TRD virus 8.1 0 . 0 1
S2 TC-83 virus 2.3 0.03
“The SIR values were obtained from results presented 
in Table 27 (pg. 234).
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Table 39. Statistical significance of lymphoblastogenic
results of the E2 amino terminal 01 and subunit peptides
in C57BL/6 mice.
Responder 
Th cells
Stimulator
antigen SIRa p value
TC-83 virus TC-83 virus 3.0 0.0006
TC-83 virus TRD virus 2 .2 0.009
TC-83 virus VE2pep01 (TC-83) 3.2 0.0007
TC-83 virus VE2pep01 (TRD) 2.3 0 . 0 0 2
TC-83 virus SI 1.9 0.0 2
TC-83 virus S3 1.8 0.06
VE2pep01 (TC-83) VE2pep01 (TC-83) 4.1 0.007
VE2pep01 (TC-83) VE2pep01 (TRD) 5.2 0.003
VE2pep01 (TC-83) Si 4.7 0.00004
VE2pep01 (TC-83) S3 2 . 6 0.03
VE2pepol (TRD) TRD virus 2.3 0.09
VE2pep01 (TRD) VE2pep01 (TC-83) 2 . 2 0.003
VE2pep01 (TRD) VE2pep01 (TRD) 3.8 0 . 0 0 0 1
VE2pep01 (TRD) SI 1.7 0.006
VE2pep01 (TRD) S2 1.6 0.006
VE2pep01 (TRD) S3 4.1 0 . 0 1
SI S3 2 . 1 0.06
S3 VE2pep01 (TC-83) 2.3 0.008
S3 VE2pep01 (TRD) 2.3 0.14
S3 SI 3.4 0.0006
S3 S3 2.3 0.06
aThe SIR values were obtained from results presented
in Table 27 (pg. 234).
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Table 40. Statistical significance of lymphoblastogenic
results of the E2 amino terminal 01 and subunit peptides
in BALB/c mice.
Responder 
Th cells
Stimulator
antigen SIR* p value
TC-83 virus TC-83 virus 6.0 0.01
TC-83 virus TRD virus 1.9 0.006
VE2pep01 (TC-83) VE2pep01 (TC-83) 3.5 0.003
VE2pep01 (TC-83) VE2pep01 (TRD) 9.4 0.00001
VE2pep01 (TC-83) SI 4.5 0.000008
VE2pep01 (TRD) VE2pep01 (TRD) 5.7 0.0007
VE2pep01 (TRD) SI 2.0 0.04
VE2pep01 (TRD) S3 2.0 0.08
SI TC-83 virus 2.0 0.07
SI VE2pep01 (TC-83) 3.9 0.007
SI VE2pep01 (TRD) 14.1 0.009
SI SI 11.3 0.0003
S2 TC-83 virus 2.7 0.0001
S2 TRD virus 1.8 0.05
S3 TC-83 virus 3.0 0.01
S3 TRD virus 3.0 0.0003
S3 VE2pep01 (TC-83) 2.7 0.0002
S3 VE2pep01 (TRD) 3.4 0.003
S3 SI 3.0 0.007
S3 S2 2.0 0.13
S3 S3 2.3 0.007
aThe SIR values were obtained from results presented in
Table 27 (pg. 234).
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